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 Benzo-fused biaryl and heterobiaryl compounds are common structural elements 
found in high value molecules such as bioactive natural products, pharmaceuticals, 
agrochemicals, conducting polymers, and organic dyes. Moreover, o-phenolic esters and 
compounds containing a naphthol moiety can serve as versatile chiral ligands in synthetic 
organic chemistry, whereas benzofuran natural products and indole alkaloids have shown an 
enormous potential as pharmacological agents. Given the predominance and diverse utility of 
benzo-fused heteroaromatics and indole alkaloids, the development of efficient 
methodologies to access these core structures has become an important goal for synthetic 
chemists. 
 Herein we describe three complementary methodologies to access benzo-fused biaryl 
and heterobiaryl compounds from cyclopropenes, alkylidene cyclopropanes and 2,3-
dihydrofuran acetals. When submitted to catalytic Lewis acid conditions, these intermediates 
underwent ring-opening cyclizations to form the corresponding functionalized arenes in good 
to high yields (up to 98%). These ring-opening cyclizations can be employed in a 
complementary manner to access a large and diverse scope of functionalized benzenoid 
compounds, with potential application in the synthesis of bioactive molecules. 
To further exploit the great potential of the ring-opening cyclizations, we were also 
interested in developing industrially-viable flow technologies toward the multi-step synthesis 
of fused-indole alkaloid frameworks. Under optimized conditions, hydropyrido[1,2-a]indoles 
were synthesized using a continuous flow tandem reactor with excellent conversions, yields 
and throughputs. This represents the first example of cyclopropanation/homo-Nazarov-type 
! xix!
cyclizations in continuous flow and carries promising results towards a multi-step continuous 
flow synthesis of hydropyrido[1,2-a]indoles with further industrial applications. 
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CHAPTER 1 
INTRODUCTION: IMPORTANCE OF BENZANNULATED (HETERO)AROMATIC 
COMPOUNDS AND RELEVANT BENZANNULATION REACTIONS 
 
1.1 Statement of Purpose 
Heterocyclic compounds, including heteroaromatics, make up for more than one-half 
of all known molecules.1 These essential scaffolds are not only present in different biological 
metabolism pathways but also exist in a large pool of natural/unnatural bioactive molecules, 
as well as commercially relevant products. Thus, the development of efficient synthetic 
methods to access heterocyclic compounds has been precedent in the literature and still 
represents a very active area of current research. More specifically, the assembly of 
polysubstituted benzo-fused (hetero)aromatics is highly important in modern organic 
chemistry due to their prevalence in natural products and materials science.1-3 
Benzannulation represents an important strategy in organic synthesis for the 
assemblage of benzo-fused polycycles.4 Here we disclose three ‘complementary’ 
intramolecular ring-opening benzannulations to access a large array of functionalized 
(hetero)aromatic scaffolds. Besides the novelty of the methodologies, these benzannulation 
reactions aim to open the synthetic door to a handful of bioactive natural products as well as 
providing different points for easy functionalization by using the same preparation methods 
to access the starting materials (hence the term ‘complementary’). Also, as part of our 
interest in providing the scientific community with industrial methods for rapid scale-up, we 
used the chemistry developed in our laboratory to establish a tandem, bicatalytic continuous 
! 2!
flow cyclopropanation/ring-opening cyclization protocol to access hydropyrido[1,2-a]indoles 
in a multi-gram scale. 
 
1.2 Heterocycles, Heteroaromatics, and Arenes 
1.2.1 Relevance 
Heterocycles comprise the basic building blocks for many biologically important 
molecules as well as other common structural elements found in bioactive natural products, 
pharmaceuticals, agrochemicals, conducting polymers, and organic dyes.1-3 Particularly, their 
role in the design of therapeutic molecules can be shown when over 80% of the top small-
molecule drugs by US retail sales in 2010 contain at least one heterocyclic fragment in their 
structures (Figure 1-1).1 
 
 
Figure 1-1. Selected top small molecule drugs in US. 
 
Functionalized aromatic heterocycles (or heteroaromatics) and other aromatic 














































For example, benzofurans3b and benzothiophenes3c have shown potential applications in 
medicinal chemistry and materials science;5 meanwhile, indole alkaloids are present in a 
large variety of bioactive natural products6 (Figure 1-2). Moreover, naphthols and o-phenolic 
esters can serve as versatile chiral ligands in synthetic organic chemistry.7 The predominance 
and diverse utility of benzo-fused (hetero)aromatics have increased the interest towards the 
development of efficient syntheses, becoming an important goal of synthetic chemists. 
 
 
Figure 1-2. Examples of bioactive benzenoid natural products. 
 
1.2.2 Relevant benzannulation reactions 
Over the past decades, functional group manipulation of aromatic precursors has been 
a common strategy to access new aromatic compounds. However, these classical methods, 
such as Friedel-Crafts alkylations and electrophilic/nucleophilic aromatic substitutions, have 
shown lack of regioselectivity besides the use of activators in excess amounts.8 To this end, 
numerous benzannulations to form benzo-fused substrates via Diels-Alder (DA), ring-closing 
metathesis (RCM), cycloaddition, and transition-metal-promoted processes have been 































R = H  Clausamine A
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classical methods due to the likely reduction of reaction steps and superior regiocontrol. 
However, many of these benzannulation reactions require air- and/or moisture- sensitive 
reaction conditions, a last oxidation step, or the use of highly functionalized precursors. Here, 
a condensed review on benzannulation reactions is presented. 
1.2.2.1 Benzannulation via Diels-Alder reaction 
The Diels-Alder (DA) cycloaddition is a well-used transformation due to its high 
regiochemistry control when reacting a substituted diene and dienophile. For this reason, the 
synthesis of several polycyclic aromatic compounds using the DA reaction has been 
reported.9 For example, Yamamoto and co-workers found that naphtyl ketone derivative 1-3 
was made when enynal [o-(alkynyl)benzaldehyde] 1-1 reacted with alkyne 1-2 in the 
presence of catalytic amounts of AuCl3. In contrast, the decarbonylated naphthalene 
derivative 1-4 was formed selectively when using catalytic Cu(OTf)2 and stoichiometric 
amounts of Brønsted acid (Scheme 1-1).10 Also, various benzannulated indane- and 
fullerene-based α-amino acid derivatives as well as benzene ring-fused annulenes have been 
synthesized using the DA approach as a key step.11 
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1.2.2.2 Benzannulation via ring-closing metathesis (RCM) 
Ring-closing metathesis (RCM) is a powerful strategy for the synthesis of simple and 
complex cyclic compounds from acyclic dienes. Thus, using Grubbs and Schrock catalysts, a 
wide variety of carbo- and heterocyclic compounds have been prepared under mild reaction 
conditions and with high functional group tolerance.12 This [2+2] 
cycloaddition/cycloreversion approach has also been extended to the preparation of aromatic 
compounds. As an example, Kotha and Mandal described a benzannulation using a double 
Claisen rearrangement followed by a one-pot RCM and DDQ oxidation sequence to form 
tetraquinone derivative 1-7 (Scheme 1-2).13 Other important scaffolds, such as phenanthrene, 
dibenzanthracene, carbazole, and indole derivatives have also been synthesized using RCM 
as a main or key step.4 
 
 
Scheme 1-2. Benzannulation via one-pot RCM/DDQ oxidation 
 
1.2.2.3 Benzannulation via Danheiser protocol 
The Danheiser benzannulation is a regiocontrolled formation of phenols in a single 
step from the combination of cyclobutenones (such as 1-8) and hetero-substituted acetylenes 
(such as 1-10). This strategy was used by Danheiser and co-workers to construct (-)-
ascochlorin (1-14), a natural product that exhibits antiviral, antibiotic and antitumour 
activities.14 The regioselectivity of this process is determined by the regiospecific [2+2] 















Scheme 1-3. Formation of phenols via the Danheiser benzannulation. 
 
A modified Danheiser benzannulation (or second generation Danheiser 
benzannulation) has also been reported. In this case, a photochemical Wolff rearrangement of 
an unsaturated α-diazo ketone 1-16 generates an aryl or vinylketene, which reacts with 
acetylene 1-15 to produce cyclobutenone 1-17 (Scheme 1-4).15a After a series of ring-opening 
and ring-closing electrocyclic reactions, phenol 1-18 is formed. Both, the first and second 
generation Danheiser benzannulations are capable of producing a range of highly substituted 
phenols, naphthalenes, benzofurans, benzothiophenes and indoles. Using this metholology, a 
series of natural products has also been synthesized.15b-d 
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R1 = Et, R2 = H,
R3 = R4 = Me, X = OMe
1-17 1-18 (46%)
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1.2.2.4 Benzannulation via Dötz protocol 
Highly functionalized aromatic rings can also be constructed using the Dötz 
benzannulation. This protocol proceeds through a [3+2+1] cycloaddition of an aromatic or 
vinylic alkoxy pentacarbonyl chromium carbene complex (1-19) with an alkyne (1-20) and 
carbon monoxide to give phenol (1-22) after exposure to air (Scheme 1-5). The 
regioselectivity is determined by the size of the substituents on the alkyne. This protocol is 
one of the most used transition-metal-promoted benzannulations for the formation of highly-
functionalized phenols16 and has also been applied to the construction of large-ring systems 
(Scheme 1-6), as shown recently by Nakata.17 
 
 
Scheme 1-5. Generation of phenols via Dötz benzannulation. 
 
 
Scheme 1-6. Generation of large-ring systems via Dötz benzannulation. 
 
1.2.2.5 Benzannulation via Lewis acid-catalyzed cyclization 
Cyclopropanes have also played a role in benzannulation reactions. Nishi and co-
workers reported the synthesis of highly substituted α-arylnaphthalenes (1-26a or 1-26b) 






























50 °C, 5 h
1-23 1-24 (50%)
! 8!
expansion, followed by an intramolecular Friedel-Crafts reaction (Scheme 1-7). The 
regioselectivity of the reaction products depends on the Lewis acid used due to the ability of 
MCl4 (M = Sn, Ti) to go through a chelation mechanism versus a non-chelated mechanism 
using TMSOTf.18 In a separate report, when 3-aryl-2,2’-dihalocyclopropanecarbonyl 
chlorides 1-27 were submitted to Lewis acid in the presence of substituted benzenes, 4-aryl-
1-naphthols 1-28 were synthesized in moderate yields (Scheme 1-8).19 
 
 
Scheme 1-7. Synthesis of α-arylnaphthalenes via Lewis-acid promoted benzannulation. 
 
 
Scheme 1-8. Synthesis of 4-aryl-1-naphthols via Lewis-acid promoted benzannulation. 
 
1.2.2.6 Other benzannulation reactions 
Benzo-fused (hetero)aromatic compounds have also been synthesized utilizing other 
benzannulation reactions such as cycloaddition tactics, base-induced rearrangements, photo-
induced cyclizations, transition-metal-promoted processes, or through other methods not 




























1-27 R1 = Me, 1-28 (52%)
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1.3 Benzannulations of Cyclopropenes, Alkylidene Cyclopropanes, and 2,3-
Dihydrofuran O,O- and N,O-Acetals: A Complementary Approach to Benzo-Fused 
(Hetero)aromatics 
As part of our ongoing efforts in studying carbo- and hetero- cycles,20 we were 
interested in developing new benzannulations to access a wide array of highly functionalized 
(hetero)aromatic benzenoid compounds. To this end, three complementary benzannulation 
procedures were developed, which allow for easy derivatization at different stages of the 
synthesis and access to different benzenoid regioisomers. These methodologies are 
considered complementary because of using similar procedures to prepare the starting 
materials and products. In the presence of Rh(II), α-diazo-β-ketoester compounds (1-29) 
were reacted with alkynes (1-30), allenes (1-33) or enol ether (or enamides) (1-35) to obtain 
the corresponding cyclopropenes (1-31), alkylidene cyclopropanes (ACPs, 1-34) or 2,3-
dihydrofuran acetals (1-36), respectively, as three different synthetic intermediates or 
building blocks (Figure 1-3). 
These building blocks were submitted to Lewis acid conditions to promote the ring-
opening/benzannulation cascade. More specifically, when submitted to catalytic In(OTf)3, 
cyclopropenes 1-31 were isomerized to form benzo-fused heteroaromatics (1-32) through a 
ring-opening Friedel-Crafts-type alkenylation, which mode of activation resulted 
mechanistically different than previously observed.20c, 21 In the case of ACPs 1-34, an 
underexplored system for the intramolecular ring-opening cyclization, a formal homo-
Nazarov-type cyclization in the presence of Yb(OTf)3 yielded fully substituted and/or 
different benzenoid regioisomers (1-32).20d Lastly, the Al(OTf)3-promoted ring-
opening/cyclization/elimination cascade of 2,3-dihydrofuran (2,3-DHF) O,O- and N,O- 
! 10!
acetals 1-36 resulted in a novel transformation to generate o-phenolic esters and different 
regioisomers of benzo-fused aromatics (1-32).22 
 
 
Figure 1-3. Complementary benzannulation protocols from cyclopropenes, alkylidene cyclopropanes and 
2,3-dihydrofuran acetals to access an array of highly functionalized benzo-fused compounds. 
 
Due to the large library of known bench stable diazo compounds and the huge 
availability of carbene-reactive π-systems, the combination of these methodologies can be 
impactful. By means, these ring-opening benzannulations can be employed in a 
complementary manner to access a large and diverse scope of functionalized benzenoid 
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Cascade of 2,3-Dihydrofuran Acetals








1.4 A Contribution to Industrial Processes: A Tandem, Bicatalytic Continuous Flow 
Cyclopropanation/Ring-Opening Cyclization 
Historically, batch processing has been the major strategy in the synthesis of complex 
molecules, especially molecules of pharmaceutical interest. In general, this approach has 
been fraught with high cost, excessive time for scale-up, and waste issues. Alternatively, 
continuous flow technology has been identified as a production vehicle since it has both 
environmental and economic advantages. Continuous flow technology offers superior mass 
and heat transfer, and lower production costs when compared with the traditional batch 
technology.23 Herein, we take advantage of continuous flow technology to conduct the multi-
step synthesis of the hydropyrido[1,2-a]indoles 1-39, a skeleton present in many naturally 
occurring indole alkaloids and pharmaceutically relevant compounds (Scheme 1-9).24 
 
 




1. a) Gomtsyan, A. Chemistry of Heterocyclic Compounds 2012, 48, 7-10; b) Han, C.; 









































2. a) Senthil Kumar, N.; Clement, J. A.; Mohanakrishnan, A. K. Tetrahedron 2009, 65, 
822; b) Li, H.; Sun, S.; Salim, T.; Bomma, S.; Grimsdale, A. C.; Lam, Y. M. J. 
Polym. Sci. Part A 2012, 50, 250.   
3. a) Rodriguez, D.; Castedo, L.; Dominguez, D.; Saa, C. Org. Lett. 2003, 15, 3119-
3121; b) Abu-Hashem, A. A.; Hussein, H. A.; Aly, A. S.; Gouda, M. A. Synthetic 
Communications, 2014, 44, 2285; c) Ming, W.; Liu, X.; Wang, L.; Liu, J.; Wang, M. 
Org. Lett. 2015, 17, 1746-1749. 
4. For reviews on benzannulations, see: a) Kotha, S.; Misra, S.; Halder, S. Tetrahedron 
2008, 64, 10775-10790; b) Rubin, M.; Sromek, A. W.; Gevorgyan, V. Synlett 2003, 
2265-2291; c) Saito, S.; Yamamoto, Y. Chem. Rev. 2000, 100, 2901-2915. 
5. a) Hsu, D.-T.; Lin, C.-H. J. Org. Chem. 2009, 74, 9180-9187; b) Kumar, N. S.; 
Mohanakrishnan, A. K. Tetrahedron 2010, 66,  5660-5670; c) Mohanakrishnan, A. 
K.; Amaladass, P.; Arul, C. J. Tetrahedron Lett. 2007, 48, 779-784. 
6. a) Bronner, S. M.; Im, G.-Y. J.; Garg N. K. in Heterocycles in Natural Product 
Synthesis (Eds.: Majumdar, K. C.; Chattopadhyay, S. K.), Wiley-VCH, Weinheim, 
Germany, 2011, pp. 221-265; b) Juwarker, H.; Suk, J.-m.; Jeong, K.-S. Top. 
Heterocycl. Chem. 2010, 24, 177-204; c) Taber, D. F.; Tirunahari, P. K. Tetrahedron 
2011, 67, 7195-7210; d) Vicente, R. Org. Biomol. Chem. 2011, 9, 6469-6480. 
7. Panda, N.; Mothkuri, R.; Pal, A.; Paital, A. Adv. Synth. Catal. 2013, 355, 2809. 
8. Smith, K.; El-Hiti, G. A. Green Chem. 2011, 13, 1579-1608. 
9. Kotha, S.; Chavan, A.; Deepti, G. ACS Comb. Sci. 2015, 17, 253-302. 
! 13!
10. a) Asao, N.; Takahashi, K.; Lee, S.; Kasahara, T.; Yamamoto, Y. J. Am. Chem. Soc. 
 2002, 124, 12650-12651; b) Asao, N.; Nogami, T.; Lee, S.; Yamamoto, Y. J. Am. 
 Chem. Soc. 2003, 125, 10921-10925.   
11. a) Kotha, S.; Ghosh, A. K. Tetrahedron 2004, 60, 10833-10841; b) Kotha, S.; 
Brahmachary, E. Bioorg. Med. Chem. Lett. 1997, 7, 2719-2722; (c) Kotha, S.; 
Ganesh, T.; Ghosh, A. Bioorg. Med. Chem. Lett. 2000, 10, 1755-1757.   
12. a) Grubbs, R. H. Tetrahedron 2004, 60, 7117-7140; b) Kotha, S.; Sreenivasachary, N. 
Indian J. Chem. 2001, 40B, 763-780; c) Schrock, R. R.; Hoveyda, A. H.  Angew. 
Chem. Int. Ed. 2003, 42, 4592-4633.   
13. a) Kotha, S.; Mandal, K. Tetrahedron Lett. 2004, 45, 2585-2589; b) Kotha, S.; Shah, 
V. R.; Mandal, K. Adv. Synth. Catal. 2007, 349, 1159-1172.   
14. Danheiser, R. L.; Takaki, K.; Cha, D. Org. Lett. 2000, 2, 3407-3410. 
15. a) Danheiser, R. L.; Brisbois, R. G.; Kowalczyk, J. J.; Millar, R. F. J. Am. Chem. Soc. 
1990, 112, 3093-3100; b) Danheiser, R. L.; Gee, S. K.; Perez, J. J. J. Am. Chem. Soc. 
1986, 108, 806-810; c) Danheisr, R. L.; Helgason, A. L. J. Am. Chem. Soc. 1994, 116, 
9471-9479; d) Danheiser, R. L.; Casebier, D. S.; Firooznia, F. J. Org. Chem. 1995, 
60, 8341-8350. 
16. Watanabe, M.; Tanaka, K.; Saikawa, Y.; Nakata, M. Tetrahedron Lett. 2007, 48, 203-
206.  
17. Tanaka, K.; Matsuyama, H.; Watanabe, M.; Fujimori, Y.; Ishibashi, K.; Ozawa, T.; 
Sato, T.; Saikawa, Y.; Nakata, M. J. Org. Chem. 2014, 79, 9922-9947. 
18. Nishii, Y.; Yoshida, T.; Tanbe, Y. Tetrahedron Lett. 1997, 38, 7195-7198. 
19. Nishii, Y.; Tanbe, Y. J. Chem. Soc., Perkin Trans. 1 1997, 477-486. 
! 14!
20. a) Phun, L. H.; Patil, D. V.; Cavitt, M. A. Org. Lett. 2011, 13, 1952; b) Patil, D. V.; 
Cavitt, M. A.; Grzybowski, P.; France, S. Chem. Comm. 2011, 47, 10278; c) Phun, L. 
H.; Aponte-Guzman, J.; France, S. Angew. Chem. Int. Ed. 2012, 51, 3198; d) Aponte-
Guzmán, J.; Taylor, J. E., Jr.; Tillman, E.; France, S. Org. Lett. 2014, 16, 3788; e) 
Shenje, R.; Williams, C. W.; Francois, K. M.; France, S. Organic Lett. 2014, 16, 
6468; f) Shenje, R.; Martin, M. C.; France, S. Angew. Chem. Int. Ed. 2014, 53, 13907; 
g) Martin, M. C.; Patil, D. V.; France, S. J. Org. Chem. 2014, 79, 3030; h) Cavitt, M. 
C.; Phun, L. H.; France, S. Chem. Soc. Rev. 2014, 43, 804. 
21. Phun, L.; Aponte-Guzmán, J.; France, S. Synlett 2012, 23, 2723. 
22. Aponte-Guzmán, J.; Phun, L.; Taylor, J. E., Jr.; Cavitt, M.; France, S. 2015, 
Manuscript in Preparation. 
23. Malet-Sanz, L.; Susanne, F. J. Med. Chem. 2012, 55, 4062. 
24. Aponte-Guzmán, J.; Shenje, R.; Huang, Y.; Woodham, W. H.; Saunders, S. R.; 
Mostaghimi, S. M.; Flack, K. R.; Pollet, P.; Eckert, C. E.; Liotta, C. L.; France, S. 
Ind. Eng. Chem. Res. 2015, 54, 9550. 
! 15!
CHAPTER 2 
BENZANNULATION VIA INDIUM-CATALYZED CYCLOISOMERIZATION OF 
CYCLOPROPENE-3,3-DICARBONYL COMPOUNDS 
 
The work about to be presented is adapted from a previous publication. My contribution on 
this project includes, but is not limited to, the synthesis and characterization of the following 
compounds: cyclopropenes 2-23a, 2-23f, and 2-23g; furans 2-24l, 2-24r, 2-24s, and 2-24t; 
and benzo-fused compounds 2-25l and 2-26g. For a better understanding on the topic, access 
the corresponding references.5,8 
 
2.1 Introduction 
Cyclopropenes, the smallest carbocycles in chemistry, are recognized for their high 
ring strain. This remarkable strain makes cyclopropenes highly reactive and interesting to 
study. Moreover, the high p-character in the carbon-carbon (C-C) bond and the strong s-
character of the carbon-hydrogen (C-H) bond in cyclopropenes allow for novel 
transformations not available to normal olefins, allenes and alkynes. For example, the 
presence of a double bond allows cyclopropenes to undergo addition transformations (in 
some cases comparable to olefins), but the liberation of the inherent ring strain enables 
cyclopropenes to undergo interesting ring-opening transformations. Other types of reactivity 
include, but are not limited to, an assortment of substitutions, cycloadditions, and metal-
promoted transformations.1 
Cyclopropene cycloisomerizations, usually promoted by transition metals, have 
dominated the literature due to their ability to construct carbo- and heterocyclic scaffolds 
! 16!
with a high degree of molecular complexity and atom economy. Important scaffolds, such as 
furans and pyrroles, have been accessed via metallocarbene species generated with Rh (II) or 
Cu(I) catalyst.2-4 However, only a few examples of protic- or Lewis acid-catalyzed 
cycloisomerizations have been reported.5 Furthermore, Lewis acid-promoted benzannulations 
via cyclopropene cycloisomerizations are rare in literature.  
In 2007, Shi and co-workers reported a novel benzannulation reaction under catalytic 
Lewis acid conditions. Using BF3!OEt, vinyl cyclopropenes 2-1 were transformed to 
naphthalene derivatives 2-2 via a Friedel-Crafts rearrangement (Scheme 2-1). The 
chemoselectivity of the reaction depends on the Lewis acid used. This was shown when the 




Scheme 2-1. Lewis acid catalyzed cyclopropene cycloisomerization. 
 
Mechanistically, it was proposed that the naphthalene formation involves the initial 
generation of HBFn(OH)4–n, a Brønsted acid, upon reaction of BF3!OEt with trace amounts of 
water (Scheme 2-2). Subsequent protonation of the vinyl cyclopropene 2-1 produces a 




























intermediate 2-5. An intramolecular Friedel–Crafts reaction with the substituted aromatic 
ring then leads to the corresponding naphthalene 2-2 after rearomatization.  
 
 
Scheme 2-2. Proposed mechanism for naphthalene formation. 
 
In the case of indenes 2-3, the authors proposed that due to the steric repulsion 
between the Lewis acid and the aromatic group, zwitterionic intermediate 2-9 is formed upon 
π-attack on the Lewis acid (Scheme 2-3). Subsequent ring opening provides cation-
delocalized intermediates 2-10 and 2-11. Finally, Friedel–Crafts trapping of the cation by one 
of the aryl rings gives the corresponding indene 3 upon rearomatization. 
  
 





































































Due to the versatility of this small-strained ring, we were interested in examining the 
intramolecular cycloisomerization of the cyclopropene-3,3-dicarbonyl compounds in the 
presence of Lewis acids. We hypothesized an activation mode analogous to cyclopropanes 2-
13, where they have been shown to behave as ‘masked’ 1,3-dipoles and homo-Michael 
acceptors 2-15 (Scheme 2-4a).7 In this scenario, we envisioned that the presence of electron-
accepting groups at the C3 position and a good electron-donating group at C1 is pivotal in 
order to polarize the C1-C3 bond upon formation of a six-membered chelate 2-17 between the 
1,3-dicarbonyl and the Lewis acid. This combination of electron-accepting and electron-
donating groups make the C1-C3 bond weaker, allowing the cyclopropene to undergo a SN1-
like ring opening of the cyclopropene under mild conditions, hence requiring a lower loading 
of the Lewis acid. In the extreme case, this polarization would lead to bond cleavage and 
formation of the 1,3-dipolar vinylic cation intermediate 2-18 (Scheme 2-4b). This is the first 
example of Lewis acid-catalyzed ring-opening cycloisomerization of cyclopropene-3,3-















































2.2 Results and Discussion 
2.2.1 Synthetic methods 
To prove our hypothesis, cyclopropene-3,3-dicarbonyl compounds were prepared 
taking advantage of either Gonzales-Bobes’9 or Davies10 Rh(II)-catalyzed cyclopropenation 
method using α-diazo-β-ketoesters 2-21 and terminal alkynes 2-22. Depending on the nature 
of the alkyne and choice of Rh catalyst,11 cyclopropenes 2-23 and/or furans 2-24 can be 
obtained from cyclopropenation reactions (Scheme 2-5). Thus, an increase of the reaction 
temperature with active rhodium present can lead to the rearrangement of cyclopropene 2-23 
to furan 2-24. Also, it is important to note that under the same Lewis acid-catalyzed reaction 
conditions, cyclopropenes 2-23 and furans 2-24 readily undergo ring-opening 
cycloisomerization to form the benzo-fused heteroaromatics 2-25. The focus of this Chapter 
is the cycloisomerizations of the cyclopropene-3,3-dicarbonyl compounds; thus, furan ring-
opening cycloisomerizations will not be discussed in details. However, the scope of the furan 
cycloisomerizations will be summarized in this Chapter. 
 
 
Scheme 2-5. Synthesis of cyclopropenes 2-23, furans 2-24 and their Lewis acid-catalyzed 
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2.2.2 Reaction optimization 
To optimize the reaction conditions, we chose to utilize the cyclopropene-3,3-
dicarbonyl compound 2-23a, derived from 2-thiophene, as the model substrate. Inspired by 
our previous report,7b we treated 2-23a with 30 mol% In(OTf)3 in CH2Cl2 at room 
temperature (Table 2-1). The reaction went to full conversion to give the desired ben- 
zo[b]thiophene 2-25a after ~2 h. When other Lewis acids were explored, such as Sc(OTf)3, a 
significant amount of furan 2-24a was observed. Cu(OTf)2 gave 2-25a after ~10 h. Others, 
such as AgOTf, Al(OTf)3 and Zn(OTf)2, were much less efficient and did not achieve 
completion even after 12 h. Other solvents were screened without improvement on the 
reaction yield. A longer reaction time (~10 h) was observed upon reducing the catalyst 
loading to 5 mol%, but the product 2-25a was obtained in 86% yield. 
 
























2.2.3 Reaction scope: Benzo-fused (hetero)aromatics from cyclopropene-3,3-dicarbonyl 
A variety of cyclopropene-3,3-dicarbonyl compounds were synthesized and 
submitted to the optimized cycloisomerization conditions to yield the corresponding benzo-
fused heteroaromatic compound (Tables 2-2 and 2-3). 
We began our study by exploring the effect of the pendant heteroaryl group. With our 
model substrate 2-23a, derived from 2-thiophene diazo 2-21a, benzothiophene 2-25a was 
obtained in 86% yield (Table 2-2, entry 1). Meanwhile, 3-thienyl cyclopropene 2-23b 
underwent cycloisomerization to furnish benzothiophene 2-25b in 48% yield (Table 2-2, 
entry 2).  2-Bromo-3-thiophene cyclopropene 2-23c provided the benzo[c]thiophene 2-25c in 
43% (Table 2-2, entry 3). Benzofurans 2-25d and 2-25e, cycloisomerized from 2-furyl  and 
3-furyl cyclopropene 2-23d and 2-23e, required higher loading of In(OTf)3 (30 mol%) and 
were formed in 26% and 46% yield, respectively (Table 2-2, entry 4 and 5). These low yields 
could be attributed to the degradation of the cyclopropenes in presence of the Lewis acid. 
Dibenzofuran 2-25f was obtained from cyclopropene 2-23f in 48% yield (Table 2-2, entry 6). 
It is important to note that the benzofuran and dibenzofuran moieties are present in a number 
of natural products. Interestingly, N-acyl-3-methylindole cyclopropene 2-23g provided 
pyrido[1,2-a]indole 2-26g in 65% yield (Table 2-2, entry 7). It is important to note that 








Table 2-2. Cycloisomerization of cyclopropene-3,3-dicarbonyls. 
 
 
Next, we synthesized cyclopropenes with different groups at C1. As expected, 
cyclopropenes substituted with a phenyl group (2-23h and 2-23i), provided their 
corresponding benzothiophene 2-25h and benzofuran 2-25i in 63 and 46% yield, respectively 
(Table 2-3, entries 1 and 2). When a cyclopropene with highly electron-withdrawing group, 
such as C6H4-4-CF3 (2-23j), as anticipated, no cycloisomerized product was obtained (Table 
2-3, entry 3). This is due to the fact that this group does not stabilize the build-up of positive 









































































a) Performed with 30 mol% in(OTf)3, b) performed with 30 mol% In(OTf)3 at 40 °C,
c) mixture of mono- and dibrominated products determined by MS, d) isolated yields
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charge at C1. It is notable that when we subjected a TMS-substituted cyclopropene (2-23k), 
derived readily from TMS-acetylene, to our cycloisomerization reaction conditions, only the 
unsubstituted product was isolated (2-25k, Table 2-3, entry 4).  This can be rationalized by 
the fact that upon the formation of the six-membered chelate, the cycloisomerization 
undergoes with an inverse regioselectivity, followed by a protiodesilylation to furnish our 
unsubstituted product. 
 
Table 2-3. Effect on the C1 substitution for the cyclopropene cycloisomerization. 
 
 
In some cases, the isolation of highly reactive cyclopropenes was not possible due to 
either decomposition or isomerization to the corresponding furan substrate. For these cases 
we decided to implement a tandem cyclopropenation/cycloisomerizations protocol. Starting 
from the diazo compound 2-21a and 4-ethynylanisole 2-22l, benzothiophene 2-25l was 
obtained in only 15% yield (Table 2-4, entry 1). Similarly, benzothiophenes 2-25m and 2-
25n were obtained in 25 and 30% yield, respectively, from their corresponding alkynes 2-











































a) Isolated yields, b) no reaction
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22m and 2-22n (Table 2-4, entries 2 and 3). These low yields could be attributed to different 
factors such as rapid decomposition of the diazo or the decomposition of the highly reactive 
cyclopropene under Lewis acid conditions. For cyclopropene 2-23n (not isolated), besides 
bearing an alkyl group, the cycloisomerization is possible due to the stabilization of the 
build-up of positive charge at C1 by the β-silyl effect. In contrast, for cyclopropene 2-23o 
(not isolated), was found that a simple alkyl group, such as n-butyl, is not donating enough to 
promote the reaction (Table 2-4, entry 4). Besides the low yield or no reactivity of these 
substrates, these results provide some useful mechanistic insights. 
 
Table 2-4. Tandem cyclopropenation/cycloisomerization protocol. 
 
 
Finally, after fully examining both the heteroaryl effect and the substituent effect, we 
then changed directions and focused on the difference of the acceptor groups. Having a 
ketone as an acceptor group will provide another chemical handle such as alkylation or 
condensations post-cycloisomerization. Taking diazo 2-27a with a ketone as the acceptor 



















































a) Isolated yield, b) no reaction
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group and subjecting it to 4-ethynylanisole 2-22l, we found that only the benzofused 
heteroaromatic product 2-28a was isolated in modest yield of 62% (Table 2-5, entry 1). We 
also wanted to apply this for the formation of benzofurans, and we found that subjecting 
diazo 2-27e, derived from 3-furan, benzofuran 2-28e was formed in 31% yield (Table 2-5, 
entry 2). Changing the acceptor group to an amide, such as the case of N-acylpyrrole diazo 2-
21p, we were able to form indolizine 2-26p in 51% yield (Table 2-5, entry 3). This strategy 
allows for us to quickly access substituted benzofused heteroaromatic products in modest 
yield and short reaction times. 
 
Table 2-5. Effects of varying the acceptor. 
 
 
2.2.4 Reaction scope: Benzo-fused (hetero)aromatics from furan substrates 
The cycloisomerizations of furans were conducted as detailed for cyclopropenes. 
Furans bearing an electron-donating group underwent cycloisomerizations under Lewis acid 
conditions in moderate to good yields (55-86% yield) to provide us with an array of benzo-
fused compounds (Tables 2-6 and 2-7). As expected, furans containing an electron poor 
aromatic group or a simple alkyl group did not undergo cycloisomerization. This furan 







































cycloisomerization still needs to be explored in more details, not only for sharing the same 
proposed reaction intermediate (1,3-dipolar vinylic cation intermediate 2-18) but because 
more substituted furan substrates can be accesed through other synthetic methods, allowing 
more diversity on the benzo-fused heteroaromatics that can be formed. 
 







































































a) Performed with 1,2-DCE at reflux, b) isolated yield, c) no reaction
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Table 2-7. Cycloisomerization of various heteroaryl furans to benzo-fused heteroaromatics. 
 
 
2.2.5 Mechanistic rationale 
We envision that two plausible reaction pathways may occur depending on the extent 
of C1-C3 bond polarization (Scheme 2-6). Complete heterolytic cleavage (pathway a) would 
afford the intermediate vinylic cationic species 2-29, which should undergo a Friedel–Crafts-
type alkenylation to give 2-31. Alternatively, a direct nucleophilic (SN1-like) ring-opening 
mechanism (pathway b) could be responsible for the product formation. Given that electron-
poor aromatics and simple alkyl groups (such as n-butyl) do not work, we believe that 
pathway a is more plausible due the importance of the substituent in stabilizing the vinylic 
















































































a) Performed with 1,2-DCE at reflux, b) isolated yield
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carbocation. Reaction enthalpies of substituted vinylic cations have established that simple 
alkyl and electron-poor aromatics result in a large-degree destabilization.12 Therefore, 
through pathway a, these substrates are predicted to be unreactive. However, the two 
pathways can seemingly converge if the intermediate 2-29 is substantially short-lived prior to 
the Friedel–Crafts reaction. 
Another mechanism insight comes from the isomerization of furan substrates 2-24. 
The fact that furans need to go through a ring-opening followed by enol isomerization to 
afford the benzo-fused compound 2-25, its indicative of a short living stabilized vinylic 




Scheme 2-6. Proposed pathways for the isomerization mechanism. 
 
2.3 Conclusion 
Through the cycloisomerization of cyclopropene-3,3-carbonyl compounds we were 
able to show a different mode of action never seen before for cyclopropenes. We believe this 




































existence of a short-living 1,3-dipolar vinylic cation intermediate was proven by using furans 
to access benzo-fused heteroaromatics. A wide array of highly substituted benzannulated 
products, such as benzofurans, dibenzofurans, benzothiophenes and indoles alkaloids, were 
formed in up to 86% yield from furan and cyclopropene cycloisomerizations using low 
Lewis acid loading. However, the furan transformation needs to be studied in more details in 




The experimental data and compounds characterization has been published and can be found 
on the cited reference.8 
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BENZANNULATION VIA ALKYLIDENE CYCLOPROPANE-1,1-KETOESTERS 
FORMAL HOMO-NAZAROV-TYPE CYCLIZATIONS 
 
The work about to be presented is adapted from a previous publication. My contribution on 
this project includes the synthesis and characterization for all the compounds reported. For a 
better understanding on the topic, access the corresponding reference.6 
 
3.1 Introduction 
Alkylidene cyclopropanes (ACPs) have been considerably studied for the past fifty 
years.1 With 12-13 kcal mol-1 greater ring strain2 than simple cyclopropanes, these small 
carbocycles possess a remarkable thermodynamic driving force that allows transformations 
that otherwise would be unfavorable. Thus, ACPs are considered useful building blocks in 
organic chemistry besides their presence in naturally occurring and biologically active 
compounds. The presence of an exocyclic double bond and a three-membered ring makes 
ACPs exploitable intermediates and appealing to the synthetic community. For this reason, 
several transformations at the double bond have been reported, including H-Nuc additions, 
hydrometalations, dimetalations, and cycloadditions. Also, ring-opening reactions in the 
presence of nucleophiles, transition metal catalysts, and acids have been of great interest.1 
Acid-promoted ring-opening pathways are one of the most attractive transformations 
and are categorized into two general patterns: heterolytic cleavage of the C1/C3 distal bond 
and heterolytic breakage of the C2/C3 proximal bond (Figure 3-1a). By altering the 
substitution pattern about the cyclopropane and by choosing appropriate metal reagents or 
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catalysts, ring-opening selectivity can be achieved. For example, distal cleavage (C1/C3 
cleavage) is preferentially observed when ACPs are substituted with acceptors on C1 of the 
cyclopropyl ring (Figure 3-1b).  
 
 
Figure 3-1. Heterolytic reactivity of alkylidene cyclopropanes (ACPs) [adapted from manuscript]6. 
 
A special attention has been paid to ACPs bearing two electron-withdrawing groups 
(EWG) on C1. Coordination of the acceptor groups with a Lewis acid induces a distal bond 
ring-opening to give a resonance stabilized 1,3-dipole that can reacts with a nucleophile 
inter- or intramolecularly. As an example, the intermolecular trapping of the carbocation was 
shown in the synthesis of tetrahydrofuran 3-3 from ACP 3-1 and p-anisaldehyde 3-2 (Scheme 
3-1).3 In contrast, different annulated scaffolds can be access from an intramolecular Friedel-
Crafts-type alkylation as shown by Wang and co-workers. This first intramolecular Friedel-
Crafts-type alkylation of ACP-1,1-diesters 3-4 initiated with a distal cleavage and ended with 






















Scheme 3-1. Intermolecular reactivity of ACP-1,1-diesters with an aldehyde. 
 
 
Scheme 3-2. Intramolecular reactivity of ACP-1,1-diesters with Lewis acids. 
 
Despite the progress with ACPs over the past years,1 the intramolecular Friedel-
Crafts-type alkylation of ACPs still underexplored. In a seminal report, Shi and co-workers 
reported the synthesis of naphthalene derivatives from ACP diaryl alcohols.5 However, no 
benzannulation reaction has been demonstrated, besides our report, using ACP-1,1-diesters.6 
For this reason, we sought to explore the compatibility of ACP-1,1-dicarbonyls within our 
mechanistic regime.7 Here, we disclose the catalytic, formal homo-Nazarov-type 


















































  (10 mol%)
     DCE, 80 °C
        Yb(OTf)3
   (10 mol%)
DCE, 80 °C
R = OMe 88%
R = Me    97%
R = Br     80%
R = Cl     72%
R = F      69%
R = H     65%
R = Br    70%
R = Cl    26%
R = F     38%
R = H     87%
R = Br    70%
R = Cl    56%
R = F     58%
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benzannulated molecules (Scheme 3-3). Mechanistically, the reaction involves Lewis acid-
catalyzed heterolytic distal cleavage of the ACP 3-10 to afford a 1,3-dipole containing a 
resonance stabilized allyl cation. Intramolecular π-attack can occur at either end of the 
delocalized allyl cation (pathways a and b) to afford a six-membered ring. Proton loss and 
alkene isomerization provide two isomeric o-phenolic ester8 derivatives A and B, whose 
ratios are dependent upon the nature of R1. In most cases, product A, arising from the 
thermodynamically preferred allyl cation, is expected to be the major product formed. 
 
 
Scheme 3-3. Formal Homo-Nazarov-Type Cyclizations of ACPs (adapted from manuscript)6. 
 
3.2 Results and Discussion 
3.2.1 Synthetic methods 
Several procedures for the synthesis of ACPs, such as rearrangements, base-promoted 
eliminations from 1-alkyl-1-halo-substituted cyclopropanes, metal-mediated formations, 
between others, has been disclosed.1a,9 However, the addition of carbenes to allenes is the 
most straightforward approach to ACPs and has found wide applications since its first 




























ways using the Rh(II)-catalyzed cyclopropanation of allenes 3-13 with α-diazo dicarbonyl 
compounds 3-12 (Scheme 3-4).11  
 
 
Scheme 3-4. Preparation of ACP-1,1-ketoesters (adapted from manuscript)6. 
 
3.2.2 Reaction optimization 
Due to the commercial availability of cyclohexyl allene 3-13a and the large amount 
of the corresponding α-diazo compound on hand, 3-furyl ACP 3-10a was chosen as the 
model system for reaction optimization. Various metal triflates were examined at 15 mol% in 
CH2Cl2 (Table 3-1). For ACP 3-10a, the reactions proved to be regioselective for the favored 
benzofuran 3-15a (>88:12 in all cases). For In(OTf)3, Sc(OTf)3, Al(OTf)3, and Ga(OTf)3, 
each reaction went to completion and afforded 3-15a in 66−74% yield (Table 3-1, entries 1-
4). In contrast, Cu(OTf)2 and Zn(OTf)2 proved to be inefficient catalysts for the trans- 
formation as low yields/conversions (<20%) of 3-15a were obtained (Table 3-1, entries 5 and 
6). 
Interestingly, although the reaction with Yb(OTf)3 did not reach completion,12 
benzofuran 3-15a was obtained in 57% yield along with ∼40% unreacted starting material 






































the product yield increased to 91% (Table 1, entry 8). Similar yield improvements were 
obtained for the other Lewis acids in CH2Cl2 at reflux (Table 3-1, entries 9-12); however, 
none of the catalysts gave higher yields than Yb(OTf)3. When the Yb(OTf)3 loading was 
changed to either 20 and 10 mol%, the yields decreased to 74% and 81%, respectively (Table 
3-1, entries 13 and 14).13 Therefore, 15 mol% Yb(OTf)3 in CH2Cl2 at reflux was chosen as 
the conditions for the examination of substrate scope.14 
 
Table 3-1. Optimization for the benzannulation of ACP-1,1-ketoesters (adapted from manuscript)6. 
 
 
3.2.3 Reaction scope 
First, the effects of the alkylidene substituents were examined (Table 3-2). When the 
alkylidene was substituted with a 4-methoxyphenyl group (as in 3-10b), the expected 
benzofuran 3-15b was formed in 53% as the only product (Table 3-2, entry 1). In contrast, 














Entrya Lewis acid Loading (mol %) Temp (˚C) Time (h) % Yieldb
1 In(OTf)3 15 rt 8 66
2 Sc(OTf)3 15 rt 8 68
3 Al(OTf)3 15 rt 20 74
4 Ga(OTf)3 15 rt 9 70
5 Cu(OTf)2 15 rt 48 20
6 Zn(OTf)2 15 rt 48 --d
7 Yb(OTf)3 15 rt
8 Yb(OTf)3 15 40 12 91
10 Sc(OTf)3 15 40 4 74
9 In(OTf)3 15 40 4 77
11 Al(OTf)3 15 40 8 80
12 Ga(OTf)3 15 40 4 77
























14 Yb(OTf)3 10 40 14 81 97:3
a) Reactions run with Lewis acid, ACP 3-10a, and 4 Å molecular sieves in CH2Cl2 (0.1 M) at the indicated 
temperature; b) Combined yield of 3-15a and 3-15a' after column chromatography; c) Product ratios 
determined by 1H NMR of isolated mixture; d) ~15% conversion observed as determined by crude 1H NMR.
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was obtained in 71% combined yield (Table 3-2, entry 2). A similar result was observed with 
ACP 3-10d (bearing a 4-chlorophenyl group) as a 53% yield of a 2.0:1 mixture of 3-15d:3-
15d′ was formed (Table 3-2, entry 3). These observations suggest activation barriers that are 
closer in energy for the intramolecular cyclization at either terminus of the allyl cation as 
compared to ACP 3-10b.15  
 
Table 3-2. Alkylidene substituent effect (adapted from manuscript)6. 
 
 
When the alkylidene substituent was an electron-withdrawing group, an alternative 
reaction outcome was observed. For instance, when the alkylidene substituent was an ester 
group, the 2,3′-bifuran derivative 3-16 was generated in 69% yield and none of the 
benzofuran product(s) were seen (Table 3-2, entry 4).16 Bifuran 3-16 arises from an 
intramolecular attack of the enolate oxygen on the alkylidene cyclopropane to form a 










































































a) Reactions run with Lewis acid (15 mol%), ACP 3-10, and 4 Å molecular sieves in CH2Cl2 (0.1 
M) at 40 °C; b) Isolated yield after column chromatography; c) Combined isolated yield of 3-15 
and 3-15'; d) Reactions performed in 1,2-dichloroethane at reflux; e) Product ratios determined 
by 1H NMR of isolated mixture.
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The regiochemical outcome suggests that the allyl cation is not formed, which is in 




Scheme 3-5. Formation of 2,3′-bifuran 3-16 (adapted from manuscript)6. 
 
In hopes of generating more functionalized/functionalizable products, ACPs bearing a 
second substituent on the alkylidene were employed (Scheme 3-6). In one example, the ACP 
(3-10f) had two methyl alkylidene substituents and gave the 4-oxo-4,7- dihydrobenzofuran 
derivative 3-18 in 63% yield (Scheme 3-6a). Compound 3-18 contains both a quaternary 
center and an alkylidene β-ketoester moiety, which can serve as a site for further reactivity.17 
In another example, the alkylidene was substituted with a methyl and a trimethylsilyl group 
(Scheme 3-6b). Benzofuran 3-19 was formed in 68% yield and presumably arises via 
formation of a silyl-stabilized18 methyl allyl cation II followed by Friedel−Crafts-type 
cyclization and subsequent aromatization. This approach offers potential for 
functionalization, as the proper choice of silyl group would allow for facile C−C19 and C−O20 




















Scheme 3-6. Effects of alkylidene disubstitution (adapted from manuscript)6. 
 
To further explore the reaction scope, the reactive π-systems on the ACP were 
modified in three different ways and the resulting reactivities were cataloged. First, other 
heteroaryl π-systems were employed under the same reaction conditions (Scheme 3-7).7a,21 
The 2-benzofuryl ACP 3-20b bearing an 4-methoxyphenyl alkylidene substituent gave the 
corresponding dibenzofuran product 3-21b in 78% yield. Similarly, 2-indolyl ACP 3-22b 
smoothly afforded carbazole 3-23b in 69% yield. 
 
 
Scheme 3-7. Formation of dibenzofuran 3-21b and carbazole 3-23b (adapted from manuscript)6. 
 
Next, the effect of employing aryl groups22 as the intramolecular π-nucleophile for 
the ring-opening cyclization was examined (Table 3-3). When the ACP was substituted with 
a 3-methoxyphenyl group as the π-donor and a 4-methoxyphenyl group on the alkylidene (as 


























































3-21b X = O; 78% yield











3-20b X = O
3-22b X = NMe
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(Table 3-3, entry 1). If the π-nucleophile is a 2-naphthyl group, two regioisomeric products 
are possible via Friedel−Crafts-type alkylation at C1 or C3 of the naphthalene. The preferred 
reactivity is expected to occur at C1 given the relative stability of the resulting Wheland 
intermediate.23 Indeed, the only observed cyclization product is phenanthrene 3-27b, 
resulting from C1 attack, in 44% yield (Table 3-3, entry 2). When 3,5-dimethoxyphenyl was 
the π-donor, regiochemical outcomes were found to be dependent upon the alkylidene 
substituent. For instance, a 4-methoxyphenyl substituent gives the favored naphthalene 
product 3-29b in 80% yield (Table 3-3, entry 3), whereas a phenyl group gives a 1.8:1 
preference for the less energetically favorable 3-29c′ over 3-29c (98% yield, Table 3-3, entry 
4). This outcome is seemingly the result of a combination of electronic and steric effects in 
the transition state for cyclization. To assess the steric influence on the regiooutcome, ACP 
3-28a (bearing the cyclohexyl alkylidene substituent) was prepared. As anticipated, the only 
observed product was naphthalene derivative 3-29a′ in 39% yield (Table 3-3, entry 5). Thus, 












Table 3-3. Aryl groups as the intramolecular π-nucleophiles (adapted from manuscript)6. 
 
 
Next, the ACP π-nucleophilic moiety was changed to alkenyl groups and evaluated 
for performance (Table 3-4).7a,21a,24 For the isopropenyl π-donor, similar reactivity trends 
were observed for ACPs bearing either a cyclohexyl (3-30a)25 or a 4-methoxyphenyl (3-30b) 
alkylidene substituent, as phenols 3-31a and 3-31b were formed in 66% and 49% yield, 
respectively (Table 3-4, entries 1 and 2). For 3-30c, bearing the phenyl group, an 
unsurprising 2.7:1 mixture of phenols 3-31c and 3-31c′ was observed in 59% yield (Table 3-
4, entry 3). With dihydropyran as the π-nucleophile, phenol 3-33b was obtained in 26% yield 
(Table 3-4, entry 4). The conformation and steric impact of the pyranyl ring are implicated in 
the decreased reaction efficiency. To examine that premise, the ACP 3-34b, containing an 
ethoxy vinyl subtituent, was prepared. Compound 3-34b, having less destabilizing steric and 












































































a) Reactions run with Lewis acid (15 mol%), ACP (3-24b, 3-26b, or 3-28a to 3-28c), and 4 Å molecular 
sieves in CH2Cl2 (0.1 M) at 40 °C; b) Isolated yield after column chromatography; c) Combined isolated 
yield of 3-29c and 3-29c'; d) Product ratios determined by 1H NMR of isolated mixture; e) Reactions 
performed in 1,2-dichloroethane at reflux.
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conformational influences, should perform more effectively. Indeed, 3-34b smoothly 
afforded phenol 3-35b in 51% yield (Table 3-4, entry 5). 
 
Table 3-4. Performance of alkenyl ketone substituents (adapted from manuscript)6. 
 
 
Finally, to understand the regioselectivity of the reaction of ACPs derived from 1,3-
disubstituted allenes, we prepared 3-30h from 3-methyl-1-(4-methoxyphenyl)allene 3-13h. 
Under the standard reaction conditions, 3-30h afforded the expected phenol 3-31h in 58% 
yield (Scheme 3-8).  
 
 





































































a) Reactions run with Lewis acid (15 mol%), ACP (3-30a to 3-30c, 3-32b, or 3-34b), and 4 Å molecular 
sieves in CH2Cl2 (0.1 M) at 40 °C; b) Isolated yield after column chromatography; c) Reactions 
performed with 30 mol% Yb(OTf)3; d) Reactions performed in 1,2-dichloroethane at reflux; e) Combined 
isolated yield of 3-31c and 3-31c'; f) Product ratios determined by 1H NMR of isolated mixture.
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Scheme 3-8. Formation of phenol 3-31h from ACP 3-30h (adapted from manuscript)6. 
 
3.2.4 ACPs acyl shift 
In some cases of 2-acylated heteroaryl ACPs (such as 3-36a and 3-38b), an acyl shift 
was observed to obtain benzothiophene 3-37a and benzofuran 3-15b in 88 and 45% yield, 
respectively (Scheme 3-9). This is a rare type of reactivity for ACPs that need to be further 
studied with computational calculations. 
 
 
Scheme 3-8. Acyl shift of 2-heteroaryl ACPs. 
 
3.3 Conclusion 
We have disclosed a Lewis acid catalyzed, formal homo-Nazarov-type cyclization of 
alkylidene-1,1-ketoesters to form functionalized arenes and heteroarenes in up to 98% yield. 
Of the two possible regioisomeric outcomes, the major product arises from intramolecular π-
attack on the most energetically favorable allylic cationic intermediate, unless steric 
constraints prevent such an attack. The choice of alkylidene substituents also affects reaction 














































nucleophiles to produces a wide array of highly substituted benzofurans, dibenzofurans, 
naphthalenes, phenanthrenes, carbazoles, and other. This is a novel reactivity for ACP-1,1-
ketoesters since no benzannulation of these substrates have been reported before. 
 
3.4 Experimental 
3.4.1 General methods 
All reactions were carried out in pre-dried glassware from the oven and any 
additional moisture was removed by flame-drying the reaction vessel under vacuum. Each 
reaction proceeded under a nitrogen atmosphere with anhydrous solvents. Tetrahydrofuran 
and diethyl ether were distilled from a sodium/benzophenone ketyl under nitrogen and stored 
in a Schlenk flask. 1,2-Dichloroethane and dichloromethane were purified by distillation 
from calcium hydride. Anhydrous acetonitrile was purchased from EMD Chemicals and used 
without further purification. Methyl- and ethyl acetate was fractionally distilled over P2O5. 
All other reagents were purchased from Acros, Sigma-Aldrich, Fluka, VWR, Merck, Alfa 
Aesar, TCI and Strem (for metal catalysts) and used without further purification. α-Diazo 
compounds 3-12a to 3-12c and 3-12g were synthesized as previously reported.26 β-ketoester 
compounds 3-11d to 3-11e were synthesized as previously reported.27 Allenes 3-13b to 3-
13d and 3-13h were synthesized as previously reported.28 
Chromatographic purification was performed as flash chromatography with Dynamic 
Adsorbents silica gel (32-65 µm) and solvents indicated as eluent with 0.1-0.5 bar pressure. 
For quantitative flash chromatography, technical grades solvents were utilized. Analytical 
thin-layer chromatography (TLC) was performed on EMD silica gel 60 F254 TLC glass 
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plates. Visualization was accomplished with UV light or iodine chamber. Each yield refers to 
an isolated, analytically-pure material. 
Infrared (IR) spectra were obtained using a Bruker alpha FTIR with an ATR 
attachment. The IR bands are characterized as weak (w), medium (m), and strong (s). Proton 
and carbon nuclear magnetic resonance spectra (1H NMR and 13C NMR) were recorded on 
Bruker 400 MHz or 500 MHz spectrometer with solvent resonances as the internal standard 
(1H NMR: CDCl3 at 7.26 ppm; 13C NMR: CDCl3 at 77.0 ppm). 1H NMR data are reported as 
follows: chemical shift (ppm), multiplicity (s = singlet, d = doublet, dd = doublet of doublets, 
dt = doublet of triplets, ddd = doublet of doublet of doublets, t = triplet, m = multiplet), 
coupling constants (Hz), and integration. Mass spectra were obtained using a VG-70SE 
instrument. Uncorrected melting points were measured with a digital melting point apparatus 
(DigiMelt MPA 160). 
 
3.4.2 Experimental procedures 
 a. Formation of α-Diazo compounds 3-12d to 3-12f 
General Diazo Transfer Procedure: To a solution of β-ketoester 3-11 (1 equiv) in CH3CN 
(0.1 M) was added triethylamine (1.2 equiv) at RT. After 5 min of vigorous stirring, tosyl 
azide (1.2 equiv) was added and the reaction was stirred for 3 h at room temperature.  At this 
point, the reaction mixture was concentrated in vacuo and purified via silica gel flash 










Methyl 2-diazo-3-(3-methoxyphenyl)-3-oxopropanoate (3-12d). The general procedure 
was followed using β-ketoester 3-11d (10.28 g, 49.37 mmol) in CH3CN (50.0 mL), 
triethylamine (5.97 g, 59.0 mmol) and tosyl azide (11.69 g, 59.3 mmol).  The reaction 
mixture was concentrated under reduced pressure and purified via column chromatography to 
afford diazo 3-12d (6.35 g, 55%) as a bright yellow oil. 1H NMR (500 MHz, CDCl3): δ 7.30 
- 7.36 (m, 1H), 7.18 - 7.22 (m, 1H), 7.15 (dd, J = 2.4, 1.5 Hz, 1H), 7.07 (ddd, J = 8.2, 2.4, 0.9 
Hz, 1H), 3.83 (s, 3H), 3.80 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 186.3, 161.4, 159.2, 
138.1, 128.9, 120.7, 118.5, 113.1, 75.6, 55.4, 52.4. IR: 3004.5 (w), 2953.5 (w), 2838.2 (w), 
2127.8 (m), 1724.9 (m), 1626.8 (m), 1579.9 (m), 1433.4 (m), 1309.6 (s), 1272.2 (s), 1115.6 
(m). HRMS (EI) m/z: [M+] calcd. for C11H10N2O4, 234.0641; found, 234.0638. 
 
!
Methyl 2-diazo-3-(naphthalen-2-yl)-3-oxopropanoate (3-12e). The general procedure was 
followed using β-ketoester 3-11e (5.22 g, 22.9 mmol) in CH3CN (45.0 mL), triethylamine 
(2.78 g, 27.5 mmol) and tosyl azide (5.41 g, 27.4 mmol).  The reaction mixture was 
concentrated under reduced pressure and purified via column chromatography to afford diazo 
3-12e (5.30 g, 91%) as a yellow solid (mp: 74-75 °C). 1H NMR (400 MHz, CDCl3): δ 8.19 
(d, J = 1.0 Hz, 1H), 7.93 (dd, J = 7.9, 1.0 Hz, 1H), 7.85 - 7.90 (m, 2H), 7.69 (dd, J = 8.5, 1.8 
Hz, 1H), 7.50 - 7.62 (m, 2H), 3.81 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ 186.5, 
161.5, 135.2, 134.2, 132.1, 129.6, 129.3, 128.1, 127.8, 127.6, 126.7, 124.6, 76.2, 52.4. IR: 
3057.5 (w), 2955.1 (w), 2131.6 (m), 1725.5 (s), 1618.8 (m), 1434.7 (m), 1308.5 (s), 1234.2 









Methyl 2-diazo-3-(3,5-dimethoxyphenyl)-3-oxopropanoate (3-12f). 
!
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Preparation of Methyl 3-(3,5-dimethoxyphenyl)-3-oxopropanoate (3-11f). To a solution of 
LHMDS (1.0 M in THF, 52.0 mL, 52.0 mmol) at -78 °C was added MeOAc (1.91 g, 25.8 
mmol) in one shot. The reaction mixture was stirred at -78 °C for 45 min prior the addition of 
3,5-dimethoxybenzoyl chloride (4.76 g, 23.7 mmol) in THF (24.0 mL). After stirring for 30 
min at -78 °C, the reaction was quenched with saturated NH4Cl, extracted with EtOAc (3x), 
dried over Na2SO4, and purified via column chromatography (15% Et2O/hexane, Rf = 0.15) 
to afford β-ketoester 3-11f (4.73 g, 84%) as an orange oil. 1H NMR (500 MHz, CDCl3) - 
keto/enol mixture (1:0.33): δ 12.47 (s, 0.33, minor), 7.04 - 7.08 (m, 2.00, major), 6.90 (d, J = 
2.4 Hz, 0.66, minor), 6.65 - 6.68 (m, 1.00, major), 6.55 (t, J = 2.4 Hz, 0.33, minor), 5.63 (s, 
0.33, minor), 3.96 (s, 2.00, major), 3.82 (s, 6.00, major), 3.81 (s, 1.98, minor), 3.79 (s, 0.99, 
minor), 3.75 (s, 3.00, major). 13C NMR (125 MHz, CDCl3): δ 192.0, 173.4, 171.3, 167.8, 
160.9, 160.8, 137.8, 135.3, 106.3, 106.0, 104.0, 103.6, 87.4, 55.6, 55.4, 52.5, 51.4, 45.8. IR: 
3088.6 (w), 3004.6 (w), 2951.2 (w), 2840.7 (w), 1740.6 (m), 1683.7 (m), 1589.2 (s), 1455.9 
(m), 1426.6 (m), 1322.0 (m), 1203.8 (s), 1151.8 (s), 1062.6 (m), 1007.4 (m). HRMS (EI) 









Preparation of 3-12f. The general diazo transfer procedure was followed using β-ketoester 3-
11f (4.06 g, 17.0 mmol) in CH3CN (34.0 mL) triethylamine (2.07 g, 20.5 mmol) and tosyl 
azide (4.03 g, 20.4 mmol).  The reaction mixture was concentrated under reduced pressure 
and purified via column chromatography to afford diazo 3-12f (3.98 g, 89%) as a yellow 
solid (mp: 100-101 °C). 1H NMR (400 MHz, CDCl3): δ 6.75 (d, J = 2.4 Hz, 2H), 6.61 (t, J = 
2.4 Hz, 1H), 3.80 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 186.1, 161.3, 160.3 (2C), 138.6, 
106.1 (2C), 104.5, 75.7, 55.5 (2C), 52.4. IR: 3003.1(w), 2954.2 (w), 2840.7 (w), 2128.6 (m), 
1723.7 (m), 1589.2 (s), 1455.4 (m), 1426.3 (m), 1304.3 (s), 1202.9 (s), 1153.9 (s). HRMS 
(EI) m/z: [M+] calcd. for C12H12N2O5, 264.0746; found, 264.0754. 
 
 b. Formation of alkylidene cyclopropanes 
General Cyclopropanation Procedure: A round bottom flask was charged with Rh2esp2 (0.1-
0.2 mol %) and CH2Cl2 (1.5-2.0 mL). After cooling the solution to 0 °C, the corresponding 
allene (1.0 equiv.) was added to the reaction vessel. A solution of the α-diazo ester (1.3-1.5 
equiv.) in CH2Cl2 (1.0 M) was added via syringe pump over 2 hrs, keeping the reaction 
mixture at 0 °C. After completion of addition, the ice bath was removed and the reaction was 
allowed to warm up to rt and stirred for 1-2 hr. After complete consumption of the diazo 
compound, the reaction was quenched with saturated aqueous thiourea and allowed to stir for 
30 minutes. The mixture was transferred to a separatory funnel and extracted with CH2Cl2 
(2x). The organic layer was washed with brine, dried with Na2SO4, concentrated, and column 





10a). The general procedure was followed using a solution of Rh2esp2 (1.3 mg, 1.7 µmol) in 
CH2Cl2 (2.0 mL), allene 3-13a (210 mg, 1.72 mmol), and diazo 3-12a (500 mg, 2.58 mmol) 
in CH2Cl2 (2.6 mL). The reaction was quenched and column chromatography (10% 
Et2O/hexane, Rf = 0.14) afforded 3-10a (287 mg, 58%) as a white solid (mp: 61-63 °C). 
Diasteromeric mixture: (2.3:1 E/Z ratio). 1H NMR (400 MHz, CDCl3): δ 8.03 (dd, J = 1.4, 
0.9 Hz, 0.43, minor), 8.00 (dd, J = 1.5, 0.8 Hz, 1.00, major), 7.42 (dd, J = 2.0, 1.5 Hz, 1.00, 
major), 7.41 (dd, J = 1.9, 1.4 Hz, 0.43, minor), 6.72 - 6.76 (m, 1.43, major + minor), 5.89 - 
5.94 (m, 1.00, major), 5.86 (dt, J = 8.3, 2.4 Hz, 0.43, minor), 3.72 (s, 1.29, minor), 3.67 (s, 
3.00, major), 2.14 - 2.34 (m, 3.86, major + minor), 2.10 (ddd, J = 8.7, 2.4, 1.0 Hz, 0.43, 
minor), 1.76 - 1.87 (m, 2.00, major), 1.56 - 1.76 (m, 5.15, major + minor), 1.06 - 1.35 (m, 
7.15, major + minor). 13C NMR (100 MHz, CDCl3): δ 187.1, 186.3, 170.4, 170.0, 147.7, 
147.3, 143.8, 143.6, 127.5, 126.6, 126.6, 126.1, 119.7, 119.7, 109.3, 109.2, 52.6, 52.6, 40.5, 
39.8, 38.2, 36.8, 32.3, 32.2, 26.0, 25.9, 25.8, 25.7, 18.1, 17.4. IR: 3145.3 (w), 2924.3 (m), 
2850.7 (m), 1725.8 (s), 1672.2 (s), 1561.0 (m), 1507.8 (m), 1389.4 (m), 1310.4 (s), 1154.6 

















in CH2Cl2 (2.0 mL), allene 3-13b (258 mg, 1.76 mmol), and diazo 3-12a (502 mg, 2.59 
mmol) in CH2Cl2 (2.6 mL). The reaction was quenched and column chromatography (25% 
Et2O/hexane, Rf = 0.24) afforded 3-10b (180 mg, 33%) as a yellow solid (mp: 71-73 °C). 1H 
NMR (500 MHz, CDCl3): δ 8.08 (dd, J = 1.5, 0.9 Hz, 1H), 7.45 - 7.47 (m, 1H), 7.42 - 7.45 
(m, 2H), 6.87 - 6.90 (m, 2H), 6.84 (t, J = 2.4 Hz, 1H), 6.79 (dd, J = 2.0, 0.9 Hz, 1H), 3.82 (s, 
3H), 3.72 (s, 3H), 2.55 (dd, J = 9.5, 2.4 Hz, 1H), 2.47 (dd, J = 9.5, 2.4 Hz, 1H). 13C NMR 
(125 MHz, CDCl3): δ 185.9, 170.1, 159.7, 147.8 (2C), 143.9, 128.7, 128.3, 126.4, 120.1, 
119.8, 114.1 (2C), 109.2, 55.3, 52.8, 36.2, 18.2. IR: 3133.38 (w), 2954.7 (w), 2838.1 (w), 
1722.3 (m), 1671.1 (m), 1510.3 (s), 1246.9 (s). HRMS (EI) m/z: [M+] calcd. for C18H16O5, 
312.0998; found, 312.1003. 
!
!
Methyl (E)-2-benzylidene-1-(furan-3-carbonyl)cyclopropane-1-carboxylate (3-10c). The 
general procedure was followed using a solution of Rh2esp2 (2.7 mg, 3.6 µmol) in CH2Cl2 
(2.0 mL), allene 3-13c (200 mg, 1.72 mmol), and diazo 3-12a (503 mg, 2.59 mmol) in 
CH2Cl2 (2.6 mL). The reaction was quenched and column chromatography (25% 
Et2O/hexane, Rf = 0.33) afforded 3-10c (166 mg, 34%) as a white solid (mp: 122-124 °C). 1H 
NMR (500 MHz, CDCl3): δ 8.08 - 8.10 (m, 1H), 7.51 (d, J = 7.3 Hz, 2H), 7.47 (t, J = 1.7 Hz, 
1H), 7.33 - 7.38 (m, 2H), 7.26 - 7.31 (m, 1H), 6.90 (t, J = 2.6 Hz, 1H), 6.80 (dd, J = 1.8, 0.6 
Hz, 1H), 3.73 (s, 3H), 2.59 (dd, J = 9.6, 2.6 Hz, 1H), 2.51 (dd, J = 9.6, 2.6 Hz, 1H). 13C 
NMR (125 MHz, CDCl3): δ 185.6, 169.9, 147.8, 144.0, 135.5 (2C), 128.6, 128.2 (2C), 127.4, 







(s), 1672.5 (s), 1560.5 (m), 1507.8 (m), 1313.2 (m), 1259.6 (s). HRMS (EI) m/z: [M+] calcd. 




(3-10d). The general procedure was followed using a solution of Rh2esp2 (2.7 mg, 3.6 µmol) 
in CH2Cl2 (2.0 mL), allene 3-13d (257 mg, 1.71 mmol), and diazo 3-12a (502 mg, 2.59 
mmol) in CH2Cl2 (2.6 mL). The reaction was quenched and column chromatography (20% 
Et2O/hexane, Rf = 0.20) afforded 3-10d (157 mg, 29%) as a yellow solid (mp: 78-80 °C). 1H 
NMR (500 MHz, CDCl3): δ 8.07 - 8.10 (m, 1H), 7.47 (t, J = 1.7 Hz, 1H), 7.41 - 7.45 (m, 
2H), 7.30 - 7.34 (m, 2H), 6.85 (t, J = 2.4 Hz, 1H), 6.79 (dd, J = 1.7, 0.6 Hz, 1H), 3.73 (s, 3H), 
2.56 (dd, J = 9.8, 2.4 Hz, 1H), 2.48 (dd, J = 9.8, 2.4 Hz, 1H). 13C NMR (125 MHz, CDCl3): 
δ 185.3, 169.8, 147.9, 144.1, 134.1, 134.0, 128.9 (2C), 128.6 (2C), 126.4, 122.7, 119.5, 
109.1, 52.9, 36.1, 18.0. IR: 3138.6 (w), 2953.3 (w), 1725.4 (s), 1672.5 (s), 1491.9 (m), 





carboxylate (3-10e). The general procedure using a solution of Rh2esp2 (1.3 mg, 1.7 µmol) 












mmol) in CH2Cl2 (2.6 mL). The reaction was quenched and column chromatography (20% 
Et2O/hexane, Rf = 0.17) afforded 3-10e (83.9 mg, 17%) as a yellow oil. 1H NMR (500 MHz, 
CDCl3): δ 8.24 (dd, J = 1.5, 0.6 Hz, 1H), 7.40 - 7.43 (m, 1H), 6.82 (dd, J = 1.8, 0.6 Hz, 1H), 
6.30 (t, J = 2.3 Hz, 1H), 4.18 (qd, J = 7.2, 1.2 Hz, 2H), 3.73 (s, 3H), 2.47 (dd, J = 10.7, 2.3 
Hz, 1H), 2.28 (dd, J = 10.7, 2.3 Hz, 1H), 1.23 (t, J = 7.2 Hz, 3H). 13C NMR (125 MHz, 
CDCl3): δ 184.0, 168.6, 164.3, 149.2, 143.4, 138.9, 126.0, 112.2, 109.5, 60.8, 52.9, 38.3, 
16.3, 14.1. IR: 3133.9 (w), 2984.0 (w), 2957.5 (w), 1726.8 (s), 1663.5 (m), 1436.1 (m), 
1369.6 (m), 1330.2 (m), 1278.4 (m), 1180.0 (s). HRMS (EI) m/z: [M+] calcd. for C14H14O6, 
278.0790; found, 278.0793. 
 
!
Methyl 1-(furan-3-carbonyl)-2-(propan-2-ylidene)cyclopropane-1-carboxylate (3-10f). 
The general procedure was followed using a solution of Rh2esp2 (1.4 mg, 1.8 µmol) in 
CH2Cl2 (2.0 mL), allene 3-13f (118 mg, 1.73 mmol), and diazo 3-12a (508 mg, 2.62 mmol) 
in CH2Cl2 (2.6 mL). The reaction was quenched and column chromatography (15% 
Et2O/hexane, Rf = 0.26) afforded 3-10f (239 mg, 59%) as a colorless oil. 1H NMR (500 
MHz, CDCl3): δ 7.98 (s, 1H), 7.41 (t, J = 1.7 Hz, 1H), 6.73 - 6.76 (m, 1H), 3.72 (s, 3H), 2.20 
- 2.27 (m, 1H), 2.06 - 2.12 (m, 1H), 1.90 - 1.92 (m, 3H), 1.88 (t, J = 2.0 Hz, 3H). 13C NMR 
(125 MHz, CDCl3): δ 187.7, 170.2, 147.2, 143.6, 126.3, 126.2, 116.5, 109.3, 52.6, 39.0, 22.4, 
21.9, 18.6. IR: 3136.3 (w), 2978.4 (w), 2952.7 (w), 2914.5 (w), 2861.0 (w), 1723.7 (s), 
1670.1 (s), 1560.6 (m), 1507.3 (m), 1436.1 (m), 1273.2 (s), 1161.3 (s), 1088.6 (m). HRMS 











carboxylate (3-10g). The general procedure was followed using a solution of Rh2esp2 (1.5 
mg, 2.0 µmol) in CH2Cl2 (2.0 mL), allene 3-13g (220 mg, 1.74 mmol), and diazo 3-12a (512 
mg, 2.64 mmol) in CH2Cl2 (2.6 mL). The reaction was quenched and column 
chromatography (15% Et2O/hexane, Rf = 0.32) afforded 3-10g (279 mg, 55%) as a colorless 
oil. 1H NMR (500 MHz, CDCl3): δ 8.00 (dd, J = 1.5, 0.9 Hz, 1H), 7.40 - 7.41 (m, 1H), 6.75 
(dd, J = 2.0, 0.9 Hz, 1H), 3.72 (s, 3H), 2.35 (dq, J = 9.0, 2.2 Hz, 1H), 2.25 (dq, J = 9.0, 2.2 
Hz, 1H), 1.91 (t, J = 2.2 Hz, 3H), 0.15 (s, 9H). 13C NMR (125 MHz, CDCl3): δ 187.4, 169.9, 
147.2, 143.6, 128.8, 127.9, 126.3, 109.4, 52.6, 37.5, 19.6, 18.9, -2.0 (3C). IR: 3153.9 (w), 
2954.1 (w), 2897.8 (w), 2853.9 (w), 1725.6 (m), 1660.4 (m), 1507.8 (m), 1435.2 (m), 1386.5 
(m), 1263.1 (m), 1192.9 (m), 1083.1 (m), 748.0 (s). HRMS (EI) m/z: [M+] calcd. for 
C15H20O4Si, 292.1131; found, 292.1140. 
 
!
Diethyl 2-(cyclohexylmethylene)cyclopropane-1,1-dicarboxylate (3-14a). According to 
the general cyclopropanation procedure, to a solution of Rh2esp2 (2.7 mg, 3.6 µmol) in 
CH2Cl2 (2.0 mL) at 0 °C was added allene 3-13a (219 mg, 1.79 mmol) followed by the 
addition of diazo 3-12g (503 mg, 2.70 mmol) in CH2Cl2 (2.7 mL) over 2 hrs via syringe 














0.39) afforded 3-14a (256 mg, 51%) as a colorless oil. 1H NMR (500 MHz, CDCl3) - 
Diasteromeric mixture (E/Z 5.3:1.0): δ 5.93 - 5.99 (m, 1.00, major), 5.76 - 5.81 (m, 0.19, 
minor), 4.14 - 4.21 (m, 4.76, major + minor), 2.18 - 2.27 (m, 1.19, major + minor), 2.16 (dd, 
J = 2.7, 1.8 Hz, 2.00, major), 2.11 (dd, J = 2.3, 1.1 Hz, 0.38, minor), 1.77 - 1.88 (m, 2.00, 
major), 1.60 - 1.76 (m, 3.95, major + minor), 1.13 - 1.33 ppm (m, 13.09, major + minor). 13C 
NMR (125 MHz, CDCl3): δ 168.3, 168.3, 126.3, 126.0, 120.1, 119.9, 61.4, 40.5, 39.6, 32.2, 
32.2, 30.9, 26.1, 26.0, 25.9, 25.8, 18.3, 17.6, 14.1, 14.0. IR: 2980.0 (w), 2931.0 (m), 2854.2 
(w), 1728.4 (s), 1447.3 (m), 1368.7 (m), 1251.7 (s), 1095.6 (s). HRMS (EI) m/z: [M+] calcd. 
for C16H24O4, 280.1675; found, 280.1668. 
 
!
Dimethyl (E)-2-(4-methoxybenzylidene)cyclopropane-1,1-dicarboxylate (3-14b). The 
general cyclopropanation procedure was followed using a solution of Rh2esp2 (3.3 mg, 4.4 
µmol) in CH2Cl2 (2.0 mL), allene 3-13b (308 mg, 2.11 mmol), and diazo 3-12c (507 mg, 
3.21 mmol) in CH2Cl2 (3.2 mL). The reaction was quenched and column chromatography 
(20% Et2O/hexane, Rf = 0.10) afforded 3-14b (447 mg, 77%) as a white solid (mp: 95-96 
°C). 1H NMR (500 MHz, CDCl3): δ 7.42 - 7.46 (m, 2H), 6.87 - 6.91 (m, 3H), 3.82 (s, 3H), 
3.75 (s, 6H), 2.47 (d, J = 2.7 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 168.4 (2C), 159.6, 
128.7 (2C), 128.4, 120.1, 119.8, 114.1 (2C), 55.3, 52.8 (2C), 30.1, 19.3. IR: 3000.9 (w), 
2954.5 (w), 2840.1 (w), 1730.5 (s), 1606.1 (m), 1512.7 (m), 1435.8 (m), 1249.6 (s), 1103.6 









Dimethyl (E)-2-benzylidenecyclopropane-1,1-dicarboxylate (3-14c). The general 
cyclopropanation procedure was followed using a solution of Rh2esp2 (3.3 mg, 4.4 µmol) in 
CH2Cl2 (2.0 mL), allene 3-13c (245 mg, 2.11 mmol), and diazo 3-12c (509 mg, 3.22 mmol) 
in CH2Cl2 (3.2 mL). The reaction was quenched and column chromatography (20% 
Et2O/hexane, Rf = 0.24) afforded 3-14c (425 mg, 82%) as a light yellow oil. 1H NMR (500 
MHz, CDCl3): δ 7.50 - 7.53 (m, 2H), 7.34 - 7.39 (m, 2H), 7.26 - 7.31 (m, 1H), 6.94 (t, J = 2.7 
Hz, 1H), 3.76 (s, 6H), 2.51 (d, J = 2.7 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 168.2 (2C), 
135.5, 128.6 (2C), 128.2, 127.5 (2C), 122.4, 120.3, 52.8 (2C), 30.0, 19.3. IR: 3009.1 (w), 
2953.8 (w), 1730.9 (s), 1436.0 (m), 1255.1 (m), 1104.8 (m). HRMS (EI) m/z: [M+] calcd. for 
C14H14O4, 246.0892; found, 246.0898. 
 
!
Diethyl (E)-2-(4-methoxybenzylidene)-3-methylcyclopropane-1,1-dicarboxylate (3-14h). 
According to the general cyclopropanation procedure, to a solution of Rh2esp2 (3.0 mg, 4.0 
µmol) in CH2Cl2 (2.0 mL) at 0 °C was added racemic allene 3-13h (283 mg, 1.77 mmol) 
followed by the addition of diazo 3-12g (506 mg, 2.72 mmol) in CH2Cl2 (2.7 mL) over 2 hrs 
via syringe pump. The reaction was quenched and column chromatography (10% 
Et2O/hexane, Rf = 0.09) afforded 3-14h (423 mg, 75%) as a yellow oil. 1H NMR (500 MHz, 
CDCl3): δ 7.34 - 7.39 (m, 2H), 6.87 - 6.91 (m, 2H), 6.86 (d, J = 2.4 Hz, 1H), 4.15 - 4.30 (m, 













(m, 6H). 13C NMR (125 MHz, CDCl3): δ 168.6 (2C), 166.8, 159.4, 128.7 (2C), 125.7, 120.1, 
114.1 (2C), 61.7, 61.4, 55.3, 35.9, 25.5, 19.7, 14.0 (2C). IR: 2981.5 (w), 2935.3 (w), 2837.5 
(w), 1831.1 (m), 1720.7 (s), 1606.2 (m), 1512.3 (m), 1242.8 (s), 1098.3 (m), 1021.9 (m). 




carboxylate (3-20b). The general procedure was followed using a solution of Rh2esp2 (2.2 
mg, 2.9 µmol) in CH2Cl2 (2.0 mL), allene 3-13b (199 mg, 1.36 mmol), and diazo 3-12b (498 
mg, 2.04 mmol) in CH2Cl2 (2.0 mL). The reaction was quenched and column 
chromatography (20% EtOAc/hexane, Rf = 0.31) afforded 3-20b (400 mg, 81%) as a yellow 
oil. 1H NMR (500 MHz, CDCl3): δ 7.75 (d, J = 7.9 Hz, 1H), 7.63 (dd, J = 8.5, 0.9 Hz, 1H), 
7.60 (d, J = 0.9 Hz, 1H), 7.51 (ddd, J = 8.5, 7.9, 0.9 Hz, 1H), 7.42 - 7.48 (m, 2H), 7.31 - 7.38 
(m, 1H), 6.98 (t, J = 2.6 Hz, 1H), 6.86 - 6.90 (m, 2H), 3.81 (s, 3H), 3.71 (s, 3H), 2.65 (dd, J = 
9.5, 2.6 Hz, 1H), 2.52 (dd, J = 9.5, 2.6 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 182.0, 
170.1, 159.7, 155.8, 152.2, 128.8 (2C), 128.4 (2C), 127.1, 124.0, 123.4, 120.6, 119.7, 114.1 
(2C), 113.8, 112.5, 55.3, 52.8, 35.0, 18.0. IR: 3057.1 (w), 3005.7 (w), 2952.7 (w), 2837.6 
(w), 1792.7 (m), 1723.2 (m), 1605.8 (m), 1511.1 (m), 1435.5 (m), 1247.4 (s), 1109.6 (m). 


















1-carboxylate (3-22b): To a solution of N-methylindole (143 mg, 1.09 mmol) in Et2O (4.5 
mL) at 0 °C was added n-BuLi (2.5 M in hexane, 0.43 mL, 1.1 mmol) and stirred for 15 min 
at 0 °C prior refluxing for 3 hrs. The reaction mixture was then cooled to -78 °C and a 
solution of cyclopropane 3-14b (151 mg, 0.547 mmol) in THF (2.3 mL) was added in one 
shot and stirred for 10 min. At this point, the reaction was quenched with saturated NH4Cl, 
extracted with EtOAc (2x), dried over Na2SO4, and purified via column chromatography 
(20% EtOAc/hexane, Rf = 0.30) to afford 3-22b (137 mg, 67%) as a yellow solid (mp: 135-
137 °C). 1H NMR (500 MHz, CDCl3): δ 7.76 (d, J = 7.9 Hz, 1H), 7.46 (d, J = 8.9 Hz, 2H), 
7.40 - 7.42 (m, 2H), 7.38 (s, 1H), 7.19 (dt, J = 8.2, 4.0 Hz, 1H), 6.94 (t, J = 2.6 Hz, 1H), 6.88 
(d, J = 8.9 Hz, 2H), 4.09 (s, 3H), 3.82 (s, 3H), 3.69 (s, 3H), 2.60 (dd, J = 9.3, 2.6 Hz, 1H), 
2.48 (dd, J = 9.3, 2.6 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 184.3, 170.8, 159.5, 140.2, 
134.0, 128.7 (2C), 128.6, 126.2, 126.0, 123.2, 120.9, 120.3, 120.0, 114.0 (2C), 112.9, 110.4, 
55.3, 52.8, 36.0, 32.1, 18.1. IR: 2949.8 (w), 1725.8 (m), 1655.3 (m), 1606.4 (w), 1511.8 (s), 





carboxylate (3-24b). The general procedure was followed using a solution of Rh2esp2 (2.2 
mg, 2.9 µmol) in CH2Cl2 (2.0 mL), allene 3-13b (210 mg, 1.44 mmol), and diazo 3-12d (506 








chromatography (20% Et2O/hexane, Rf = 0.13) afforded 3-24b (322 mg, 63%) as a light 
yellow oil. 1H NMR (500 MHz, CDCl3): δ 7.58 (dq, J = 7.6, 0.8 Hz, 1H), 7.53 (dd, J = 2.6, 
1.7 Hz, 1H), 7.41 - 7.47 (m, 3H), 7.14 (ddd, J = 8.2, 2.6, 0.8 Hz, 1H), 6.86 - 6.91 (m, 3H), 
3.87 (s, 3H), 3.81 (s, 3H), 3.65 (s, 3H), 2.62 (dd, J = 9.5, 2.4 Hz, 1H), 2.47 (dd, J = 9.5, 2.4 
Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 191.0, 170.7, 159.9, 159.6, 137.3, 129.6 (2C), 
128.7, 128.5, 121.7, 120.3, 120.0, 119.8, 114.1 (2C), 113.0, 55.5, 55.3, 52.7, 35.0, 18.2. IR: 
3003.5 (w), 2954.1 (w), 2837.2 (w), 1792.1 (m), 1723.5 (m), 1604.5 (m), 1511.7 (m), 1249.1 




26b). The general procedure was followed using a solution of Rh2esp2 (1.4 mg, 1.8 µmol) in 
CH2Cl2 (1.5 mL), allene 3-13b (132 mg, 0.903 mmol), and diazo 3-12e (311 mg, 1.22 mmol) 
in CH2Cl2 (1.7 mL). The reaction was quenched and column chromatography (20% 
Et2O/hexane, Rf = 0.14) afforded 3-26b (203 mg, 60%) as a light yellow solid (mp: 95-97 
°C). 1H NMR (500 MHz, CDCl3): δ 8.54 (s, 1H), 8.06 (dd, J = 8.5, 1.8 Hz, 1H), 8.03 (d, J = 
7.9 Hz, 1H), 7.95 (d, J = 8.5 Hz, 1H), 7.91 (d, J = 7.9 Hz, 1H), 7.61 - 7.66 (m, 1H), 7.56 - 
7.61 (m, 1H), 7.46 (d, J = 8.9 Hz, 2H), 6.94 (t, J = 2.6 Hz, 1H), 6.88 (d, J = 8.9 Hz, 2H), 3.81 
(s, 3H), 3.65 (s, 3H), 2.68 (dd, J = 9.5, 2.6 Hz, 1H), 2.55 (dd, J = 9.5, 2.6 Hz, 1H). 13C NMR 
(125 MHz, CDCl3): δ 191.1, 170.8, 159.6, 135.7, 133.4, 132.6, 130.8, 129.7, 128.7 (2C), 






3058.5 (w), 3001.0 (w), 2953.4 (w), 2837.0 (w), 1790.0 (m), 1724.0 (m), 1511.4 (m), 1249.1 




carboxylate (3-28a). The general procedure was followed using a solution of Rh2esp2 (1.0 
mg, 1.3 µmol) in CH2Cl2 (2.0 mL), allene 3-13a (160 mg, 1.31 mmol), and diazo 3-12f (503 
mg, 1.90 mmol) in CH2Cl2 (1.9 mL). The reaction was quenched and column 
chromatography (20% Et2O/hexane, Rf = 0.30) afforded 3-28a (342 mg, 73%) as a light 
yellow oil. 1H NMR (500 MHz, CDCl3): δ 7.06 (d, J = 2.1 Hz, 2H), 6.65 (t, J = 2.3 Hz, 1H), 
5.94 - 5.98 (m, 1H), 3.83 (s, 6H), 3.62 (s, 3H), 2.33 - 2.37 (m, 1H), 2.20 - 2.28 (m, 1H), 2.15 
- 2.19 (m, 1H), 1.77 - 1.87 (m, 2H), 1.68 - 1.76 (m, 2H), 1.60 - 1.68 (m, 1H), 1.12 - 1.34 (m, 
5H). 13C NMR (125 MHz, CDCl3): δ 191.5, 170.8, 160.8 (2C), 138.1, 126.8, 119.8, 106.7 
(2C), 105.4, 55.6 (2C), 52.5, 39.9, 35.7, 32.2 (2C), 26.1, 25.9 (2C), 17.4. IR: 2923.7 (m), 
2849.3 (w), 1726.3 (m), 1680.9 (m), 1591.2 (m), 1426.6 (m), 1319.1 (m), 1155.1 (s). HRMS 




carboxylate (3-28b). The general procedure was followed using a solution of Rh2esp2 (1.5 














mg, 1.15 mmol) in CH2Cl2 (1.7 mL) over 2 hrs via syringe pump. The reaction was quenched 
and column chromatography (35% Et2O/hexane, Rf = 0.21) afforded 3-28b (130 mg, 39%) as 
a yellow oil. 1H NMR (500 MHz, CDCl3): δ 7.45 (d, J = 8.5 Hz, 2H), 7.14 (d, J = 2.1 Hz, 
2H), 6.86 - 6.91 (m, 3H), 6.68 (t, J = 2.6 Hz, 1H), 3.85 (s, 6H), 3.81 (s, 3H), 3.66 (s, 3H), 
2.60 (dd, J = 9.3, 2.6 Hz, 1H), 2.46 (dd, J = 9.3, 2.6 Hz, 1H). 13C NMR (125 MHz, CDCl3): 
δ 190.9, 170.5, 160.9 (2C), 159.6, 137.9 (2C), 128.7, 128.4, 120.3, 119.9, 114.0 (2C), 106.8 
(2C), 105.5, 55.6 (2C), 55.3, 52.7, 35.0, 18.2. IR: 3003.1 (w), 2953.5 (w), 2837.8 (w), 
1723.4 (m), 1679.6 (m), 1591.6 (m), 1511.4 (m), 1426.3 (m), 1298.7 (m), 1247.9 (s), 1155.2 
(s). HRMS (EI) m/z: [M+] calcd. for C22H22O6, 382.1416; found, 382.1412. 
!
!
Methyl (E)-2-benzylidene-1-(3,5-dimethoxybenzoyl)cyclopropane-1-carboxylate (3-28c). 
The general procedure was followed using a solution of Rh2esp2 (1.8 mg, 2.4 µmol) in 
CH2Cl2 (2.0 mL), allene 3-13c (91.6 mg, 0.786 mmol), and diazo 3-12f (304 mg, 1.15 mmol) 
in CH2Cl2 (1.2 mL). The reaction was quenched and column chromatography (20% 
Et2O/hexane, Rf = 0.17) afforded 3-28c (194 mg, 70%) as a light yellow oil. 1H NMR (500 
MHz, CDCl3): δ 7.49 - 7.54 (m, 2H), 7.32 - 7.38 (m, 2H), 7.25 - 7.29 (m, 1H), 7.15 (d, J = 
2.1 Hz, 2H), 6.94 (t, J = 2.7 Hz, 1H), 6.69 (t, J = 2.3 Hz, 1H), 3.86 (s, 6H), 3.67 (s, 3H), 2.64 
(dd, J = 9.5, 2.7 Hz, 1H), 2.50 (dd, J = 9.5, 2.7 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 
190.7, 170.4, 160.9 (2C), 137.8, 135.6, 128.6 (2C), 128.1, 127.4 (2C), 122.2, 120.9, 106.8 








1681.1 (m), 1591.7 (m), 1454.4 (m), 1427.1 (m), 1319.9 (m), 1155.8 (m). HRMS (EI) m/z: 
[M+] calcd. for C21H20O5, 352.1311; found, 352.1299. 
 
!
Ethyl (E)-2-(cyclohexylmethylene)-1-methacryloylcyclopropane-1-carboxylate (30a). To 
a solution of cyclopropane 3-14a (109 mg, 0.389 mmol) in THF (1.9 mL) at -78 °C was 
added isoprenylmagnesium bromide (0.5 M in THF, 0.93 mL, 0.47 mmol). After stirring for 
90 min at -78 °C, the reaction was quenched with saturated NH4Cl, extracted with EtOAc 
(2x), dried over Na2SO4, and purified via column chromatography (10% Et2O/hexane, Rf = 
0.27) to afford 3-30a (90.5 mg, 84%) as a colorless oil. 1H NMR (500 MHz, CDCl3): δ 5.89 
- 5.92 (m, 1H), 5.83 - 5.86 (m, 1H), 5.82 (dd, J = 1.5, 0.6 Hz, 1H), 4.06 - 4.24 (m, 2H), 2.17 - 
2.26 (m, 2H), 2.02 - 2.07 (m, 1H), 1.93 (dd, J = 1.5, 0.9 Hz, 3H), 1.77 - 1.85 (m, 2H), 1.68 - 
1.75 (m, 2H), 1.60 - 1.67 (m, 1H), 1.23 - 1.34 (m, 3H), 1.12 - 1.23 (m, 5H). 13C NMR (125 
MHz, CDCl3): δ 193.9, 170.4, 143.9, 126.2, 125.5, 120.0, 61.3, 39.7, 35.3, 32.3 (2C), 26.1, 
25.9 (2C), 17.7, 17.2, 13.9. IR: 2978.4 (w), 2924.4 (m), 2851.4 (m), 1721.0 (s), 1678.5 (s), 



















was added isoprenylmagnesium bromide (0.5 M in THF, 0.87 mL, 0.44 mmol). After stirring 
for 1 hr at -78 °C, the reaction was quenched with saturated NH4Cl, extracted with EtOAc 
(2x), dried over Na2SO4, and purified via column chromatography (20% Et2O/hexane, Rf = 
0.18) to afford 3-30b (82.4 mg, 79%) as a light yellow oil. 1H NMR (500 MHz, CDCl3): δ 
7.41 - 7.46 (m, 2H), 6.86 - 6.91 (m, 2H), 6.77 (t, J = 2.6 Hz, 1H), 6.03 - 6.05 (m, 1H), 5.92 - 
5.94 (m, 1H), 3.82 (s, 3H), 3.70 (s, 3H), 2.48 (dd, J = 9.3, 2.6 Hz, 1H), 2.34 (dd, J = 9.3, 2.6 
Hz, 1H), 1.96 (dd, J = 1.5, 0.9 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 193.0, 170.7, 159.6, 
143.7, 128.6 (2C), 128.5, 126.2, 120.1, 119.9, 114.1 (2C), 55.3, 52.6, 34.4, 18.0, 17.7. IR: 
2952.9 (w), 2839.0 (w), 1723.7 (m), 1605.5 (m), 1511.7 (m), 1247.4 (s), 1173.78 (m), 1030.9 
(m). HRMS (EI) m/z: [M+] calcd. for C17H18O5, 286.1205; found, 286.1197. 
 
!
Methyl (E)-2-benzylidene-1-methacryloylcyclopropane-1-carboxylate (3-30c). To a 
solution of cyclopropane 3-14c (198 mg, 0.804 mmol) in THF (4.0 mL) at -78 °C was added 
isoprenylmagnesium bromide (0.5 M in THF, 2.0 mL, 1.0 mmol). After stirring for 1 hr at -
78 °C, the reaction was quenched with saturated NH4Cl, extracted with EtOAc (2x), dried 
over Na2SO4, and purified via column chromatography (20% Et2O/hexane, Rf = 0.30) to 
afford 3-30c (154 mg, 75%) as a colorless oil. 1H NMR (500 MHz, CDCl3): δ 7.50 (d, J = 
7.6 Hz, 2H), 7.35 (t, J = 7.6 Hz, 2H), 7.28 (d, J = 7.6 Hz, 1H), 6.83 (t, J = 2.7 Hz, 1H), 6.06 
(s, 1H), 5.93 - 5.96 (s, 1H), 3.71 (s, 3H), 2.51 (dd, J = 9.5, 2.7 Hz, 1H), 2.38 (dd, J = 9.5, 2.7 
Hz, 1H), 1.96 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 192.7, 170.5, 143.6, 135.7, 128.6 












carboxylate (3-30h). To a solution of cyclopropane 3-14h (154 mg, 0.484 mmol) in THF 
(2.4 mL) at -78 °C was added isoprenylmagnesium bromide (0.5 M in THF, 1.1 mL, 0.55 
mmol). After stirring for 1 hr at -78 °C, the reaction was quenched with saturated NH4Cl, 
extracted with EtOAc (2x), dried over Na2SO4, and purified via column chromatography 
(15% Et2O/hexane, Rf = 0.23) to afford 3-30h (70.7 mg, 47%) as a yellow oil. Diasteromeric 
mixture: (2:1 E/Z ratio). 1H NMR (500 MHz, CDCl3): δ 7.32 - 7.39 (m, 3.00, major + 
minor), 6.86 - 6.91 (m, 3.50, major + minor), 6.69 (d, J = 2.4 Hz, 1.00, major), 6.03 (s, 1.00, 
major), 5.96 (s, 0.50, minor), 5.84 - 5.88 (m, 1.50, major + minor), 4.11 - 4.23 (m, 3.00, 
major + minor), 3.81 (s, 4.50, major + minor), 2.94 - 3.05 (m, 1.50, major + minor), 1.92 - 
1.97 (m, 4.50, major + minor), 1.37 - 1.41 (m, 3.00, major), 1.18 - 1.25 (m, 6.00, major + 
minor). 13C NMR (125 MHz, CDCl3): δ 194.2, 193.1, 169.7, 168.7, 159.4, 159.3, 145.5, 
144.3, 128.8, 128.7, 128.6, 125.9, 125.6, 125.3, 125.0, 120.6, 119.9, 114.1, 114.0, 61.6, 61.4, 
55.3, 40.8, 38.9, 26.0, 23.0, 17.8, 17.6, 14.2, 14.0, 12.3, 11.1. IR: 2964.07 (w), 2931.5 (w), 
2838.4 (w), 1726.5 (m), 1675.8 (m), 1511.8 (m), 1452.4 (m), 1246.5 (s), 1028.8 (m). HRMS 













methoxybenzylidene)cyclopropane-1-carboxylate (3-32b). To a solution of 3,4-
dihydropyran (163 mg, 1.94 mmol) in THF (5.0 mL) at -78 °C was added t-BuLi (1.7 M in 
pentane, 1.1 mL, 1.9 mmol). The reaction mixture was then warmed up to 0 °C, stirred for 30 
min, and then cooled to -78 °C prior addition of cyclopropane 3-14b (149 mg, 0.539 mmol) 
in THF (2.2 mL). After stirring for 20 min at -78 °C, the reaction was quenched with 
saturated NH4Cl, extracted with EtOAc (2x), dried over Na2SO4, and purified via column 
chromatography (20% EtOAc/hexane, Rf = 0.21) to afford 3-32b (112 mg, 63%) as a yellow 
oil. 1H NMR (500 MHz, CDCl3): δ 7.39 - 7.48 (m, 2H), 6.86 - 6.91 (m, 2H), 6.84 (t, J = 2.7 
Hz, 1H), 6.05 (t, J = 4.3 Hz, 1H), 4.13 - 4.20 (m, 1H), 4.08 (dd, J = 7.2, 3.5 Hz, 1H), 3.81 (s, 
3H), 3.72 (s, 3H), 2.47 (dd, J = 9.5, 2.7 Hz, 1H), 2.29 (dd, J = 9.5, 2.7 Hz, 1H), 2.23 - 2.28 
(m, 2H), 1.85 - 1.96 (m, 2H). 13C NMR (125 MHz, CDCl3): δ 187.8, 170.3, 159.5, 150.6, 
128.7, 128.7 (2C), 120.2, 119.8, 114.0 (2C), 110.8, 66.4, 55.3, 52.4, 34.3, 21.8, 20.8, 17.4. 
IR: 2952.6 (w), 2837.5 (w), 1724.6 (w), 1693.7 (w), 1511.6 (m), 1435.6 (w), 1247.7 (s), 
1173.2 (m), 1120.7 (m), 1029.7 (m). HRMS (ESI) m/z: [M-H+] calcd. for C19H21O5, 
329.1384; found, 329.1380. 
 
 
Methyl (E)-1-(2-ethoxyacryloyl)-2-(4-methoxybenzylidene)cyclopropane-1- carboxylate 












was added t-BuLi (1.7 M in pentane, 1.4 mL, 2.4 mmol). The reaction mixture was then 
warmed up to 0 °C, stirred for 30 min, and then cooled to -78 °C prior addition of 
cyclopropane 3-14b (200 mg, 0.722 mmol) in THF (3.0 mL). After stirring for 25 min at -78 
°C, the reaction was quenched with saturated NH4Cl, extracted with EtOAc (2x), dried over 
Na2SO4, and purified via column chromatography (15% EtOAc/hexane, Rf = 0.20) to afford 
3-34b (162 mg, 71%) as a yellow oil. 1H NMR (500 MHz, CDCl3): δ 7.41 - 7.45 (m, 2H), 
6.86 - 6.89 (m, 2H), 6.82 (t, J = 2.6 Hz, 1H), 5.28 (d, J = 2.5 Hz, 1H), 4.51 (d, J = 2.5 Hz, 
1H), 3.84 - 3.97 (m, 2H), 3.81 (s, 3H), 3.71 (s, 3H), 2.50 (dd, J = 9.3, 2.6 Hz, 1H), 2.30 (dd, J 
= 9.3, 2.6 Hz, 1H), 1.41 (t, J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 188.7, 170.1, 
159.5, 156.8, 128.9, 128.7 (2C), 120.2, 119.9, 114.0 (2C), 91.9, 64.0, 55.3, 52.3, 34.7, 17.3, 
14.4. IR: 2982.4 (w), 2954.7 (w), 2840.0 (w), 1797.8 (w), 1730.1 (s), 1606.9 (m), 1512.0 (s), 
1247.8 (s), 1174.2 (s), 1109.3 (s), 1024.9 (s). HRMS (EI) m/z: [M-H+] calcd. for C18H20O5, 
316.1311; found, 316.1319.  
 
 c. Reaction optimizations 
Procedure for Catalyst Screening: To a flask charged with a stir bar, 4 Å molecular sieves 
(approx. 0.6 g) and an appropriate loading of the relevant Lewis acid was added a solution of 
alkylidene cyclopropane 3-10a (1.0 equiv) in CH2Cl2 (0.1 M) at room temperature. The 
reaction mixture was either kept at room temperature or refluxed. Upon complete 
disappearance of cyclopropane 3-10a on TLC, the reaction was quenched with water. The 
mixture was extracted with CH2Cl2, dried with Na2SO4, and purification via column 
chromatography provided the o-phenolic ester product.  
 
! 67!
Procedure for Optimization of Catalyst Loading: To a flask charged with a stir bar, 4 Å 
molecular sieves (approx. 0.6 g), and the appropriate Yb(OTf)3 loading (20, 15 or 10 mol%) 
was added a solution of alkylidene cyclopropane 3-10a (1.0 equiv.) in CH2Cl2 (0.1 M) at 
room temperature and then the mixture was heated to reflux. Upon complete disappearance 
of cyclopropane 3-10a on TLC, the reaction was quenched with water. The mixture was 
extracted with CH2Cl2, dried with Na2SO4, and purification via column chromatography 
provided the o-phenolic ester product.  
 
Procedure for Solvent Screening: To a flask charged with a stir bar, 4 Å molecular sieves 
(approx. 0.6 g), and 15 mol% Yb(OTf)3 was added a solution of alkylidene cyclopropane 3-
10a (1.0 equiv) in the appropriate solvent (PhMe, 1,2-DCE, or MeCN) (0.1 M) at room 
temperature. The reaction mixture was heated to the indicated temperature and upon 
complete disappearance of cyclopropane 3-10a on TLC, the reaction was quenched with 
water. The mixture was extracted with CH2Cl2, dried with Na2SO4, and purification via 
column chromatography provided the o-phenolic ester product.  
 
 d. Catalytic formal homo-Nazarov-type cyclizations 
General Procedure: A solution of the corresponding cyclopropane (0.1 M in CH2Cl2 or 1,2-
DCE) was added to a dried round bottom flask containing Yb(OTf)3 and 4 Å molecular 
sieves (1-2 mm beads, 0.6-0.8 g). The reaction was heated to reflux and monitored via TLC. 
Upon complete disappearance of the starting material, the reaction was quenched with water. 
The mixture was extracted with CH2Cl2, dried with Na2SO4, and purification via column 




Methyl 7-cyclohexyl-4-hydroxy-6-methylbenzofuran-5-carboxylate (3-15a). According to 
the general procedure, Yb(OTf)3 (24.1 mg, 3.89*10-2 mmol), cyclopropane 3-10a (75.1 mg, 
0.260 mmol), and CH2Cl2 (2.6 mL) were mixed and refluxed for 12 hrs to afford 3-15a (68.0 
mg, 91%) after purification via flash chromatography (5% Et2O/hexane, Rf = 0.30) as a white 
solid (mp: 140-142 °C). 1H NMR (500 MHz, CDCl3): δ 11.28 (s, 1H), 7.51 (d, J = 2.1 Hz, 
1H), 6.88 - 6.91 (d, J = 2.1 Hz, 1H), 3.97 (s, 3H), 2.98 - 3.06 (m, 1H), 2.55 (s, 3H), 2.07 - 
2.18 (m, 2H), 1.84 - 1.90 (m, 2H), 1.75 - 1.80 (m, 1H), 1.66 (d, J = 12.8 Hz, 2H), 1.36 - 1.46 
(m, 3H). 13C NMR (125 MHz, CDCl3): δ 172.7, 157.8, 155.3, 143.0, 132.8, 123.4, 115.6, 
107.8, 104.4, 52.0, 39.0, 30.9 (2C), 27.4 (2C), 26.1, 18.6. IR: 2941.9 (m), 2928.5 (m), 2854.1 
(m), 1663.9 (m), 1432.7 (m), 1300.7 (s), 1290.2 (s), 1203.6 (m). HRMS (EI) m/z: [M+] calcd. 
for C17H20O4, 288.1362; found, 288.1367. 
 
 
Methyl 4-hydroxy-7-(4-methoxyphenyl)-6-methylbenzofuran-5-carboxylate (3-15b). 
According to the general procedure, Yb(OTf)3 (21.6 mg, 3.48*10-2 mmol), cyclopropane 3-
10b (72.0 mg, 0.231 mmol), and CH2Cl2 (2.3 mL) were mixed and refluxed for 5 hrs to 
afford 3-15b (38.2 mg, 53%) after purification via flash chromatography (5% Et2O/hexane, 
Rf = 0.15) as a white solid (mp: 130-131 °C). 1H NMR (500 MHz, CDCl3): δ 11.99 (s, 1H), 















3.99 (s, 3H), 3.88 (s, 3H), 2.44 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 173.0, 158.9, 157.3, 
157.3, 144.0, 134.8, 131.7 (2C), 127.7, 119.8, 114.8, 113.8 (2C), 107.2, 104.9, 55.2, 52.1, 
20.3. IR: 3121.4 (w), 3000.2 (w), 2953.6 (w), 2835.2 (w), 1726.6 (m), 1654.9 (m), 1512.5 
(m), 1224.1 (s). HRMS (EI) m/z: [M+] calcd. for C18H16O5, 312.0998; found, 312.1003. 
 
 
Methyl 4-hydroxy-6-methyl-7-phenylbenzofuran-5-carboxylate (3-15c, major) and 
methyl 6-benzyl-4-hydroxybenzofuran-5-carboxylate (3-15c’, minor). According to the 
general procedure, Yb(OTf)3 (24.1 mg, 3.89*10-2 mmol), cyclopropane 3-10c (73.6 mg, 
0.261 mmol), and CH2Cl2 (2.6 mL) were mixed and refluxed for 24 hrs to afford a 2.2:1 
mixture of 3-15c and 3-15c’ (52.0 mg, 71%) after purification via flash chromatography (5% 
Et2O/hexane, Rf = 0.28) as a white solid (mp: 118-120 °C). 1H NMR (500 MHz, CDCl3): δ 
12.11 (s, 0.45, minor), 12.01 (s, 1H, major), 7.53 (d, J = 2.1 Hz, 0.45, minor), 7.46 - 7.51 (m, 
2H, major), 7.46 (d, J = 2.1 Hz, 1H, major), 7.40 - 7.44 (m, 1H, major), 7.32 - 7.35 (m, 2H, 
major), 7.24 - 7.29 (m, 0.90, minor), 7.15 - 7.20 (m, 0.45, minor), 7.05 - 7.09 (m, 0.90, 
minor), 6.97 (d, J = 2.1 Hz, 1H, major), 6.95 - 6.96 (m, 0.45, minor), 6.89 (s, 0.45, minor), 
4.39 (s, 0.90, minor), 4.00 (s, 3H, major), 3.79 (s, 1.35, minor), 2.43 (s, 3H, major). 13C 
NMR (125 MHz, CDCl3): δ 173.0, 172.3, 159.0, 158.4, 157.5, 157.1, 144.0, 141.3, 139.6, 
135.7, 134.6, 130.6, 128.4, 128.3, 127.5, 125.9, 120.1, 115.9, 114.9, 107.8, 107.2, 106.0, 
104.9, 52.1, 51.8, 42.6, 20.4. IR: 3058.2 (w), 3003.3 (w), 2953.1 (w), 1726.6 (s), 1655.2 (m), 

















Methyl 7-(4-chlorophenyl)-4-hydroxy-6-methylbenzofuran-5-carboxylate (3-15d) and 
methyl 6-(4-chlorobenzyl)-4-hydroxybenzofuran-5-carboxylate (3-15d’). According to 
the general procedure B, Yb(OTf)3 (22.8 mg, 3.68*10-2 mmol), cyclopropane 3-10d (74.3 
mg, 0.235 mmol), and 1,2-DCE (2.4 mL) were mixed and refluxed for 3 hrs to afford a 2.0:1 
mixture of 3-15d and 3-15d’ (39.4 mg, 53%) after purification via flash chromatography (2% 
Et2O/hexane, Rf = 0.12) as a white solid (mp: 118-120 °C). 1H NMR (500 MHz, CDCl3): δ 
12.14 (s, 0.51, minor), 12.07 (s, 1H, major), 7.57 (d, J = 2.1 Hz, 0.51, minor), 7.46 - 7.50 (m, 
3H, major), 7.28 - 7.32 (m, 2H, major), 7.25 (d, J = 8.5 Hz, 1.02, minor), 7.02 (d, J = 8.5 Hz, 
1.02, minor), 7.00 (d, J = 2.1 Hz, 1H, major), 6.98 - 6.99 (m, 0.51, minor), 6.91 (s, 0.51, 
minor), 4.37 (s, 1.02, minor), 4.02 (s, 3H, major), 3.82 (s, 1.53, minor), 2.45 (s, 3H, major). 
13C NMR (125 MHz, CDCl3): δ 172.9, 172.0, 159.1, 158.3, 157.7, 156.9, 144.2, 144.0, 
139.9, 138.8, 134.7, 134.0, 133.5, 132.0, 131.6, 129.5, 128.6, 128.4, 118.8, 116.1, 115.0, 
107.8, 107.3, 105.9, 105.0, 104.9, 52.2, 51.9, 42.0, 20.3. IR: 3126.7 (w), 2953.0 (w), 1728.4 
(w), 1656.2 (s), 1437.5 (s), 1294.0 (s), 1222.7 (s). HRMS (EI) m/z: [M+] calcd. for 
C17H13O4Cl, 316.0502; found, 316.0495. 
 
 
Methyl 4-(2-ethoxy-2-oxoethyl)-[2,3'-bifuran]-3-carboxylate (3-16). According to the 




















0.252 mmol), and CH2Cl2 (2.5 mL) were mixed and refluxed for 20 hrs to afford 3-16 (48.5 
mg, 69%) after purification via flash chromatography (20% Et2O/hexane, Rf = 0.23) as a 
yellow oil. 1H NMR (500 MHz, CDCl3): δ 8.34 - 8.39 (m, 1H), 7.43 (t, J = 1.7 Hz, 1H), 7.33 
(s, 1H), 6.91 (dd, J = 1.7, 0.9 Hz, 1H), 4.16 (q, J = 7.0 Hz, 2H), 3.81 (s, 3H), 3.64 (s, 2H), 
1.26 (t, J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 171.0, 164.0, 153.2, 143.8, 142.6, 
139.6, 119.3, 116.5, 112.0, 109.2, 60.8, 51.1, 30.9, 14.2. IR: 2984.6 (w), 2955.1 (w), 1714.0 
(s), 1439.0 (m), 1160.4 (s), 1083.0 (s), 1020.6 (s). HRMS (EI) m/z: [M+] calcd. for C14H14O6, 
278.0790; found, 278.0778. 
 
 
Methyl 6,7,7-trimethyl-4-oxo-4,7-dihydrobenzofuran-5-carboxylate (3-18). According to 
the general procedure, Yb(OTf)3 (29.5 mg, 4.76*10-2 mmol), cyclopropane 3-10f (76.4 mg, 
0.326 mmol), and CH2Cl2 (3.2 mL) were mixed and refluxed for 5 hrs to afford 3-18 (48.3 
mg, 63%) after purification via flash chromatography (30% Et2O/hexane, Rf = 0.14) as a light 
brown oil. 1H NMR (500 MHz, CDCl3): δ 7.40 (d, J = 2.1 Hz, 1H), 6.71 (d, J = 2.1 Hz, 1H), 
3.87 (s, 3H), 2.03 (s,3 H), 1.48 (s, 6H). 13C NMR (125 MHz, CDCl3): δ 178.4, 170.0, 167.7, 
156.5, 143.0, 133.2, 117.6, 106.1, 52.3, 39.4, 24.7 (2C), 15.3. IR: 3125.4 (w), 3981.2 (w), 
2952.0 (w), 1731.5 (s), 1655.5 (s), 1471.8 (m), 1168.9 (s). HRMS (EI) m/z: [M+] calcd. for 















Methyl 4-hydroxy-7-methyl-6-((trimethylsilyl)methyl)benzofuran-5-carboxylate (3-19). 
According to the general procedure, Yb(OTf)3 (22.4 mg, 3.61*10-2 mmol), cyclopropane 3-
10g (74.8 mg, 0.256 mmol), and CH2Cl2 (2.5 mL) were mixed and refluxed for 5 hrs to 
afford 3-19 (51.1 mg, 68%) after purification via flash chromatography (5% Et2O/hexane, Rf 
= 0.26) as a colorless oil. 1H NMR (500 MHz, CDCl3): δ 12.10 (s, 1H), 7.40 (d, J = 2.1 Hz, 
1H), 6.82 (d, J = 2.1 Hz, 1H), 3.83 (s, 3H), 2.71 (s, 2H), 2.19 (s, 3H), 0.26 (s, 9H). 13C NMR 
(125 MHz, CDCl3): δ 171.9, 163.8, 157.8, 140.8, 136.3, 135.2, 121.1, 108.9, 93.2, 51.2, 26.8, 
18.1, 0.4. IR: 2952.7 (m), 2893.3 (w), 1743.3 (w), 1639.3 (m), 1607.3 (m), 1232.6 (s). 




21b). According to the general procedure, Yb(OTf)3 (20.0 mg, 3.22*10-2 mmol), 
cyclopropane 3-20b (74.8 mg, 0.206 mmol), and CH2Cl2 (2.0 mL) were mixed and refluxed 
for 4 hrs to afford 3-21b (58.4 mg, 78%) after purification via flash chromatography (5% 
Et2O/hexane, Rf = 0.14) as a white solid (mp: 173-175 °C). 1H NMR (500 MHz, CDCl3): δ 
12.16 (s, 1H), 8.18 - 8.23 (m, 1H), 7.44 - 7.47 (m, 1H), 7.34 - 7.40 (m, 2H), 7.28 - 7.32 (m, 
2H), 7.04 - 7.08 (m, 2H), 4.01 (s, 3H), 3.91 (s, 3H), 2.48 (s, 3H). 13C NMR (125 MHz, 
CDCl3): δ 172.8, 159.0, 158.8, 158.4, 155.6, 138.6, 131.9 (2C), 127.6, 126.2, 123.6, 123.4, 
122.8, 119.7, 113.9 (2C), 111.3, 110.7, 107.7, 55.3, 52.2, 20.8. IR: 3004.1 (w), 2959.3 (w), 
2926.1 (w), 2837.8 (w), 1655.3 (m), 1608.0 (m), 1480.1 (m), 1208.7 (s), 1011.9 (s), 799.5 











23b). According to the general procedure, Yb(OTf)3 (29.8 mg, 4.80*10-2 mmol), 
cyclopropane 3-22b (114.1 mg, 0.304 mmol), and CH2Cl2 (3.0 mL) were mixed and refluxed 
for 6 hrs to afford 3-23b (79.2 mg, 69%) after purification via preparatory TLC (5% 
Et2O/hexane, Rf = 0.21) as a yellow solid (mp: 174-176 °C). 1H NMR (500 MHz, CDCl3): δ 
12.05 (s, 1H), 7.34 - 7.43 (m, 2H), 7.18 - 7.24 (m, 2H), 7.05 - 7.11 (m, 2H), 6.88 (ddd, J = 
7.9, 6.8, 0.9 Hz, 1H), 6.59 (d, J = 7.9 Hz, 1H), 4.25 (s, 3H), 4.01 (s, 3H), 3.95 (s, 3H), 2.36 
(s, 3H). 13C NMR (125 MHz, CDCl3): δ 173.7, 158.8, 150.7, 142.8, 133.0, 131.1 (2C), 
128.4, 127.5, 127.0, 126.8, 126.4, 123.0, 122.3, 118.8, 114.3 (2C), 108.7, 108.7, 55.3, 52.1, 
32.1, 19.7. IR: 2998.0 (w), 2951.4 (w), 2834.6 (w), 1654.0 (m), 1440.0 (s), 1321.6 (s), 
1241.5 (s), 1149.0 (s), 1038.4 (m). HRMS (ESI) m/z: [M-H+] calcd. for C23H22O4N, 
376.1543; found, 376.1535. 
 
 
Methyl 1-hydroxy-7-methoxy-4-(4-methoxyphenyl)-3-methyl-2-naphthoate (3-25b). 
According to the general procedure B, Yb(OTf)3 (30.1 mg, 4.85*10-2 mmol), cyclopropane 
3-24b (109.0 mg, 0.309 mmol), and CH2Cl2 (3.1 mL) were mixed and refluxed for 16.5 hrs 
to afford 3-25b (84.3 mg, 77%) after purification via flash chromatography (5% 
















12.42 (s, 1H), 7.73 (d, J = 2.7 Hz, 1H), 7.16 (d, J = 9.2 Hz, 1H), 7.10 - 7.13 (m, 2H), 7.08 
(dd, J = 9.2, 2.7 Hz, 1H), 6.99 - 7.04 (m, 2H), 4.01 (s, 3H), 3.95 (s, 3H), 3.90 (s, 3H), 2.31 (s, 
3H). 13C NMR (125 MHz, CDCl3): δ 173.4, 159.8, 158.5, 157.0, 132.3, 131.8 (2C), 131.7, 
130.8, 129.8, 128.0, 124.2, 121.6, 113.8 (2C), 107.3, 101.9, 55.4, 55.2, 52.2, 20.9. IR: 
2998.2 (w), 2952.3 (w), 2834.8 (w), 1732.5 (w), 1646.3 (m), 1580.1 (m), 1513.5 (s), 1436.8 
(m), 1326.6 (m), 1219.0 (s), 1034.0 (m), 829.9 (m). HRMS (EI) m/z: [M+] calcd. for 
C21H20O5, 352.1311; found, 352.1307. 
 
 
Methyl 1-hydroxy-4-(4-methoxyphenyl)-3-methylphenanthrene-2-carboxylate (3-27b). 
According to the general procedure, Yb(OTf)3 (21.0 mg, 3.39*10-2 mmol), cyclopropane 3-
26b (80.6 mg, 0.216 mmol), and CH2Cl2 (2.2 mL) were mixed and refluxed for 3 hrs to 
afford 3-27b (35.8 mg, 44%) after purification via flash chromatography (10% Et2O/hexane, 
Rf = 0.32) as a yellow solid (mp: 141-143 °C). 1H NMR (500 MHz, CDCl3): δ 11.98 (s, 1H), 
8.41 (d, J = 8.9 Hz, 1H), 7.77 - 7.84 (m, 1H), 7.73 (d, J = 9.2 Hz, 1H), 7.46 (d, J = 8.9 Hz, 
1H), 7.40 - 7.44 (m, 1H), 7.10 - 7.17 (m, 2H), 7.00 - 7.10 (m, 3H), 4.02 (s, 3H), 3.92 (s, 3H), 
2.33 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 172.8, 159.1, 158.7, 135.9, 135.2, 135.0, 133.8, 
131.7 (2C), 131.3, 130.1, 128.9, 128.4, 126.7, 126.7, 124.8, 122.2, 120.8, 114.7 (2C), 109.0, 
55.3, 52.3, 21.6. IR: 3053.5 (w), 2952.4 (w), 2835.5 (w), 1734.1 (w), 1649.6 (m), 1607.1 
(m), 1589.8 (m), 1438.8 (m), 1335.3 (m), 1235.6 (s), 1166.7 (s). HRMS (EI) m/z: [M+] calcd. 










Methyl 3-(cyclohexylmethyl)-1-hydroxy-5,7-dimethoxy-2-naphthoate (3-29a’). 
According to the general procedure, Yb(OTf)3 (19.2 mg, 3.10*10-2 mmol), cyclopropane 3-
28a (74.8 mg, 0.209 mmol), and 1,2-DCE (2.1 mL) were mixed and refluxed for 3 hrs to 
afford 3-29a’ (29.4 mg, 39%) after purification via flash chromatography (5% Et2O/hexane, 
Rf = 0.26) as a light yellow solid (mp: 135-137 °C). 1H NMR (500 MHz, CDCl3): δ 12.45 (s, 
1H), 7.35 (s, 1H), 7.23 (d, J = 2.1 Hz, 1H), 6.59 (d, J = 2.1 Hz, 1H), 3.99 (s, 3H), 3.95 (s, 
3H), 3.93 (s, 3H), 2.89 (d, J = 6.7 Hz, 2H), 1.56 - 1.71 (m, 5H), 1.35 - 1.45 (m, 1H), 1.11 - 
1.18 (m, 3H), 0.99 (m, 2H). 13C NMR (125 MHz, CDCl3): δ 173.2, 160.8, 157.7, 155.7, 
134.8, 124.9, 123.6, 115.5, 107.0, 100.9, 93.8, 55.7, 55.5, 52.1, 45.0, 39.9, 33.5 (2C), 26.6, 
26.4 (2C). IR: 2995.1 (w), 2924.7 (m), 2843.5 (m), 1642.8 (m), 1600.7 (m), 1583.9 (m), 
1433.9 (s), 1340.5 (m), 1247.4 (s), 1194.0 (s). HRMS (EI) m/z: [M+] calcd. for C21H26O5, 
358.1780; found, 358.1779. 
 
 
Methyl 1-hydroxy-5,7-dimethoxy-4-(4-methoxyphenyl)-3-methyl-2-naphthoate (3-29b). 
According to the general procedure, Yb(OTf)3 (27.5 mg, 4.43*10-2 mmol), cyclopropane 3-
28b (110.0 mg, 0.288 mmol), and CH2Cl2 (2.9 mL) were mixed and refluxed for 3 hrs to 
afford 3-29b (88.3 mg, 80%) after purification via flash chromatography (10% Et2O/hexane, 
Rf = 0.18) as a yellow solid (mp: 153-155 °C). 1H NMR (500 MHz, CDCl3): δ 12.11 (s, 1H), 
















3.99 (s, 3H), 3.94 (s, 3H), 3.88 (s, 3H), 3.33 (s, 3H), 2.19 (s, 3H). 13C NMR (125 MHz, 
CDCl3): δ 173.2, 158.9, 157.5, 157.5, 157.5, 136.6, 130.2 (3C), 129.1, 125.7, 123.4, 112.6 
(2C), 108.1, 102.9, 94.5, 55.8, 55.4, 55.3, 52.2, 20.6. IR: 3048.0 (w), 2952.9 (w), 2380.0 (w), 
1649.5 (m), 1584.1 (m), 1512.2 (m), 1439.8 (m), 1327.2 (m), 1209.3 (s), 1062.9 (m). HRMS 
(EI) m/z: [M+] calcd. for C22H22O6, 382.1416; found, 382.1399. 
 
 
Methyl 1-hydroxy-5,7-dimethoxy-3-methyl-4-phenyl-2-naphthoate (3-29c, minor) and 
methyl 3-benzyl-1-hydroxy-5,7-dimethoxy-2-naphthoate (3-29c’, major). According to 
the general procedure, Yb(OTf)3 (20.8 mg, 3.35*10-2 mmol), cyclopropane 3-28c (66.2 mg, 
0.188 mmol), and CH2Cl2 (2.1 mL) were mixed and refluxed for 18.5 hrs to afford a mixture 
of 3-29c and 3-29c’ (64.9 mg, 98%) after purification via flash chromatography (5% 
Et2O/hexane, Rf = 0.19) as a yellow solid (mp: 119-121 °C). 1H NMR (500 MHz, CDCl3): δ 
12.50 (s, 1H, major), 12.17 (s, 0.57, minor), 7.54 (s, 1H, major), 7.40 (d, J = 2.4 Hz, 0.57, 
minor), 7.32 - 7.38 (m, 1.14, minor), 7.29 - 7.31 (m, 0.57, minor), 7.28 (d, J=2.4 Hz, 1H, 
major), 7.21 - 7.25 (m, 2H, major), 7.11 - 7.17 (m, 2.14, major + minor), 7.06 (d, J = 7.0 Hz, 
2H, major), 6.64 (d, J = 2.4 Hz, 1H, major), 6.51 (d, J = 2.4 Hz, 0.57, minor), 4.41 (s, 2H, 
major), 3.99 (s, 1.71, minor), 3.94 - 3.97 (m, 7.71, major + minor), 3.76 (s, 3H, major), 3.29 
(s, 1.71, minor), 2.19 (s, 1.71, minor). 13C NMR (125 MHz, CDCl3): δ 173.2, 172.6, 161.1, 
159.0, 158.1, 157.5, 157.3, 155.8, 144.3, 142.1, 133.3, 129.8, 129.5, 129.3, 128.1, 128.0, 
127.1, 125.7, 125.5, 125.4, 123.7, 123.0, 116.4, 108.0, 107.0, 102.8, 101.0, 94.5, 93.9, 55.6, 
















1649.9 (s), 1437.6 (m), 1331.1 (m), 1283.1 (s), 1248.0 (s), 1166.8 (s). HRMS (EI) m/z: [M+] 
calcd. for C21H20O5, 352.1311; found, 352.1318. 
 
 
Ethyl 3-cyclohexyl-6-hydroxy-2,5-dimethylbenzoate (3-31a). According to the general 
procedure, Yb(OTf)3 (38.8 mg, 6.26*10-2 mmol), cyclopropane 3-30a (60.0 mg, 0.217 
mmol), and CH2Cl2 (2.2 mL) were mixed and refluxed for 23 hrs to afford 3-31a (39.4 mg, 
66%) after purification via flash chromatography (2% Et2O/hexane, Rf = 0.12) as a colorless 
oil. 1H NMR (500 MHz, CDCl3): δ 10.62 (s, 1H), 7.16 (s, 1H), 4.43 (q, J = 7.3 Hz, 2H), 2.68 
- 2.77 (m, 1H), 2.45 (s, 3H), 2.23 (s, 3H), 1.71 - 1.90 (m, 5H), 1.24 - 1.47 (m, 8H). 13C NMR 
(125 MHz, CDCl3): δ 172.0, 157.3, 137.0, 134.2, 132.7, 123.4, 113.4, 61.5, 39.6, 34.0 (2C), 
27.2 (2C), 26.3, 17.4, 16.0, 14.2. IR: 2980.1 (w), 2924.7 (m), 2850.5 (m), 1653.0 (s), 1446.6 
(m), 1320.0 (s), 1260.3 (s), 1093.4 (m). HRMS (EI) m/z: [M+] calcd. for C17H24O3, 
276.1725; found, 276.1723. 
 
 
Methyl 4-hydroxy-4'-methoxy-2,5-dimethyl-[1,1'-biphenyl]-3-carboxylate (3-31b). 
According to the general procedure, Yb(OTf)3 (26.5 mg, 4.27*10-2 mmol), cyclopropane 3-
30b (72.0 mg, 0.251 mmol), and CH2Cl2 (2.5 mL) were mixed and refluxed for 23 hrs to 
afford 3-31b (35.3 mg, 49%) after purification via flash chromatography (5% Et2O/hexane, 














3H), 6.91 - 6.96 (m, 2H), 3.98 (s, 3H), 3.85 (s, 3H), 2.36 (s, 3H), 2.26 (s, 3H). 13C NMR 
(125 MHz, CDCl3): δ 172.7, 159.6, 158.4, 137.2, 135.1, 134.4, 133.9, 130.8 (2C), 123.6, 
113.5 (2C), 112.6, 55.3, 52.1, 20.5, 15.8. IR: 2997.9 (w), 2952.8 (w), 2853.5 (w), 1655.4 
(m), 1608.3 (m), 1512.8 (m), 1435.4 (m), 1233.5 (s), 1174.3 (s), 1053.6 (s), 802.9 (s). HRMS 
(EI) m/z: [M+] calcd. for C17H18O4, 286.1205; found, 286.1213. 
 
 
Methyl 4-hydroxy-2,5-dimethyl-[1,1'-biphenyl]-3-carboxylate (3-31c, major) and methyl 
6-benzyl-2-hydroxy-3-methylbenzoate (3-31c’, minor). According to the general 
procedure, Yb(OTf)3 (41.8 mg, 6.74*10-2 mmol), cyclopropane 3-30c (120.0 mg, 0.468 
mmol), and 1,2-DCE (4.6 mL) were mixed and refluxed for 5.5 hrs to afford a 2.7:1 mixture 
of 3-31c and 3-31c’ (70.6 mg, 59%) after purification via flash chromatography (2% 
Et2O/hexane, Rf = 0.12) as a white solid (mp: 60-62 °C). 1H NMR (500 MHz, CDCl3): δ 
11.50 (s, 0.37, minor), 11.32 (s, 1H, major), 7.42 - 7.46 (m, 2H, major), 7.35 - 7.39 (m, 1H, 
major), 7.27 - 7.31 (m, 3.11, major + minor), 7.23 (s, 1H, major), 7.18 - 7.22 (m, 0.37, 
minor), 7.09 (dd, J = 7.9, 0.9 Hz, 0.74, minor), 6.69 (d, J = 7.6 Hz, 0.37, minor), 4.32 (s, 
0.74, minor), 4.02 (s, 3H, major), 3.80 (s, 1.11, minor), 2.41 (s, 3H, major), 2.29 - 2.33 (m, 
4.11, major + minor). 13C NMR (125 MHz, CDCl3): δ 172.6, 172.0, 161.2, 159.8, 142.0, 
141.5, 140.0, 136.9, 135.0, 135.0, 134.3, 129.7, 128.2, 128.1, 128.0, 126.6, 125.7, 125.2, 
123.7, 122.8, 112.6, 111.5, 52.1, 51.8, 42.0, 20.5, 15.9, 15.7. IR: 3027.0 (w), 2951.6 (w), 
1656.2 (s), 1611.1 (m), 1584.2 (m), 1434.4 (s), 1335.2 (s), 1195.1 (s), 992.0 (m). HRMS (EI) 

















Ethyl 2-ethyl-4-hydroxy-4'-methoxy-5-methyl-[1,1'-biphenyl]-3-carboxylate (3-31h). 
According to the general procedure, Yb(OTf)3 (22.1 mg, 3.56*10-2 mmol), cyclopropane 3-
30h (63.4 mg, 0.202 mmol), and CH2Cl2 (2.0 mL) were mixed and refluxed for 2.5 hrs to 
afford 3-31h (36.8 mg, 58%) after purification via flash chromatography (15% Et2O/hexane, 
Rf = 0.50) as a yellow oil. 1H NMR (500 MHz, CDCl3): δ 11.18 (s, 1H), 7.13 - 7.18 (m, 2H), 
7.11 (s, 1H), 6.90 - 6.95 (m, 2H), 4.47 (q, J = 7.3 Hz, 2H), 3.86 (s, 3H), 2.85 (q, J = 7.3 Hz, 
2H), 2.24 (s, 3H), 1.44 (t, J = 7.3 Hz, 3H), 1.00 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, 
CDCl3): δ 172.0, 159.6, 158.4, 141.7, 137.4, 134.5, 133.7, 130.6 (2C), 123.5, 113.3 (2C), 
111.9, 61.7, 55.2, 24.9, 16.3, 15.8, 13.9. IR: 2978.8 (w), 2932.7 (w), 2835.4 (w), 1651.5 (m), 
1608.6 (m), 1512.4 (m), 1457.0 (m), 1371.3 (m), 1284.3 (s), 1226.4 (s), 1082.8 (m), 869.6 
(m). HRMS (EI) m/z: [M+] calcd. for C19H22O4, 314.1518; found, 314.1528. 
 
 
Methyl 8-hydroxy-5-(4-methoxyphenyl)-6-methylchromane-7-carboxylate (3-33b). 
According to the general procedure, Yb(OTf)3 (32.5 mg, 5.24*10-2 mmol), cyclopropane 3-
32b (102.0 mg, 0.311 mmol), and 1,2-DCE (3.0 mL) were mixed and refluxed for 2.5 hrs to 
afford 3-33b (26.3 mg, 26%) after purification via flash chromatography (20% 
EtOAc/hexane, Rf = 0.24) as a yellow solid (mp: 115-117 °C). 1H NMR (500 MHz, CDCl3): 












3.85 (s, 3H), 2.28 (t, J = 6.4 Hz, 2H), 2.08 (s, 3H), 1.84 - 1.93 (m, 2H). 13C NMR (125 MHz, 
CDCl3): δ 171.9, 158.4, 149.3, 141.4, 133.5, 132.2, 130.7 (2C), 127.9, 126.5, 113.9 (2C), 
112.2, 66.1, 55.2, 52.1, 24.8, 22.1, 19.5. IR: 3427.9 (w), 2951.3 (w), 2873.6 (w), 2836.7 (w), 
1727.0 (m), 1655.3 (m), 1608.0 (m), 1513.0 (m), 1422.4 (m), 1333.1 (m), 1224.4 (s), 1066.1 
(s). HRMS (ESI) m/z: [M-Na+] calcd. for C19H20O5Na, 351.1203; found, 351.1195. 
 
 
Methyl 5-ethoxy-4-hydroxy-4'-methoxy-2-methyl-[1,1'-biphenyl]-3-carboxylate (3-35b). 
According to the general procedure, Yb(OTf)3 (18.1 mg, 2.92*10-2 mmol), cyclopropane 3-
34b (58.5 mg, 0.185 mmol), and 1,2-DCE (1.8 mL) were mixed and refluxed for 2.5 hrs to 
afford 3-35b (30.1 mg, 51%) after purification via flash chromatography (15% 
EtOAc/hexane, Rf = 0.22) as a yellow oil. 1H NMR (500 MHz, CDCl3): δ 9.72 (s, 1H), 7.15 - 
7.20 (m, 2H), 6.92 - 6.96 (m, 2H), 6.86 (s, 1H), 4.08 (q, J = 7.0 Hz, 2H), 3.97 (s, 3H), 3.85 
(s, 3H), 2.25 (s, 3H), 1.45 (t, J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 171.4, 158.5, 
149.2, 144.7, 134.3, 133.6, 130.7 (2C), 127.7, 118.1, 115.7, 113.5 (2C), 64.7, 55.3, 52.3, 
19.2, 14.8. IR: 3414.3 (w), 2953.7 (w), 2930.6 (w), 2839.7 (w), 1728.7 (m), 1438.6 (m), 
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CHAPTER 4 
CATALYTIC, CASCADE RING-OPENING BENZANNULATIONS OF 2,3-
DIHYDROFURAN O,O- AND N,O-ACETALS 
 
4.1 Introduction 
One of the most significant utilities of the 2,3-dihydrofuran (2,3-DHF) subunit relies 
on their presence in many important biologically active compounds.1 In addition, they have 
shown to be extremely useful building blocks in organic synthesis as synthetic precursors for 
furans (via oxidation2 or Pd-catalyzed dehydrogenation3), tetrahydrofurans and even more 
complex structures, such as bioactive synthetic molecules,4 The presence of a donor-acceptor 
substituted C-C double bond allows them to participate in several cycloadditions and 
nucleophile/electrophile trapping reactions.5 Not limited to that, 2,3-DHF have also 
participated in Pd-catalyzed cross-couplings6, ring-expansion7 and cycloisomerizations.8-9 
For instance, the positioning and the nature of the functional groups its very important to tune 
the reactivity of 2,3-DHF. For example, Fristad and co-workers reported the formation of 
substituted tetralones 4-2, a family of bioactive naturally occurring lignans, via ring-opening 
cycloisomerization of 2,3-dihydrofurans 4-1 (Scheme 4-1). The right positioning of an ester 
as an acceptor/coordinating group, an aryl as a π-nucleophile (Ar1), and an aryl donor group 
(Ar2) to facilitate the ring-opening was part of the strategy employed on the transformation. 




Scheme 4-1. Fristad’s reported synthesis of substituted tetralones. 
 
One class of DHFs that has received particular attention from the synthetic 
community are the 2-alkoxy-2,3-dihydrofurans (or DHF O,O-acetals). Besides their presence 
in bioactive natural products containing 5,5- and 5,6-fused bicyclic DHF O,O-acetals,4b the 
inherent reactivity of the acetal moiety makes DHF acetals useful synthetically. They 
undergo two primary types of reactivity as described in the literature (Scheme 4-2). First, 
they serve as precursors for furans 4-4 following acid-promoted alcohol elimination.10 
Second, acid-promoted acetal hydrolysis results in either substitution11 of the exocyclic 
alkoxy group (in the presence of a nucleophile) or DHF ring-opening leading to a 1,3-dipolar 
intermediate (I). It is through this dipolar behavior that 2,3-DHF acetals have been employed 
in cationic ring-opening polymerizations12 and as a means to access 2-cyclopentenones 4-6 






















Scheme 4-2. General reactivity of 2,3-DHF acetals. 
 
The development of new chemical transformation to generate (hetero)aromatics has 
become an important area of research in organic chemistry due to their prevalence in 
important frameworks with broad application in natural products synthesis, medicinal 
chemistry, chemical biology, and materials science.13 Our group and others have examined 
Lewis acid-catalyzed or -mediated ring-opening cyclizations of activated cyclopropanes, 
alkylidene cyclopropanes, and cyclopropenes for the formation of these aromatic 
polycycles.14 Encouraged by finding new benzannulation transformations, we sought to 
explore 2,3-DHF acetals as a general approach to functionalized benzo-fused 
(hetero)aromatics. 
Herein, we disclose an Al(OTf)3-catalyzed, cascade ring-opening benzannulation of 
5-(hetero)aryl-2,3-dihydrofuran O,O- and N,O-acetals 4-7 (Scheme 4-3). The proposed 
cascade reaction involves initial dihydrofuran acetal ring-opening in the presence of the 
Lewis acid. Upon ring-opening, the resulting alkoxonium (or iminium) intermediate I 






















































II. Next, a Prins-type15 cyclization occurs to form intermediate III, which readily aromatizes 
via elimination of RXH to form the benzo-fused product 4-8. This transformation provides 
a powerful approach for the synthesis of benzenoid compounds and represents novel 
reactivity for DHFs.16 
 
 
Scheme 4-3. Cascade ring-opening-Prins-Type benzannulations of 2,3-DHF O,O- and N,O-acetals. 
 
4.2 Results and Discussion 
4.2.1 Synthetic methods 
DHF acetals are readily prepared in good yields via Rh(II)-catalyzed reactions17 of α-
diazo-β-ketoesters 4-9 with hetero-olefins 4-10 or Mn(III)-mediated reactions7 of  β-
ketoesters 4-11 with hetero-olefins 4-10 (Scheme 4-4). 
 
 

















































































4.2.2 Reaction optimization 
In order to optimize the cascade transformation, we chose to employ dihydrofuran 
acetal 4-7a as the model system. Given the relative instability of the furan unit in the 
presence of certain Lewis acids, we anticipated successful optimization of this substrate 
would bode well for broader exploration of substrate scope (Table 4-1). Starting with 
In(OTf)3, mainly degradation was observed with only 5% of the desired benzofuran 4-8a 
isolated (Table 4-1, entry 1). Degradation or poor conversions were observed with other 
Lewis acids, such as Sc(OTf)3, Cu(OTf)2, and Yb(OTf)3. More tangible amounts of 4-8a were 
obtained with Ga(OTf)3 and Al(OTf)3 (Table 4-1, entries 2 and 3). Performing the reaction at 
reflux with Al(OTf)3 afforded 4-8a in 35% yield (Table 4-1, entry 4). Changing the solvent 
to toluene and performing the reaction at reflux gave 40% yield (Table 4-1, entry 5). 
Reducing the temperature to 85˚C was found to increase the yield to 46% (Table 4-1, entry 
6). All other attempts to further optimize the reaction (e.g., changing temperature, catalyst 
loading, concentration, etc.) failed to provide improved yields. Therefore, the conditions used 
for the examination of reaction scope were 5 mol % Al(OTf)3 in toluene at 85 ˚C. 
 








Entrya Lewis acid Solvent Temp. (°C) Time (h) Yieldb (%)
1 In(OTf)3 CH2Cl2 23 45.0 5
2 Ga(OTf)3 CH2Cl2 23 9.5 16
3 Al(OTf)3 CH2Cl2 23 45.0 19
4 Al(OTf)3 CH2Cl2 40 6.5 35
5 Al(OTf)3 toluene 110 1.0 40






a) Reaction conditions: Lewis acid (5 mol%), 4-7a, and solvent (0.2 M) at the indicated temperature; 
b) Isolated yield after column chromathography.
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4.2.3 Reaction scope 
With a working method in hand, the cascade reaction with other (hetero)aryl 
dihydrofuran derivatives were evaluated (Scheme 4-5). 2-Thienyl dihydrofuran 4-7b was 
readily converted to the benzothiophene 4-8b in 61% yield. 3-Furyl and 3-thienyl derivatives 
4-7c and 4-7c provided the corresponding benzofuran 4-8c and benzothiophene 4-8d in 75% 
and 81% yield, respectively. As anticipated, benzofuryl dihydrofuran 4-7e generated the 
dibenzo[b,d]furan 4-8e in 83% yield. The 2-napthyl substrate 4-7f afforded phenanthrene 4-
8f in 60% yield as the only regioisomer. 3-Methoxyphenyl dihydrofuran 4-7g similarly gave 
naphthalene 4-8g as the only regioisomer in 81% yield. High yield (93%) was observed for 
the cascade reaction of 3,5-dimethoxy dihydrofuran 4-7h to give naphthalene 4-8h. 
 
 
Scheme 4-5. Al(OTf)3-catalyzed cascade ceactions of DHF acetals 4-7. 
 
Next, the effect of changing the nature of the acetal group on reaction efficiency was 
evaluated (Table 4-2). Dihydrofuran O,O- and N,O-acetals 4-7i to 4-7l were prepared and 
subjected to the optimized cascade conditions. When dihydrofuran 4-7i (containing a tert-





















4-8b (61%) 4-8c (75%) 4-8d (81%) 4-8e (83%)











The siloxy derivative 4-7j afforded smooth conversion to 4-8h in 80% yield (Table 4-2, entry 
2). Methyl acetamido DHF 4-7k provided 4-8k with comparable yield (95%) to 2-ethoxy 
DHF 4-7h but with a longer reaction (Table 4-2, entry 3). Finally, pyrrolidin-2-one 4-7l gave 
a modest 51% yield of 4-8k (Table 4-2, entry 4). 
 
Table 4-2. Probing the effect by changing the acetal group. 
 
 
To fully broaden the reaction scope, more substituted DHF acetals (tetra-substituted 
DHF derivatives) were synthesized and explored. When 2-methoxy-2-methyl 5-thienyl DHF 
4-7m was subjected to the optimized conditions, none of the expected 7-methyl 
benzothiophene 4-8m was observed and furan 4-4m was formed instead. Interestingly, when 
the temperature was reduced to 70 ˚C and a drop of water was added to the reaction mixture, 
a 1:1.18 crude mixture of 4-8m to furan 4-4m was observed. After some optimization, it was 
found that 20 mol% Al(OTf)3 in toluene with a drop of water at 70 ˚C provided 4-8m in 80% 















































a) Reaction conditions: Al(OTf)3 (5 mol%), 4-7, and toluene (0.2 M) at 85 °C; b) Isolated yield 
after column chromathography.
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yield (Table 4-3, entry 1). It is plausible that the water may be promoting the formation of a 
dihydrofuran hemiacetal intermediate that may facilitate ring-opening over furan formation. 
Under these new conditions, the 3-ethyl-2-methoxy 5-thienyl DHF 4-7n gave the expected 6-
ethyl benzothiophene 4-8n in 69% yield (Table 4-3, entry 2). Similarly with 4-7o and 4-7p, 
the 3-ethyl and 3-phenyl naphthalenes 4-8o and 4-8m were formed in 88% and 79% yield, 
respectively (Table 4-3, entries 3 and 4). In comparison, the 2,2-gem-disubstituted acetal 4-
7q afforded the 4-methyl naphthalene 4-8q in 86% yield (Table 4-3, entry 5). These 
examples demonstrate the general strength of the method for the strategic synthesis of 
regioisomeric benzo-fused systems. Since the acetal serves as the directing group for ring 
opening, the placement of the substituent determines the regiochemistry. Therefore, the 
selection of the alkene for DHF synthesis becomes an important reaction design component 
as it will dictate the cascade product regiochemistry. This level of regiocontrol is 













Table 4-3. Cascade reactions of tetra-substituted 2,3-DHF acetals. 
 
 
For the fused bicyclic DHF acetals (4-7r to 4-7t), the original reaction conditions [5 
mol% Al(OTf)3, 85 ˚C] offered better yields of the expected products. 3a,5,6,7a-Tetrahydro-
4H-furo[2,3-b]pyran 4-7r gave 85% yield of naphthalene 4-8r,  which contains a pendant 



















































































































a) Reaction conditions: Al(OTf)3 (20 mol%), 4-7, and toluene (0.2 M), water (1 drop), 70 °C; b) Isolated 
yield after column chromathography; c) Performed using Al(OTf)3 (5 mol%) at 85 °C (no water added); d) 
Performed using Al(OTf)3 (30 mol%) at 110 °C.
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hydroxypropyl unit (Table 4-3, entry 6). In contrast, lactonization was observed for 
2,3,3a,6a-tetrahydrofuro[2,3-b]furan 4-7s as the tricyclic 3,4-dihydro-1H-
benzo[g]isochromen-1-one 4-8s was generated in 90% yield (Table 4-3, entry 7). Finally, 6-
Boc-3a,5,6,6a-tetrahydro-4H-furo[2,3-b]pyrrole 4-7t (a bicyclic N,O-acetal) provided 17% 
yield (52%, BSRM) of naphthalene 4-8t (Table 4-3, entry 8). The low yield can be attributed 
to catalyst deactivation by coordination with the pendant carbamate group; thus, requiring 
increased catalyst loading. Surprisingly, spirocyclic acetal 4-7u afforded 6,7-dihydro-3H,5H-
2,8-(metheno)benzo[e]oxecin-3-one 4-8u in 47% yield (Table 4-3, entry 9). While formation 
of the naphthyl ring was expected, macrolactonization to form a bridging eight-membered 
bicycle was not. This framework is completely unprecedented in the literature. Finally, all 
attempts to access the expected naphthalene from penta-substituted DHF acetal 4-7v failed 
and only furan formation was observed (Scheme 4-6). 
 
 
Scheme 4-6. Formation of furan 4-4v from penta-substituted DHF 4-7v. 
 
Based on our ongoing interest in the synthesis of indole-containing compounds, a 
series of DHF acetals substituted at the 5-position with the nitrogen of an indole was 
prepared and subjected to the initial reaction conditions (Scheme 4-7). In each case, only 
cycloisomerization was observed and the final elimination/aromatization does not take place. 
For example, N-indole substituted DHF N,O-acetals 4-7w and 4-7x gave the resulting 





















n-Pr desired product (4-8v) (not observed)
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2-(1H-Indol-1-yl)-3a,4,5,6a-tetrahydrofuro[2,3-b]furan 4-7y provided the tetracyclic 8,9-
dihydropyrido[1,2-a]indol-6(7H)-one 4-12y in 85% yield. Lastly, the corresponding 2-(1H-
pyrrol-1-yl) DHF N,O-acetal 4-7z afforded 7,8-dihydroindolizin-5(6H)-one 4-12z in 54% 
yield. The barrier to heteroaromatization is presumably too high for compounds 4-12w to 4-
12z when compared to formation of a benzene ring. 
 
 
Scheme 4-7. Reactions of 2-(1H-indol-1-yl) and 2-(1H-pyrrol-1-yl) DHF acetals 4-7w to 4-7z. 
 
4.3 Conclusions 
In conclusion, we have developed a powerful new strategy towards accessing 
functionalized benzo-fused (hetero)aromatics from DHF acetals. The positioning of each 
functional group was strategic and essential for the benzannulation cascade due to: 1) the 
anchimeric assistance of the acetal heteroatom allows DHF ring-opening under catalytic 
conditions; 2) the 1,3-ketoester group provides the bidentate six-membered Lewis acid-
enolate chelate; 3) the carbocation is intramolecularly trapped by a π-nucleophile; and 4) the 

















































Benzofused products are obtained in up to 95% yield using catalytic amounts of 
Al(OTf)3. The approach offers excellent regiocontrol based on choice of alkene used to form 
the requisite DHF acetal. Moreover, in the cases of N-indolyl or N-pyrrolyl substituted DHF 
acetals, cycloisomerization products are obtained in good yields. This method represents 
novel reactivity for DHF acetals and allows for future methodologies (inter- and 
intramolecular) to be developed with DHF acetals as a versatile synthetic building block.  
Future work will involve: (1) utilization of the method to access several naturally-occurring 
compounds; (2) improving the product yields of the fused bicyclic N,O-acetals; and (3) 
accessing benzannulated products from pentasubstituted DHF acetals. 
 
4.4 Experimental 
4.4.1. General Methods  
All reactions were carried out in pre-dried glassware from the oven and any 
additional moisture was removed by flame-drying the reaction vessel under vacuum. Each 
reaction proceeded under a nitrogen atmosphere with anhydrous solvents. Tetrahydrofuran 
and diethyl ether were distilled from a sodium/benzophenoneketyl under nitrogen and stored 
in a Schlenk flask. 1,2-Dichloroethane and dichloromethane were purified by distillation 
from calcium hydride. Anhydrous toluene and acetonitrile was purchased from EMD 
Chemicals and used without further purification. Methyl- and ethyl acetate were fractionally 
distilled over P2O5. All other reagents were purchased from Acros, Sigma-Aldrich, Fluka, 
VWR, Merck, Alfa Aesar, TCI and Strem (for metal catalysts) and used without further 
purification. β-ketoester compounds 4-11a and 4-11b were synthesized as previously 
reported.18 α-Diazo compounds 4-9k, 4-9m, 4-9w, 4-9x, and 4-9z were synthesized as 
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previously reported.14 Enol ethers 4-10p, 4-10u and 4-10v were synthesized as previously 
reported. 2,3-DHF 4-7y was synthesized as previously reported.14b 
Chromatographic purification was performed as flash chromatography with Dynamic 
Adsorbents silica gel (32-65 µm) and solvents indicated as eluent with 0.1-0.5 bar pressure. 
For quantitative flash chromatography, technical grades solvents were utilized. Analytical 
thin-layer chromatography (TLC) was performed on EMD silica gel 60 F254 TLC glass 
plates. Visualization was accomplished with UV light or iodine chamber. Each yield refers to 
an isolated, analytically-pure material.  
Infrared (IR) spectra were obtained using a Bruker alpha FTIR with an ATR 
attachment. The IR bands are characterized as weak (w), medium (m), and strong (s). Proton 
and carbon nuclear magnetic resonance spectra (1H NMR and 13C NMR) were recorded on 
Variant 300 MHz, Bruker Avance 400 MHz or 500 MHz spectrometer with solvent 
resonances as the internal standard (1H NMR: CDCl3 at 7.26 ppm; 13C NMR: CDCl3 at 77.0 
ppm). 1H NMR data are reported as follows: chemical shift (ppm), multiplicity (s = singlet, d 
= doublet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of 
doublets, t = triplet, m = multiplet), coupling constants (Hz), and integration. Mass spectra 
were obtained using a VG-70SE instrument. Uncorrected melting points were measured with 
a digital melting point apparatus (DigiMelt MPA 160). 
 
4.4.2. Experimental Procedures 
 a. Formation of α-diazo compounds 4-9a to 4-9h 
General Diazo Transfer Procedure: To a solution of β-ketoester 4-11 (1 equiv.) in CH3CN 
(0.5-1.0 M) was added triethylamine (1.2 equiv.) at RT. After 5 min of vigorous stirring, 
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tosyl azide (1.2 equiv.) was added and the reaction was stirred for 3 h at room temperature. 
At this point, the reaction mixture was concentrated in vacuo and purified via silica gel flash 
chromatography (eluting with EtOAc:Hexanes or Et2O:Hexanes) to isolate the product. 
 
  
Ethyl 2-diazo-3-(furan-2-yl)-3-oxopropanoate (4-9a). The general procedure was followed 
using β-ketoester 4-11a (27.2 g, 149 mmol) in CH3CN (150.0 mL), triethylamine (25.0 mL, 
180 mmol) and tosyl azide (35.3 g, 179 mmol). The reaction mixture was concentrated under 
reduced pressure and purified via column chromatography (15% EtOAc/hexane, Rf = 0.20) to 




Ethyl 2-diazo-3-oxo-3-(thiophen-2-yl)propanoate (4-9b). The general procedure was 
followed using β-ketoester 4-11b (4.21 g, 21.2 mmol) in CH3CN (43.0 mL), triethylamine 
(3.6 mL, 26.0 mmol) and tosyl azide (5.03 g, 25.5 mmol). The reaction mixture was 
concentrated under reduced pressure and purified via column chromatography (15% 
EtOAc/hexane, Rf = 0.16) to afford diazo 4-9b (4.75 g, 99%) as a bright yellow oil. Spectral 














Ethyl 2-diazo-3-(furan-3-yl)-3-oxopropanoate (4-9c). The general procedure was followed 
using commercially available β-ketoester 4-11c (2.85 g, 15.6 mmol) in CH3CN (32.0 mL), 
triethylamine (2.6 mL, 18.6 mmol) and tosyl azide (3.70 g, 18.8 mmol). The reaction mixture 
was concentrated under reduced pressure and purified via column chromatography (15% 
EtOAc/hexane, Rf = 0.23) to afford diazo 4-9c (3.22 g, 99%) as a bright yellow oil. 1H NMR 
(500 MHz, CDCl3): δ 8.41 - 8.45 (m, 1 H), 7.39 - 7.42 (m, 1 H), 6.86 - 6.89 (m, 1 H), 4.28 (q, 
J = 7.5 Hz, 2 H), 1.34 (t, J = 7.5 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ 177.7, 160.8, 
148.9, 142.6, 124.8, 110.2, 78.0, 61.4, 14.2. IR: 2983.9 (w), 2133.3 (s), 1716.7 (s), 1373.3 




Ethyl 2-diazo-3-oxo-3-(thiophen-3-yl)propanoate (4-9d). 
 
Preparation of Ethyl 3-oxo-3-(thiophen-3-yl)propanoate (4-11d). To a solution of LHMDS 
(1.0 M in THF, 40.5 mL, 40.5 mmol) at -78 °C was added EtOAc (2.0 mL, 20.3 mmol) in 
one shot. The reaction mixture was stirred at -78 °C for 45 min prior the addition of 
thiophene-3-carbonyl chloride (2.83 g, 19.3 mmol) in THF (30.0 mL). After stirring for 30 
min at -78 °C, the reaction was quenched with saturated NH4Cl, extracted with EtOAc (3x), 














to afford β-ketoester 4-11d (3.08 g, 81%) as a bright yellow oil. Spectral data matches with 
reported values.20 
 
Preparation of 4-9d. The general procedure was followed using β-ketoester 4-11d (3.07 g, 
15.5 mmol) in CH3CN (31.0 mL), triethylamine (2.6 mL, 18.6 mmol) and tosyl azide (3.68 g, 
18.7 mmol). The reaction mixture was concentrated under reduced pressure and purified via 
column chromatography to afford diazo 4-9d (3.37 g, 97%) as a bright yellow oil. 1H NMR 
(300 MHz, CDCl3): δ 8.14 - 8.20 (m, 1 H), 7.44 - 7.51 (m, 1 H), 7.23 - 7.29 (m, 1 H), 4.23 - 
4.33 (m, 2 H), 1.26 - 1.34 (m, 3 H). 13C NMR (75 MHz, CDCl3): δ 179.2, 160.9, 139.0, 
132.7, 127.9, 124.8, 61.5, 14.2; diazo C not observed. IR: 3109.3 (w), 2983.8 (w), 2135.2 (s), 
1714.7 (s), 1587.4 (m), 1311.59 (s), 1107.14 (s). HRMS (EI) m/z: [M+] calcd. for 
C9H8O3N2S, 224.0256; found, 224.0259. 
 
 
Ethyl 3-(benzofuran-2-yl)-2-diazo-3-oxopropanoate (4-9e). 
 
Preparation of Ethyl 3-(benzofuran-2-yl)-3-oxopropanoate (4-11e). To a solution of LHMDS 
(1.0 M in THF, 32.4 mL, 32.4 mmol) at -78 °C was added EtOAc (1.6 mL, 16.3 mmol) in 
one shot. The reaction mixture was stirred at -78 °C for 45 min prior the addition of 
benzofuran-2-carbonyl chloride (2.78 g, 15.4 mmol) in THF (30.0 mL). After stirring for 30 
min at -78 °C, the reaction was quenched with saturated NH4Cl, extracted with EtOAc (3x), 







to afford β-ketoester 4-11e (2.68 g, 67%) as a orange oil. Spectral data matches with reported 
values.21 
 
Preparation of 4-9e. The general procedure was followed using β-ketoester 4-11e (2.66 g, 
11.5 mmol) in CH3CN (23.0 mL), triethylamine (1.9 mL, 13.7 mmol) and tosyl azide (2.71 g, 
13.7 mmol). The reaction mixture was concentrated under reduced pressure and purified via 
column chromatography (15% Et2O/hexane, Rf = 0.16) to afford diazo 4-9e (1.89 g, 64%) as 
a bright yellow solid (mp: 75-77 °C). 1H NMR (500 MHz, CDCl3): δ 7.82 (s, 1 H), 7.68 (d, J 
= 7.9 Hz, 1 H), 7.53 (d, J = 8.2 Hz, 1 H), 7.44 (t, J = 7.5 Hz, 1 H), 7.22 - 7.33 (m, 1 H), 4.34 
(q, J = 7.0 Hz, 2 H), 1.33 (t, J = 7.0 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ 172.2, 160.6, 
154.9, 150.4, 128.0, 126.7, 123.7, 123.2, 114.9, 112.0, 75.4, 61.7, 14.1. IR: 2982.0 (w), 
2142.9 (s), 1730.2 (s), 1612.5 (m), 1305.8 (s), 1103.3 (m). HRMS (EI) m/z: [M-Na+] calcd. 
for C13H10O4N2Na, 281.0533; found, 281.0525. 
 
 
Ethyl 2-diazo-3-(naphthalen-2-yl)-3-oxopropanoate (4-9f). 
 
Preparation of Ethyl 3-(naphthalen-2-yl)-3-oxopropanoate (4-11f). To a solution of LHMDS 
(1.0 M in THF, 33.0 mL, 33.0 mmol) at -78 °C was added EtOAc (1.6 mL, 16.3 mmol) in 
one shot. The reaction mixture was stirred at -78 °C for 45 min prior the addition of 2-
naphthoyl chloride (3.02 g, 15.8 mmol) in THF (30.0 mL). After stirring for 30 min at -78 







Na2SO4, and purified via column chromatography (10% Et2O/hexane, Rf = 0.16) to afford β-
ketoester 4-11f (3.30 g, 86%) as a orange oil. Spectral data matches with reported values.22 
 
Preparation of 4-9f. The general procedure was followed using β-ketoester 4-11f (3.27 g, 
13.5 mmol) in CH3CN (27.0 mL), triethylamine (2.3 mL, 16.6 mmol) and tosyl azide (3.19 g, 
16.2 mmol). The reaction mixture was concentrated under reduced pressure and purified via 
column chromatography (10% Et2O/hexane, Rf = 0.14) to afford diazo 4-9f (3.45 g, 95%) as 
a bright yellow solid (mp: 60-61 °C). 1H NMR (500 MHz, CDCl3): δ 8.18 (s, 1 H), 7.92 (d, J 
= 8.2 Hz, 1 H), 7.87 (d, J = 8.2 Hz, 2 H), 7.70 (dd, J = 8.5, 1.8 Hz, 1 H), 7.55 - 7.62 (m, 1 H), 
7.49 - 7.55 (m, 1 H), 4.26 (q, J = 7.2 Hz, 2 H), 1.24 (t, J = 7.2 Hz, 3 H). 13C NMR (125 
MHz, CDCl3): δ 186.7, 161.1, 135.1, 134.3, 132.1, 129.6, 129.2, 128.1, 127.8, 127.5, 126.6, 
124.6, 76.4, 61.6, 14.2. IR: 3061.0 (w), 2982.0 (w), 2144.6 (s), 1718.6 (s), 1618.3 (m), 




Ethyl 2-diazo-3-(3-methoxyphenyl)-3-oxopropanoate (4-9g). The general procedure was 
followed using commercially available β-ketoester 4-11g (3.01 g, 13.5 mmol) in CH3CN 
(25.0 mL), triethylamine (2.3 mL, 16.6 mmol) and tosyl azide (3.20 g, 16.2 mmol). The 
reaction mixture was concentrated under reduced pressure and purified via column 
chromatography (15% Et2O/hexane, Rf = 0.15) to afford diazo 4-9g (2.16 g, 64%) as a bright 








(dd, J = 2.4, 1.5 Hz, 1 H), 7.06 (ddd, J = 8.2, 2.4, 0.9 Hz, 1 H), 4.24 (q, J = 7.0 Hz, 2 H), 3.82 
(s, 3 H), 1.25 (t, J = 7.0 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ 186.5, 160.9, 159.1, 
138.2, 128.8, 120.7, 118.3, 113.1, 76.0, 61.6, 55.3, 14.1. IR: 2982.0 (w), 2133.3 (s), 1718.6 




Ethyl 2-diazo-3-(3,5-dimethoxyphenyl)-3-oxopropanoate (4-9h). 
 
Ethyl 3-(3,5-dimethoxyphenyl)-3-oxopropanoate (4-11h). To a solution of LHMDS (1.0 M in 
THF, 31.5 mL, 31.5 mmol) at -78 °C was added EtOAc (1.5 mL, 15.3 mmol) in one shot. 
The reaction mixture was stirred at -78 °C for 45 min prior the addition of 3,5-
dimethoxybenzoyl chloride (2.90 g, 14.5 mmol) in THF (30.0 mL). After stirring for 30 min 
at -78 °C, the reaction was quenched with saturated NH4Cl, extracted with EtOAc (3x), dried 
over Na2SO4, and purified via column chromatography (10% Et2O/hexane, Rf = 0.07) to 
afford β-ketoester 4-11h (2.49 g, 68%) as a colorless oil. Spectral data matches with reported 
values.23 
 
Preparation of 4-9h. The general procedure was followed using β-ketoester 4-11h (2.46 g, 
9.75 mmol) in CH3CN (20.0 mL), triethylamine (1.7 mL, 12.3 mmol) and tosyl azide (2.30 g, 
11.7 mmol). The reaction mixture was concentrated under reduced pressure and purified via 









a bright yellow oil. 1H NMR (500 MHz, CDCl3): δ 6.75 (d, J = 2.4 Hz, 2 H), 6.60 (t, J = 2.4 
Hz, 1 H), 4.25 (q, J = 7.2 Hz, 2 H), 1.26 (t, J = 7.2 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ 
186.4, 160.9, 160.3, 138.8, 106.1, 104.4, 76.0, 61.6, 55.5, 14.2. IR: 3007.0 (w), 2941.4 (w), 
2839.2 (w), 2129.4 (s), 1722.4 (s), 1591.3 (s), 1305.8 (s), 1155.4 (s). HRMS (EI) m/z: [M-
Na+] calcd. for C13H14O5N2Na, 301.0795; found, 301.0790. 
 
b. Formation of 2,3-dihydrofuran acetals 7-9a to 7-9z 
General DHF Formation Procedure: A pre-dried round bottom flask was charged with 
Rh2esp2 (0.1-0.2 mol%) and CH2Cl2 (2.0-4.0 mL). After cooling the solution to 0 °C, the 
corresponding alkene (1.0-3.0 equiv.) was added to the reaction vessel. A precooled solution 
of the α-diazo ester (1.0-1.3 equiv.) in CH2Cl2 (0.25-0.50 M) was then added to the reaction 
in one shot, keeping the reaction mixture at 0 °C. After stirring for 2 h at 0 °C, the ice bath 
was removed and the reaction was allowed to warm up to rt and stirred for 1-2 hr. After 
complete consumption of the diazo compound, the reaction was quenched with saturated 
aqueous thiourea and allowed to stir for 30 minutes. The mixture was transferred to a 
separatory funnel and extracted with CH2Cl2 (2x). The organic layer was washed with brine, 




Ethyl 5-ethoxy-4,5-dihydro-[2,2'-bifuran]-3-carboxylate (4-7a). The general protocol was 







ether (1.56 g, 21.6 mmol), and diazo 4-9a (5.00 g, 24.0 mmol) in CH2Cl2 (24 mL). The 
reaction was quenched and column chromatography (10% Et2O/hexane, Rf = 0.23) afforded 
4-7a (2.50 g, 49%) as a light yellow solid (mp: 61-63 °C). 1H NMR (300 MHz, CDCl3): δ 
7.79 (d, J = 3.7 Hz, 1H), 7.52 (d J = 1.8 Hz, 1H), 6.52 (dd, J = 3.7, 1.8 Hz, 1H), 5.67 (dd, J = 
7.3, 2.7 Hz, 1H), 4.20 (m, 2H), 3.96 (dq, J = 9.5, 7.1 Hz, 1H), 3.65 (dq, J = 9.5, 7.1 Hz, 1H), 
3.23 (dd, J=16.9, 7.3 Hz, 1H), 2.94 (dd, J=16.9, 2.7 Hz, 1H), 1.29 (t, J = 7.1 Hz, 3H), 1.24 (t, 
J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 164.3, 152.6, 144.4, 143.9, 117.6, 111.9, 
104.6, 100.8, 64.3, 59.8, 37.9, 15.0, 14.4. IR: 2980.3 (w), 1733.9 (s), 1674.8 (s), 1464.6 (m), 




Ethyl 5-ethoxy-2-(thiophen-2-yl)-4,5-dihydrofuran-3-carboxylate (4-7b). The general 
protocol was followed using a solution of Rh2esp2 (1.8 mg, 2.3 µmol) in CH2Cl2 (2.0 mL), 
ethyl vinyl ether (126 mg, 1.75 mmol), and diazo 4-9b (497 mg, 2.22 mmol) in CH2Cl2 (4.5 
mL). The reaction was quenched and column chromatography (10% Et2O/hexane, Rf = 0.24) 
afforded 4-7b (338 mg, 72%) as a white solid (mp: 35-36 °C). 1H NMR (400 MHz, CDCl3): 
δ 8.21 (dd, J = 3.9, 1.1 Hz, 1H), 7.49 (dd, J = 5.0, 1.1 Hz, 1H), 7.10 (dd, J = 5.0, 3.9 Hz, 1H), 
5.63 (dd, J = 7.3, 2.5 Hz, 1H), 4.15 - 4.30 (m, 2H), 3.94 (dq, J = 9.6, 7.1 Hz, 1H), 3.66 (dq, J 
= 9.6, 7.1 Hz, 1H), 3.25 (dd, J = 16.8, 7.3 Hz, 1H), 2.97 (dd, J = 16.8, 2.5 Hz, 1H), 1.30 (t, J 
= 7.1 Hz, 3H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 164.9, 156.5, 132.1, 







1732.7 (s), 1659.0 (s), 1516.7 (m), 1411.6 (s), 1242.0 (s), 1056.6 (m), 730.4 (s). HRMS 
(ESI) m/z: [M-Na+] calcd. for C13H16O4NaS, 291.0662; found, 291.0659. 
 
 
Ethyl 5-ethoxy-4,5-dihydro-[2,3'-bifuran]-3-carboxylate (4-7c). The general protocol was 
followed using a solution of Rh2esp2 (1.4 mg, 1.8 µmol) in CH2Cl2 (2.0 mL), ethyl vinyl 
ether (134 mg, 1.86 mmol), and diazo 4-9c (509 mg, 2.45 mmol) in CH2Cl2 (5.0 mL). The 
reaction was quenched and column chromatography (10% Et2O/hexane, Rf = 0.28) afforded 
4-7c (234 mg, 50%) as a light yellow oil. 1H NMR (400 MHz, CDCl3): δ 8.43 - 8.48 (m, 
1H), 7.38 - 7.44 (m, 1H), 6.97 - 7.03 (m, 1H), 5.57 - 5.64 (m, 1H), 4.13 - 4.27 (m, 2H), 3.86 - 
3.96 (m, 1H), 3.58 - 3.69 (m, 1H), 3.19 (dd, J = 16.6, 7.3 Hz, 1H), 2.91 (dd, J = 16.6, 2.8 Hz, 
1H), 1.29 (t, J = 7.2 Hz, 3H), 1.25 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 165.0, 
156.4, 146.8, 142.4, 116.5, 110.1, 104.1, 101.0, 64.1, 59.7, 37.9, 15.1, 14.4. IR: 2979.7 (w), 
2938.6 (w), 1734.9 (s), 1678.4 (s), 1156.2 (s). HRMS (ESI) m/z: [M-H+] calcd. for C13H17O5, 
253.1071; found, 253.1069. 
 
 
Ethyl 5-ethoxy-2-(thiophen-3-yl)-4,5-dihydrofuran-3-carboxylate (4-7d). The general 
protocol was followed using a solution of Rh2esp2 (3.7 mg, 4.8 µmol) in CH2Cl2 (4.0 mL), 
ethyl vinyl ether (295 mg, 4.09 mmol), and diazo 4-9d (1.00 g, 4.46 mmol) in CH2Cl2 (9.0 












afforded 4-7d (403 mg, 37%) as a light yellow oil. 1H NMR (500 MHz, CDCl3): δ 8.43 (dd, 
J = 3.1, 1.2 Hz, 1H), 7.76 (dd, J = 5.2, 1.2 Hz, 1H), 7.28 (dd, J = 5.2, 3.1 Hz, 1H), 5.61 (dd, J 
= 7.3, 2.4 Hz, 1H), 4.13 - 4.26 (m, 2H), 3.93 (dq, J = 9.6, 7.1 Hz, 1H), 3.65 (dq, J = 9.6, 7.1 
Hz, 1H), 3.24 (dd, J = 16.6, 7.3 Hz, 1H), 2.95 (dd, J = 16.6, 2.4 Hz, 1H), 1.23 - 1.31 (m, 6H). 
13C NMR (125 MHz, CDCl3): δ 165.0, 157.8, 130.9, 130.2, 128.4, 124.4, 103.8, 100.9, 64.1, 
59.8, 38.3, 15.2, 14.4. IR: 3112.4 (w), 2978.9 (w), 1734.2 (s), 1675.8 (s), 1508.1 (m), 1248.9 
(m). HRMS (EI) m/z: [M+] calcd. for C13H16O4S, 268.0769; found, 268.0760. 
 
 
Ethyl 2-(benzofuran-2-yl)-5-ethoxy-4,5-dihydrofuran-3-carboxylate (4-7e). The general 
protocol was followed using a solution of Rh2esp2 (1.3 mg, 1.7 µmol) in CH2Cl2 (2.0 mL), 
ethyl vinyl ether (92.3 mg, 1.28 mmol), and diazo 4-9e (355 mg, 1.37 mmol) in CH2Cl2 (4.1 
mL). The reaction was quenched and column chromatography (7% Et2O/hexane, Rf = 0.16) 
afforded 4-7e (172 mg, 45%) as a light yellow oil. 1H NMR (500 MHz, CDCl3): δ 8.21 (s, 
1H), 7.65 (d, J = 7.8 Hz, 1H), 7.55 (dd, J = 8.4, 1.2 Hz, 1H), 7.37 (td, J = 7.8, 1.2 Hz, 1H), 
7.23 - 7.28 (m, 1H), 5.74 (dd, J = 7.2, 2.6 Hz, 1H), 4.18 - 4.32 (m, 2H), 4.02 (dq, J = 9.6, 7.2 
Hz, 1H), 3.70 (dq, J = 9.6, 7.2 Hz, 1H), 3.29 (dd, J = 17.1, 7.2 Hz, 1H), 3.01 (dd, J = 17.1, 
2.6 Hz, 1H), 1.32 (t, J = 7.2 Hz, 3H), 1.24 - 1.29 (t, J = 7.2, 3H). 13C NMR (125 MHz, 
CDCl3): δ 164.2, 154.6, 152.7, 145.5, 128.0, 126.3, 123.2, 122.2, 113.6, 111.6, 104.7, 103.9, 
64.4, 60.0, 38.2, 15.0, 14.4. IR: 2979.9 (w), 2929.3 (w), 1736.1 (s), 1682.4 (s), 1555.5 (s), 










Ethyl 5-ethoxy-2-(naphthalen-2-yl)-4,5-dihydrofuran-3-carboxylate (4-7f). The general 
protocol was followed using a solution of Rh2esp2 (1.3 mg, 1.7 µmol) in CH2Cl2 (2.0 mL), 
ethyl vinyl ether (125 mg, 1.73 mmol), and diazo 4-9f (503 mg, 1.87 mmol) in CH2Cl2 (5.9 
mL). The reaction was quenched and column chromatography (10% Et2O/hexane, Rf = 0.23) 
afforded 4-7f (280 mg, 52%) as a colorless oil. 1H NMR (500 MHz, CDCl3): δ 8.37 (s, 1 H), 
7.87 - 7.93 (m, 2 H), 7.81 - 7.86 (m, 2 H), 7.46 - 7.58 (m, 2 H), 5.70 (dd, J = 7.6, 2.7 Hz, 1 
H), 4.09 - 4.23 (m, 2 H), 4.00 (dq, J = 9.6, 7.2 Hz, 1 H), 3.70 (dq, J = 9.6, 7.0 Hz, 1 H), 3.33 
(dd, J = 16.5, 7.6 Hz, 1 H), 3.03 (dd, J = 16.5, 2.7 Hz, 1 H), 1.30 (t, J = 7.0 Hz, 3 H), 1.21 (t, 
J = 7.2 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ 164.9, 162.8, 134.1, 132.4, 129.8, 128.8, 
127.6, 127.4, 127.1, 127.0, 126.2, 126.2, 104.2, 102.5, 64.3, 59.8, 38.5, 15.2, 14.3. IR: 
3071.0 (w), 2981.4 (w), 1734.9 (s), 1683.8 (s), 1124.7 (m). HRMS (ESI) m/z: [M-H+] calcd. 
for C19H21O4, 313.1434; found, 313.1431. 
 
 
Ethyl 5-ethoxy-2-(3-methoxyphenyl)-4,5-dihydrofuran-3-carboxylate (4-7g). The general 
protocol was followed using a solution of Rh2esp2 (1.2 mg, 1.6 µmol) in CH2Cl2 (2.0 mL), 
ethyl ninyl ether (94.1 mg, 1.30 mmol), and diazo 4-9g (367 mg, 1.48 mmol) in CH2Cl2 (4.4 
mL). The reaction was quenched and column chromatography (10% Et2O/hexane, Rf = 0.18) 











(m, 2 H), 7.27 - 7.33 (m, 1 H), 6.94 - 6.99 (m, 1 H), 5.63 (dd, J = 7.3, 2.7 Hz, 1 H), 4.08 - 
4.19 (m, 2 H), 3.94 (dq, J = 9.5, 7.0 Hz, 1 H), 3.83 (s, 3 H), 3.65 (dq, J = 9.5, 7.0 Hz, 1 H), 
3.26 (dd, J = 16.5, 7.3 Hz, 1 H), 2.96 (dd, J = 16.5, 2.7 Hz, 1 H), 1.26 (t, J = 7.0 Hz, 3 H), 
1.21 (t, J = 7.0 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ 164.7, 162.5, 158.8, 131.2, 128.6, 
121.8, 116.2, 114.7, 104.1, 102.3, 64.2, 59.7, 55.3, 38.4, 15.1, 14.2. IR: 2979.6 (w), 2835.7 
(w), 1730.6 (s), 1686.3 (s), 1583.2 (m), 1261.4 (s), 1032.0 (s). HRMS (EI) m/z: [M+] calcd. 
for C16H20O5, 292.1311; found, 292.1301. 
 
 
Ethyl 2-(3,5-dimethoxyphenyl)-5-ethoxy-4,5-dihydrofuran-3-carboxylate (4-7h). The 
general protocol was followed using a solution of Rh2esp2 (1.3 mg, 1.7 µmol) in CH2Cl2 (2.0 
mL), ethyl vinyl ether (87.0 mg, 1.21 mmol), and diazo 4-9h (359 mg, 1.29 mmol) in CH2Cl2 
(3.5 mL). The reaction was quenched and column chromatography (15% Et2O/hexane, Rf = 
0.15) afforded 4-7h (212 mg, 55%) as a colorless oil. 1H NMR (500 MHz, CDCl3): δ 7.03 (d, 
J = 2.4 Hz, 2 H), 6.52 (t, J = 2.4 Hz, 1 H), 5.62 (dd, J = 7.3, 2.7 Hz, 1 H), 4.08 - 4.19 (m, 2 
H), 3.93 (dd, J = 9.5, 7.2 Hz, 1 H), 3.81 (s, 6 H), 3.65 (dd, J = 9.5, 7.2 Hz, 1 H), 3.26 (dd, J = 
16.5, 7.3 Hz, 1 H), 2.96 (dd, J = 16.5, 2.7 Hz, 1 H), 1.26 (t, J = 7.0 Hz, 3 H), 1.21 (t, J = 7.2 
Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ 164.7, 162.3, 160.0 (2C), 131.6, 107.4 (2C), 
104.0, 102.7, 102.5, 64.2, 59.8, 55.4 (2C), 38.5, 15.1, 14.2. IR: 2985.9 (w), 1701.8 (m), 
1590.6 (s), 1248.4 (s), 1157.4 (s), 1082.3 (s). HRMS (ESI) m/z: [M-Na+] calcd. for 










Ethyl 5-(tert-butoxy)-2-(3,5-dimethoxyphenyl)-4,5-dihydrofuran-3-carboxylate (4-7i). 
The general protocol was followed using a solution of Rh2esp2 (1.1 mg, 1.5 µmol) in CH2Cl2 
(2.0 mL), tert-butyl vinyl ether (118 mg, 1.18 mmol), and diazo 4-9h (359 mg, 1.29 mmol) in 
CH2Cl2 (3.5 mL). The reaction was quenched and column chromatography (15% 
Et2O/hexane, Rf = 0.18) afforded 4-7i (274 mg, 67%) as a colorless oil. 1H NMR (500 MHz, 
CDCl3): δ 7.05 (d, J = 2.3 Hz, 2 H), 6.51 (t, J = 2.3 Hz, 1 H), 5.88 (dd, J = 7.6, 3.1 Hz, 1 H), 
4.09 - 4.18 (m, 2 H), 3.80 (s, 6 H), 3.27 (dd, J = 16.5, 7.6 Hz, 1 H), 2.90 (dd, J = 16.5, 3.1 
Hz, 1 H), 1.33 (s, 9 H), 1.21 (t, J = 7.2 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ 164.9, 
162.3, 159.9 (2C), 131.9, 107.4 (2C), 102.6, 102.0, 99.1, 75.7, 59.7, 55.4 (2C), 39.4, 28.8, 
14.3. IR: 2937.8 (w), 1740.1 (w), 1662.0 (m), 1607.2 (s), 1250.0 (s), 1201.5 (s), 1025.3 (m), 




(4-7j). The general protocol was followed using a solution of Rh2esp2 (1.0 mg, 1.3 µmol) in 
CH2Cl2 (2.0 mL), vinyloxy-trimethylsilane (136 mg, 1.17 mmol), and diazo 4-9h (359 mg, 
1.29 mmol) in CH2Cl2 (3.5 mL). The reaction was quenched and column chromatography 
(15% Et2O/hexane, Rf = 0.23) afforded 4-7j (192 mg, 45%) as a colorless oil. 1H NMR (500 
MHz, CDCl3): δ 7.05 (d, J = 2.4 Hz, 2 H), 6.52 (t, J = 2.4 Hz, 1 H), 5.92 (dd, J = 7.0, 2.4 Hz, 














2.4 Hz, 1 H), 1.22 (t, J = 7.0 Hz, 3 H), 0.23 (s, 9 H). 13C NMR (125 MHz, CDCl3): δ 164.9, 
161.9, 160.0 (2C), 131.6, 107.3 (2C), 102.9, 102.2, 98.8, 59.8, 55.4 (2C), 41.0, 14.3, 0.2. IR: 
2938.9 (w). 2839.9 (w), 1735.5 (w), 1661.4 (m), 1606.8 (s), 1443.0 (m), 1333.1 (m), 1249.6 





carboxylate (4-7k). The general protocol was followed using a solution of Rh2esp2 (2.2 mg, 
2.9 µmol) in CH2Cl2 (2.0 mL), N-methyl-N-vinylacetamide (139 mg, 1.40 mmol), and diazo 
4-9k (405 mg, 1.53 mmol) in CH2Cl2 (4.9 mL). The reaction was quenched and column 
chromatography (50% EtOAc/hexane, Rf = 0.14) afforded 4-7k (407 mg, 87%) as a white 
solid (mp: 142-144 °C). Mixture of rotamers. 1H NMR (500 MHz, CDCl3, 60 °C): δ 7.04 
(bs, 2.50), 6.55 (t, J = 2.3 Hz, 1.00), 6.14 - 6.47 (bs, 0.50), 3.81 (s, 6.00), 3.70 (s, 3.00), 3.31 
- 3.42 (m, 1.00), 2.94 (bs, 4.00), 2.06 - 2.36 (bs, 3.00). 13C NMR (100 MHz, CDCl3): δ 
171.3, 170.3, 164.9, 164.6, 163.9, 163.6, 160.1 (2C), 130.6, 130.4, 107.2 (2C), 103.4, 101.6, 
101.5, 88.5, 83.4, 55.5 (2C), 51.3, 51.2, 34.9, 34.5, 29.1, 26.3, 22.2, 21.7. IR: 3004.3 (w), 
2951.0 (w), 2840.3 (w), 1668.6 (s), 1588.1 (s), 1426.9 (m), 1247.3 (s), 1156.5 (s), 1091.5 (s). 



















carboxylate (4-7l). The general protocol was followed using a solution of Rh2esp2 (2.2 mg, 
2.9 µmol) in CH2Cl2 (2.0 mL), 1-vinyl-2-pyrrolidinone (119 mg, 1.07 mmol), and diazo 4-9k 
(303 mg, 1.15 mmol) in CH2Cl2 (3.2 mL). The reaction was quenched and column 
chromatography (50% EtOAc/hexane, Rf = 0.12) afforded 4-7l (254 mg, 68%) as a white 
solid (mp: 124-126 °C). 1H NMR (500 MHz, CDCl3): δ 7.02 (d, J = 2.1 Hz, 2 H), 6.57 (dd, J 
= 10.1, 4.9 Hz, 1 H), 6.50 - 6.54 (m, 1 H), 3.79 (s, 6 H), 3.68 (s, 3 H), 3.40 - 3.48 (m, 1 H), 
3.30 - 3.39 (m, 2 H), 2.92 (dd, J = 16.5, 4.9 Hz, 1 H), 2.42 (t, J = 8.1 Hz, 2 H), 1.98 - 2.10 
(m, 2 H). 13C NMR (125 MHz, CDCl3): δ 175.4, 164.8, 163.4, 160.0 (2C), 130.4, 107.1 (2C), 
103.3, 101.1, 81.6, 55.4 (2C), 51.2, 41.2, 34.2, 31.0, 17.7. IR: 2948.4 (w), 2839.2 (w), 1695.9 
(s), 1588.7 (s), 1457.6 (m), 1425.0 (m), 1248.4 (m), 1204.1 (s), 1156.0 (s), 1090.3 (m), 




Methyl 5-methoxy-5-methyl-2-(thiophen-3-yl)-4,5-dihydrofuran-3-carboxylate (4-7m). 
The general protocol was followed using a solution of Rh2esp2 (1.8 mg, 2.4 µmol) in CH2Cl2 
(2.0 mL), 2-methoxypropene (131 mg, 1.82 mmol), and diazo 4-9m (522 mg, 2.48 mmol) in 
CH2Cl2 (9.0 mL). The reaction was quenched and column chromatography (10% 
Et2O/hexane, Rf = 0.27) afforded 4-7m (286 mg, 65%) as a colorless oil. 1H NMR (300 
MHz, CDCl3): δ 8.46 (dd, J = 3.1, 1.2 Hz, 1 H), 7.77 (dd, J = 5.1, 1.2 Hz, 1 H), 7.29 (dd, J = 








1 H), 1.65 (s, 3 H). 13C NMR (75 MHz, CDCl3): δ 165.3, 158.2, 130.5, 130.4, 128.3, 124.5, 
109.6, 100.6, 51.1, 49.9, 41.0, 25.0. IR: 3123.1 (w), 2995.1 (w), 2946.3 (w), 2822.2 (w), 
1697.2 (s), 1612.2 (s), 1262.4 (m), 1110.2 (s), 1046.0 (s). HRMS (EI) m/z: [M+] calcd. for 
C12H14O4S, 254.0613; found, 254.0622. 
 
 
Ethyl 5-ethoxy-4-ethyl-2-(thiophen-3-yl)-4,5-dihydrofuran-3-carboxylate (4-7n). The 
general protocol was followed using a solution of Rh2esp2 (1.9 mg, 1.5 µmol) in CH2Cl2 (2.0 
mL), 1-butenyl ethyl ether (662 mg, 6.61 mmol), and diazo 4-9d (524 mg, 2.34 mmol) in 
CH2Cl2 (4.75 mL). The reaction was quenched and column chromatography (5% 
Et2O/hexane, Rf = 0.24) afforded 4-7n (141 mg, 21%) as a light yellow oil. Diastereomeric 
mixture: 2.8:1 (trans:cis ratio). 1H NMR (300 MHz, CDCl3): δ 8.38 (dd, J = 3.1, 1.2 Hz, 
0.36, minor), 8.22 (dd, J = 3.1, 1.2 Hz, 1.00, major), 7.72 (ddd, J = 5.1, 1.2, 0.6 Hz, 0.36, 
minor), 7.59 - 7.64 (m, 1.00, major), 7.20 - 7.27 (m, 1.36, major + minor), 5.60 (d, J = 7.3 
Hz, 1.00, major), 5.20 (dd, J = 1.7, 0.5 Hz, 0.36, minor), 4.08 - 4.27 (m, 2.72, major + 
minor), 3.83 - 3.99 (m, 1.36, major + minor), 3.54 - 3.70 (m, 1.36, major + minor), 3.24 (ddd, 
J = 9.2, 7.3, 3.7 Hz, 1.00, major), 3.03 - 3.10 (m, 0.36, minor), 1.67 - 1.93 (m, 2.36, major + 
minor), 1.39 - 1.57 (m, 0.36, minor), 1.19 - 1.30 (m, 8.16, major + minor), 0.88 - 1.00 (m, 
4.08, major + minor). 13C NMR (75 MHz, CDCl3): δ 165.3, 165.0, 157.8, 157.6, 131.1, 
131.0, 130.3, 129.7, 128.5, 128.4, 124.3, 124.2, 108.1, 106.3, 105.5, 105.3, 65.4, 64.0, 59.7, 
59.7, 51.4, 48.2, 24.3, 19.8, 15.2, 15.1, 14.3, 14.3, 12.5, 10.6. IR: 3106.7 (w), 2965.9 (w), 













Ethyl 2-(3,5-dimethoxyphenyl)-5-ethoxy-4-ethyl-4,5-dihydrofuran-3-carboxylate (4-7o). 
The general protocol was followed using a solution of Rh2esp2 (1.2 mg, 1.6 µmol) in CH2Cl2 
(2.0 mL), 1-butenyl ethyl ether (229 mg, 2.29 mmol), and diazo 4-9h (359 mg, 1.29 mmol) in 
CH2Cl2 (3.5 mL). The reaction was quenched and column chromatography (10% 
Et2O/hexane, Rf = 0.13) afforded 4-7o (206 mg, 46%) as a colorless oil. Diastereomeric 
mixture: 3.7:1 (trans:cis ratio). 1H NMR (500 MHz, CDCl3): δ 6.99 (d, J = 2.1 Hz, 0.54, 
minor), 6.86 (d, J = 2.1 Hz, 2.00, major), 6.52 (t, J = 2.1 Hz, 0.27, minor), 6.50 (t, J = 2.1 Hz, 
1.00 major), 5.63 (d, J = 7.3 Hz, 1.00, major), 5.24 (d, J = 1.8 Hz, 0.27, minor), 4.06 - 4.18 
(m, 2.54, major + minor), 3.89 - 3.97 (m, 1.27, major + minor), 3.81 (s, 1.62, minor), 3.80 (s, 
6.00, major), 3.60 - 3.71 (m, 1.27, major + minor), 3.24 - 3.31 (m, 1.00, major), 3.07 - 3.12 
(m, 0.27, minor), 1.73 - 1.96 (m, 2.27, major + minor), 1.50 - 1.61 (m, 0.27, minor), 1.24 - 
1.30 (m, 3.81, major + minor), 1.14 - 1.23 (m, 3.81, major + minor), 0.94 - 1.03 (m, 3.81, 
major + minor). 13C NMR (125 MHz, CDCl3): δ 165.2, 164.7, 162.5, 162.2, 160.0 (2C), 
132.2, 131.9, 108.5, 107.6, 107.2 (2C), 106.9, 106.8, 106.5, 102.7, 102.4, 65.4, 64.2, 59.6, 
55.4 (2C), 55.4, 51.5, 48.5, 24.3, 19.5, 15.2, 15.1, 14.2, 14.1, 12.5, 10.5. IR: 2966.6 (w), 
2839.1 (w), 1727.0 (w), 1592.3 (s), 1203.0 (s), 1153.3 (s). HRMS (ESI) m/z: [M-Na+] calcd. 













(4-7p). The general protocol was followed using a solution of Rh2esp2 (1.6 mg, 2.1 µmol) in 
CH2Cl2 (2.0 mL), (2-methoxyvinyl)benzene 4-10p (231 mg, 1.72 mmol), and diazo 4-9k 
(509 mg, 1.93 mmol) in CH2Cl2 (4.9 mL). The reaction was quenched and column 
chromatography (20% Et2O/hexane, Rf = 0.18) afforded 4-7p (306 mg, 48%) as a light 
yellow oil. 1H NMR (500 MHz, CDCl3): δ 7.29 - 7.34 (m, 2 H), 7.25 - 7.28 (m, 3 H), 7.08 (d, 
J = 2.4 Hz, 2 H), 6.58 (t, J = 2.3 Hz, 1 H), 5.72 (d, J = 7.9 Hz, 1 H), 4.59 (d, J = 7.6 Hz, 1 H), 
3.84 (m, 6 H), 3.48 (s, 3 H), 3.45 (s, 3 H). 13C NMR (125 MHz, CDCl3): δ 164.9, 163.4, 
160.1 (2C), 136.4, 131.3, 129.1 (2C), 127.8 (2C), 127.0, 107.6, 107.3 (2C), 107.2, 103.2, 
57.4, 55.5 (2C), 53.6, 51.0. IR: 3018.4 (w), 2949.3 (w), 2839.8 (w), 1734.2 (m), 1596.4 (s), 
1454.8 (m), 1204.3 (s), 1155.8 (m), 1066.4 (m). HRMS (EI) m/z: [M+] calcd. for C21H22O6, 




(4-7q). The general protocol was followed using a solution of Rh2esp2 (1.3 mg, 1.7 µmol) in 
CH2Cl2 (2.0 mL), 2-methoxypropene (101 mg, 1.40 mmol), and diazo 4-9k (401 mg, 1.52 
mmol) in CH2Cl2 (5.5 mL). The reaction was quenched and column chromatography (25% 
Et2O/hexane, Rf = 0.24) afforded 4-7q (387 mg, 90%) as a yellow oil. 1H NMR (500 MHz, 
















(s, 3 H), 3.12 - 3.19 (m, 1 H), 3.00 - 3.06 (m, 1 H), 1.65 (s, 3 H). 13C NMR (125 MHz, 
CDCl3): δ 165.1, 162.7, 160.1 (2C), 131.3, 109.8, 107.3 (2C), 103.0, 102.2, 55.5 (2C), 51.1, 
50.0, 41.4, 24.8. IR: 2999.2 (w), 2947.2 (w), 2837.1 (w), 1705.6 (m), 1588.8 (s), 1456.8 (m), 
1204.4 (s), 1156.8 (s), 1113.1 (s), 1041.5 (s), 855.1 (m). HRMS (EI) m/z: [M+] calcd. for 




carboxylate (4-7r). The general protocol was followed using a solution of Rh2esp2 (2.2 mg, 
2.9 µmol) in CH2Cl2 (2.0 mL), 3,4-dihydro-2H-pyran (117 mg, 1.39 mmol), and diazo 4-9k 
(401 mg, 1.52 mmol) in CH2Cl2 (4.9 mL). The reaction was quenched and column 
chromatography (30% Et2O/hexane, Rf = 0.31) afforded 4-7r (59 mg, 13%) as a light yellow 
oil. 1H NMR (500 MHz, CDCl3): δ 7.00 (d, J = 2.4 Hz, 2 H), 6.53 (t, J = 2.4 Hz, 1 H), 5.90 
(d, J = 7.3 Hz, 1 H), 3.83 - 3.90 (m, 2 H), 3.80 (s, 6 H), 3.68 (s, 3 H), 3.09 - 3.17 (m, 1 H), 
2.10 - 2.17 (m, 1 H), 1.64 - 1.75 (m, 3 H). 13C NMR (125 MHz, CDCl3): δ 165.3, 163.6, 
160.0 (2C), 131.3, 107.9, 107.1 (2C), 103.9, 103.4, 61.3, 55.4 (2C), 51.0, 39.4, 23.4, 20.3. 
IR: 2950.7 (m), 2841.5 (w), 1685.4 (m), 1585.8 (s), 1454.4 (m), 1425.3 (m), 1204.1 (s), 
1153.6 (s), 1087.2 (s), 1057.3 (s), 924.2 (m), 850.9 (m). HRMS (EI) m/z: [M+] calcd. for 

















7s). The general protocol was followed using a solution of Rh2esp2 (2.2 mg, 2.9 µmol) in 
CH2Cl2 (4.0 mL), 2,3-dihydrofuran (170 mg, 2.43 mmol), and diazo 4-9k (707 mg, 2.68 
mmol) in CH2Cl2 (8.0 mL). The reaction was quenched and column chromatography (30% 
Et2O/hexane, Rf = 0.24) afforded 4-7s (304 mg, 41%) as a light yellow solid (mp: 79-80 °C). 
1H NMR (500 MHz, CDCl3): δ 6.98 (d, J = 2.1 Hz, 2 H), 6.54 (t, J = 2.1 Hz, 1 H), 6.21 (d, J 
= 6.4 Hz, 1 H), 4.08 - 4.13 (m, 1 H), 3.94 - 4.00 (m, 1 H), 3.79 - 3.84 (m, 7 H), 3.70 (s, 3 H), 
2.07 - 2.26 (m, 2 H). 13C NMR (125 MHz, CDCl3): δ 165.2, 164.9, 160.0 (2C), 130.9, 108.9, 
107.2 (2C), 103.9, 103.4, 67.0, 55.5 (2C), 51.1, 48.8, 32.2. IR: 2990.4 (w), 2951.0 (m), 
2894.5 (w), 2839.9 (w), 1684.8 (m), 1586.7 (s), 1425.4 (m), 1237.0 (m), 1155.2 (s), 1054.5 





b]pyrrole-3,6-dicarboxylate (4-7t). The general protocol was followed using a solution of 
Rh2esp2 (3.5 mg, 4.6 µmol) in CH2Cl2 (4.0 mL), N-Boc-2,3-dihydro-1H-pyrrole (343 mg, 
2.03 mmol), and diazo 4-9k (1.19 g, 4.50 mmol) in CH2Cl2 (7.2 mL). The reaction was 
quenched and column chromatography (30% Et2O/hexane, Rf = 0.19) afforded 4-7t (196 mg, 
24%) as a light yellow oil. Mixture of rotamers. 1H NMR (500 MHz, CDCl3, 50 oC): δ 6.93 
(br. s., 2 H), 6.48 - 6.56 (m, 1 H), 6.11 - 6.42 (m, 1 H), 3.94 - 4.11 (m, 1 H), 3.79 (s, 6 H), 








H). 13C NMR (125 MHz, CDCl3): δ 164.9, 160.0, 107.3, 103.9, 103.2, 102.8, 100.5, 97.8, 
93.0, 92.6, 80.7, 55.4, 53.4, 51.8, 51.1, 48.6, 47.6, 44.3, 43.7, 31.0, 29.9, 28.6, 28.4, 28.3. IR: 
3002.2 (w), 2974.7 (w), 2888.8 (w), 1705.0 (s), 1589.8 (s), 1393.7 (s), 1157.5 (s), 1058.6 
(m). HRMS (EI) m/z: [M+] calcd. for C21H27NO7, 405.1788; found, 405.1783. 
 
 
Methyl 2-(3,5-dimethoxyphenyl)-1,6-dioxaspiro[4.4]non-2-ene-3-carboxylate (4-7u). The 
general protocol was followed using a solution of Rh2esp2 (1.4 mg, 1.8 µmol) in CH2Cl2 (2.0 
mL), 2-methylenetetrahydrofuran 4-10u (124 mg, 1.47 mmol), and diazo 4-9k (401 mg, 1.52 
mmol) in CH2Cl2 (4.9 mL). The reaction was quenched and column chromatography (25% 
Et2O/hexane, Rf = 0.23) afforded 4-7u along with 4-7u’ (216 mg, 46%) as a yellow oil. 
Mixture of inseparable compounds: 1.7:1 (4-7u:4-7u’ ratio). 1H NMR (500 MHz, CDCl3): δ 
6.98 (d, J = 2.4 Hz, 2.00, major), 6.97 (d, J = 2.4 Hz, 1.18, minor), 6.53 (t, J = 2.4 Hz, 0.59, 
minor), 6.51 (t, J = 2.4 Hz, 1.00, major), 4.18 - 4.01 (m, 3.18, major + minor), 3.79 - 3.82 (m, 
10.13, major + minor), 3.68 (s, 1.77, minor), 3.66 (s, 3.00, major), 3.21 (s, 2.00, major), 2.37 
- 2.42 (m, 1.18, minor), 1.97 - 2.29 (m, 4.00, major), 1.68 (s, 1.77, minor). 13C NMR (125 
MHz, CDCl3): δ 165.1 (major), 164.7 (minor), 162.4 (major), 160.9 (minor), 160.0 (2C, 
major), 159.9 (2C, minor), 131.7 (major), 131.1 (minor), 117.8 (minor), 116.3 (major), 107.3 
(2C, major), 107.2 (2C, minor), 104.0 (minor), 103.2 (minor), 102.8 (major), 101.8 (major), 
68.8 (major), 67.6 (minor), 55.5 (2C, major), 55.4 (2C, minor), 53.4 (minor), 52.4 (minor), 
51.0 (major), 39.9 (major), 36.7 (major), 31.0 (minor), 23.8 (major), 23.8 (minor). IR: 2946.5 




















(4-7v). A protocol developed by Corey was followed.7 A pre-dried round bottom flask was 
charged with anhydrous Mn(OAc)3 (1.06 g, 2.54 mmol), which was dissolved at 40 °C using 
AcOH (5.5 mL). Then, the mixture was allowed to reach room temp before the addition of 4-
methoxyhept-3-ene 4-10v (752 mg, 5.86 mmol) and β-ketoester 4-11m (283 mg, 1.54 mmol). 
The reaction mixture was stirred at room temp for 3 hrs before removing AcOH under 
reduced pressure. At this point, the crude was diluted with saturated NaHCO3, extracted with 
EtOAc (2x), dried over Na2SO4 and purified via column chromatography [5% Et2O/hexane, 
Rf = 0.31 (major diastereomer), 0.20 (minor diastereomer)] to afford 4-7v (329 mg, 69%) as a 
colorless oil. Diastereomeric mixture: 2.1:1.0. 1H NMR (500 MHz, CDCl3): δ 8.40 (dd, J = 
3.1, 1.2 Hz, 0.48, minor), 8.27 (dd, J = 3.1, 1.2 Hz, 1.00, major), 7.75 (dd, J = 5.2, 1.2 Hz, 
0.48, minor), 7.65 (dd, J = 5.2, 1.2 Hz, 1.00, major), 7.24 - 7.31 (m, 1.48, major + minor), 
3.72 (s, 4.43, major + minor), 3.42 (s, 3.00, major), 3.30 (s, 1.43, minor), 3.15 (dd, J = 7.9, 
3.7 Hz, 1.00, major), 3.10 (t, J = 5.8 Hz, 0.48, minor), 2.00 - 2.10 (m, 0.48, minor), 1.69 - 
1.93 (m, 4.96, major + minor), 1.33 - 1.58 (m, 3.44, major + minor), 0.94 - 1.02 (m, 7.43, 
major + minor), 0.90 (t, J = 7.5 Hz, 1.43, minor). 13C NMR (125 MHz, CDCl3): δ 165.8, 
165.7, 157.2, 157.2, 131.0, 130.9, 130.3, 129.8, 128.5, 128.4, 124.5, 124.3, 112.5, 112.4, 










12.7, 10.9. IR: 2982.0 (w), 1753.9 (s), 1371.4 (m), 1236.4 (s), 1045.4 (s). HRMS (EI) m/z: 




carboxylate (4-7w). The general protocol was followed using a solution of Rh2esp2 (1.6 mg, 
2.1 µmol) in CH2Cl2 (2.0 mL), 1-vinyl-2-pyrrolidinone (117 mg, 1.05 mmol), and diazo 4-9w 
(312 mg, 1.21 mmol) in CH2Cl2 (3.3 mL). The reaction was quenched and column 
chromatography (50% EtOAc/hexane, Rf = 0.18) afforded 4-7w along with 4-7w’ (72.1 mg, 
20%) as a yellow oil. Mixture of inseparable compounds: 3.4:1.0 (4-7w:4-7w’ ratio). 1H 
NMR (500 MHz, CDCl3) Only major product 4-7w reported: δ 7.55 - 7.56 (m, 2 H), 7.52 - 
7.54 (m, 1 H), 7.19 - 7.25 (m, 2 H), 6.67 (dd, J = 9.8, 4.6 Hz, 1 H), 3.69 (s, 3 H), 3.38 - 3.55 
(m, 3 H), 2.96 - 3.04 (m, 1 H), 2.44 - 2.53 (m, 2 H), 2.28 (s, 3 H), 2.06 - 2.17 (m, 2 H). 13C 
NMR (125 MHz, CDCl3): δ 175.7, 164.2, 155.7, 135.9, 130.6, 125.2, 123.5, 122.0, 119.0, 
115.7, 114.2, 85.9, 81.5, 53.2, 41.6, 32.5, 31.0, 18.0, 9.6. IR: 2953.0 (w), 1743.7 (m), 1689.6 
(s), 1450.5 (m), 1379.1 (m), 1211.2 (m). HRMS (EI) m/z: [M+] calcd. for C19H20N2O4, 






















CH2Cl2 (2.0 mL), 1-vinyl-2-pyrrolidinone (134 mg, 1.21 mmol), and diazo 4-9x (306 mg, 
1.26 mmol) in CH2Cl2 (3.6 mL). The reaction was quenched and column chromatography 
(50% EtOAc/hexane, Rf = 0.15) afforded 4-7x (271 mg, 69%) as a colorless oil. 1H NMR 
(500 MHz, CDCl3): δ 7.68 (d, J = 3.7 Hz, 1 H), 7.55 - 7.58 (m, 2 H), 7.16 - 7.25 (m, 2 H), 
6.69 (dd, J = 9.6, 5.0 Hz, 1 H), 6.63 (dd, J = 3.7, 0.8 Hz, 1 H), 3.68 (s, 3 H), 3.37 - 3.56 (m, 3 
H), 3.02 (dd, J = 15.6, 5.0 Hz, 1 H), 2.43 - 2.51 (m, 2 H), 2.04 - 2.14 (m, 2 H). 13C NMR 
(125 MHz, CDCl3): δ 175.6, 164.0, 155.5, 135.5, 129.5, 128.3, 123.4, 122.2, 121.0, 113.8, 
106.2, 87.3, 81.6, 51.1, 41.5, 32.3, 30.9, 17.9. IR: 2951.9 (w), 1740.4 (m), 1684.2 (s), 1451.2 





7z). The general protocol was followed using a solution of Rh2esp2 (2.2 mg, 2.9 µmol) in 
CH2Cl2 (2.0 mL), 1-vinyl-2-pyrrolidinone (155 mg, 1.39 mmol), and diazo 4-9z (307 mg, 
1.59 mmol) in CH2Cl2 (5.0 mL). The reaction was quenched and column chromatography 
(50% EtOAc/hexane, Rf = 0.21) afforded 4-7z (198 mg, 51%) as a light yellow solid (mp: 
125-126 °C). 1H NMR (500 MHz, CDCl3): δ 7.53 - 7.60 (m, 2 H), 6.56 (dd, J = 9.8, 4.9 Hz, 
1 H), 6.24 - 6.27 (m, 2 H), 3.72 (s, 3 H), 3.44 - 3.51 (m, 1 H), 3.33 - 3.43 (m, 2 H), 2.97 (dd, 
J = 15.6, 4.9 Hz, 1 H), 2.41 - 2.49 (m, 2 H), 2.00 - 2.12 (m, 2 H). 13C NMR (125 MHz, 








17.8. IR: 2947.6 (w), 1703.3 (s), 1624.4 (m), 1406.3 (m), 1378.5 (m), 1250.8 (m), 1121.6 
(m), 1073.15 (m). HRMS (EI) m/z: [M+] calcd. for C14H16N2O4, 276.1110; found, 276.1107. 
 
c. Reaction optimizations (tri-substituted DHF) 
Procedure for Catalyst Screening: To a flask charged with a stir bar and the appropriate 
loading of the relevant Lewis acid was added a solution of DHF 4-7a (1.0 equiv) in CH2Cl2 
(0.2 M) at room temperature. The reaction mixture was either kept at room temperature or 
refluxed. Upon complete disappearance of DHF 4-7a on TLC, the reaction was quenched 
with water. The mixture was extracted with CH2Cl2, dried with Na2SO4, and purification via 
column chromatography provided the o-phenolic ester product.  
 
Procedure for Optimization of Catalyst Loading: To a flask charged with a stir bar and 
the appropriate Al(OTf)3 loading (5-20 mol%) was added a solution of DHF 4-7a (1.0 equiv.) 
in CH2Cl2 (0.2 M) at room temperature and then the mixture was either kept at room 
temperature or heated. Upon complete disappearance of DHF 4-7a on TLC, the reaction was 
quenched with water. The mixture was extracted with CH2Cl2, dried with Na2SO4, and 
purification via column chromatography provided the o-phenolic ester product.  
 
Procedure for Solvent Screening: To a flask charged with a stir bar and 5 mol% Al(OTf)3 
was added a solution of DHF 4-7a (1.0 equiv) in the appropriate solvent (PhMe, 1,2-DCE, or 
MeCN) (0.2 M) at room temperature. The reaction mixture was heated to the indicated 
temperature and upon complete disappearance of DHF 4-7a on TLC, the reaction was 
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quenched with water. The mixture was extracted with CH2Cl2, dried with Na2SO4, and 
purification via column chromatography provided the o-phenolic ester product. 
  
Table S4-1. Full optimization data of the cascade reaction. 
 
 
d. Reaction optimizations (tetra-substituted DHF) 
A similar optimization procedure as detailed above was followed but adding a drop of water 








Lewis Acid Loading Solvent, Conc. Temp. (oC) Time (h) % Yield
In(OTf)3 5 mol % DCM, 0.2 M 23 45 5
Ga(OTf)3 5 mol % DCM, 0.2 M 23 9.5 16
Ga(OTf)3 5 mol % DCM, 0.2 M 40 1.0 22
Sc(OTf)3 5 mol % DCM, 0.2 M 23 9.5 Decomp.
Yb(OTf)3 5 mol % DCM, 0.2 M 23 20 NR
Cu(OTf)2 5 mol % DCM, 0.2 M 23 45 Decomp.
Al(OTf)3 5 mol % DCM, 0.2 M 23 45 19
Al(OTf)3 5 mol % DCM, 0.2 M 40 6.5 35
Al(OTf)3 5 mol % Toluene, 0.2 M 35 27 13
Al(OTf)3 5 mol % Toluene, 0.2 M 50 19 28
Al(OTf)3 5 mol % Toluene, 0.2 M 70 2.5 41
Al(OTf)3 10 mol % Toluene, 0.2 M 70 2.5 39
Al(OTf)3 15 mol % Toluene, 0.2 M 70 2.5 43
Al(OTf)3 20 mol % Toluene, 0.2 M 70 1.0 33
Al(OTf)3 5 mol % Toluene, 0.2 M 85 1.0 46, 42 (2nd)
Al(OTf)3 5 mol % Toluene, 0.2 M 110 1.0 40
Al(OTf)3 10 mol % Toluene, 0.2 M 85 0.67 40
Al(OTf)3 15 mol % Toluene, 0.2 M 85 0.5 37
Al(OTf)3 5 mol % Toluene, 0.1 M 85 1.0 31






Table S4-2. Full optimization data for tetra-substituted DHF 4-7m. 
 
 










Lewis Acid Loading (mol %) Solvent Temp. (oC) Time (h) Ratio 4-8m:4-4m
SnCl4 400 DCE 82 1.0 4-4m Only
In(OTf)3 5 DCE 65 4.0 1:38
In(OTf)3 5 DCM 23 4.0 1:29
Sc(OTf)3 5 DCE 65 4.0 1:21
Sc(OTf)3 10 DCM 23 3.0 1:10
Sc(OTf)3 10 DCM 0 2.0 1:9.1
Sc(OTf)3 30 DCM 23 3.0 1:9.4
Sc(OTf)3 10 CH3CN 23 2.5 1:20
Sc(OTf)3 10 C6H6 23 2.0 1:3.4
Sc(OTf)3 10 PhMe 23 2.0 1:3.5
Ga(OTf)3 10 PhMe 23 2.0 1:2.4
BF3.OEt 100 PhMe 0 4.0 4-4m Only
Hg(OTf)2 10 PhMe 23 1.0 4-4m Only
Al(OTf)3 10 PhMe 23 20 4-4m Only
Al(OTf)3, Drop H2O 5 PhMe 70 2.5 1:1.18
Al(OTf)3, Drop H2O 10 PhMe 70 2.5 1:0.26





















Lewis Acid Loading (mol %) Solvent Temp. (oC) Time (h) Ratio 4-8n:4-4n
In(OTf)3 5 DCE 82 8.0 1:1.5
Sc(OTf)3 5 DCE 82 0.25 1:0.79
Al(OTf)3, Drop H2O 20 PhMe 70 4.0 4-8n only, 69% Yield
4-7n
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e. Catalytic, ring-opening/cyclization/elimination cascade (4-8a to 4-8v and 4-
12w to 4-12z) 
General Procedure A: To a pre-dried round bottom flask charged with Al(OTf)3 (5 mol %) 
was added the corresponding 2,3-DHF 4-7 in anhydrous toluene (PhCH3, 0.2 M). The 
reaction was heated to 85 °C and monitored via TLC. Upon complete disappearance of the 
starting material, the reaction was quenched with H2O (2 mL). The mixture was extracted 
with EtOAc (2x), dried with Na2SO4, and column chromatography provided the benzo-fused 
heteroaromatic. 
 
General Procedure B: To a pre-dried round bottom flask charged with Al(OTf)3 (20 mol %) 
was added 0.5-1.0 mL of anhydrous PhCH3 and a drop of water. After stirring for 15 min at 
room temperature, the corresponding 2,3-DHF 4-7 in anhydrous PhCH3 (final concentration 
= 0.2 M). The reaction was heated to 70 °C and monitored via TLC. Upon complete 
disappearance of the starting material, the reaction was quenched with H2O (2 mL). The 
mixture was extracted with EtOAc (2x), dried with Na2SO4, and column chromatography 
provided the benzo-fused heteroaromatic. 
 
 
Ethyl 7-hydroxybenzofuran-6-carboxylate (4-8a). The general protocol A was followed 
using Al(OTf)3 (7.0 mg, 1.5*10-2 mmol) and 2,3-DHF 4-7a (74.9 mg, 2.97*10-1 mmol) in 
anhydrous PhCH3 (1.5 mL). The reaction was quenched and column chromatography (10% 






NMR (500 MHz, CDCl3): δ 11.39 (s, 1 H), 7.75 (d, J = 2.1 Hz, 1 H), 7.69 (d, J = 8.2 Hz, 1 
H), 7.07 (d, J = 8.2 Hz, 1 H), 6.77 (d, J = 2.1 Hz, 1 H), 4.43 (q, J = 7.0 Hz, 2 H), 1.43 (t, J = 
7.0 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ 170.9, 148.6, 147.8, 143.1, 134.2, 123.8, 
111.4, 108.0, 107.3, 61.4, 14.2. IR: 3140.5 (w), 3004.3 (w), 2925.5 (w), 1674.7 (m), 1487.3 
(m), 1364.5 (m), 1264.6 (m), 1066.1 (m), 730.9 (s). HRMS (EI) m/z: [M+] calcd. for 
C11H10O4, 206.0579; found, 206.0571. 
 
 
Ethyl 7-hydroxybenzo[b]thiophene-6-carboxylate (4-8b). The general protocol A was 
followed using Al(OTf)3 (9.4 mg, 2.0*10-2 mmol) and 2,3-DHF 4-7 (104 mg, 3.88*10-1 
mmol) in anhydrous PhCH3 (1.9 mL). The reaction was quenched and column 
chromatography (2% Et2O/hexane, Rf = 0.19) afforded 4-8b (62.9 mg, 61%) as a white solid 
(mp: 70-71 °C). 1H NMR (500 MHz, CDCl3): δ 11.67 (s, 1 H), 7.79 (d, J = 8.5 Hz, 1 H), 
7.63 (d, J = 5.2 Hz, 1 H), 7.27 - 7.36 (m, 3 H), 4.44 (q, J = 7.2 Hz, 2 H), 1.44 (t, J = 7.2 Hz, 3 
H). 13C NMR (125 MHz, CDCl3): δ 170.8, 157.8, 145.6, 131.0, 127.7, 125.2, 124.3, 114.6, 
106.2, 61.4, 14.2. IR: 3106.9 (w), 3043.2 (w), 2979.6 (w), 2904.2 (w), 1616.3 (s), 1474.2 (s), 
1374.6 (s), 1267.1 (s), 1154.1 (s), 1020.0 (s), 787.3 (s). HRMS (ESI) m/z: [M-H+] calcd. for 










Ethyl 4-hydroxybenzofuran-5-carboxylate (4-8c). The general protocol A was followed 
using Al(OTf)3 (8.1 mg, 1.7*10-2 mmol) and 2,3-DHF 4-7c (85.2 mg, 3.38*10-1 mmol) in 
anhydrous PhCH3 (1.7 mL). The reaction was quenched and column chromatography (2% 
Et2O/hexane, Rf = 0.20) afforded 4-8c (63.5 mg, 75%) as a white solid (mp: 55-56 °C). 1H 
NMR (500 MHz, CDCl3): δ 11.57 (s, 1 H), 7.78 (d, J = 8.9, 1 H), 7.56 (d, J = 2.4 Hz, 1 H), 
7.02 (d, J = 8.9, 1 H), 6.97 (d, J = 2.4, 1 H), 4.42 (q, J = 7.2 Hz, 2 H), 1.43 (t, J = 7.2 Hz, 3 
H). 13C NMR (125 MHz, CDCl3): δ 170.8, 159.5, 157.5, 144.2, 125.9, 117.0, 106.2, 104.7, 
103.7, 61.2, 14.2. IR: 2985.6 (w), 1663.5 (s), 1628.7 (m), 1468.6 (s), 1281.4 (s), 1178.5 (s), 




Ethyl 4-hydroxybenzo[b]thiophene-5-carboxylate (4-8d). The general protocol A was 
followed using Al(OTf)3 (14.5 mg, 3.06*10-2 mmol) and 2,3-DHF 4-7d (161 mg, 6.00*10-1 
mmol) in anhydrous PhCH3 (3.0 mL). The reaction was quenched and column 
chromatography (5% Et2O/hexane, Rf = 0.40) afforded 4-8d (108 mg, 81%) as a white solid 
(mp: 59-60 °C). 1H NMR (500 MHz, CDCl3): δ 11.69 (s, 1 H), 7.75 (d, J = 8.5 Hz, 1 H), 
7.63 (dd, J = 5.5, 0.6 Hz, 1 H), 7.36 (d, J = 5.5 Hz, 1 H), 7.34 (dd, J = 8.5, 0.6 Hz, 1 H), 4.43 
(q, J = 7.2 Hz, 2 H), 1.44 (t, J = 7.2 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ 170.9, 158.3, 










1659.2 (s), 1616.2 (m), 1431.6 (s), 1372.7 (s), 1334.2 (s), 1265.5 (s), 1155.8 (s), 751.7 (s). 
HRMS (EI) m/z: [M+] calcd. for C11H10O3S, 222.0351; found, 222.0349. 
 
 
Ethyl 4-hydroxydibenzo[b,d]furan-3-carboxylate (4-8e). The general protocol A was 
followed using Al(OTf)3 (7.2 mg, 1.5*10-2 mmol) and 2,3-DHF 4-7e (90.0 mg, 2.98*10-1 
mmol) in anhydrous PhCH3 (1.5 mL). The reaction was quenched and column 
chromatography (2% Et2O/hexane, Rf = 0.15) afforded 4-8e (63.7 mg, 83%) as a white solid 
(mp: 123-124 °C). 1H NMR (500 MHz, CDCl3): δ 11.33 - 11.41 (m, 1 H), 7.90 - 7.97 (m, 1 
H), 7.76 - 7.83 (m, 1 H), 7.65 (dd, J = 8.2, 0.6 Hz, 1 H), 7.52 (td, J = 7.8, 1.2 Hz, 1 H), 7.38 - 
7.44 (m, 1 H), 7.32 - 7.38 (m, 1 H), 4.40 - 4.50 (m, 2 H), 1.39 - 1.51 (m, 3 H). 13C NMR 
(125 MHz, CDCl3): δ 170.5, 157.2, 148.5, 143.8, 130.5, 128.5, 126.3, 123.9, 123.7, 123.1, 
121.4, 112.3, 110.6, 61.6, 14.2. IR: 3000.2 (w), 1680.4 (m), 1637.1 (m), 1374.0 (m), 1319.8 




Ethyl 1-hydroxyphenanthrene-2-carboxylate (4-8f). The general protocol A was followed 
using Al(OTf)3 (6.7 mg, 1.4*10-2 mmol) and 2,3-DHF 4-7f (82.5 mg, 2.64*10-1 mmol) in 
anhydrous PhCH3 (1.3 mL). The reaction was quenched and column chromatography (2% 









NMR (500 MHz, CDCl3): δ 11.94 (s, 1 H), 8.61 - 8.66 (m, 1 H), 8.34 (d, J = 9.5 Hz, 1 H), 
8.11 (d, J = 8.9 Hz, 1 H), 7.98 (d, J = 8.9 Hz, 1 H), 7.90 - 7.94 (m, 1 H), 7.80 (d, J = 8.9 Hz, 
1 H), 7.63 - 7.69 (m, 2 H), 4.48 (q, J = 7.2 Hz, 2 H), 1.48 (t, J = 7.2 Hz, 3 H). 13C NMR (125 
MHz, CDCl3): δ 170.8, 160.2, 135.2, 133.4, 129.5, 128.6, 127.7, 126.7, 126.5, 125.6, 123.6, 
122.4, 120.8, 113.3, 107.5, 61.5, 14.3. IR: 3061.6 (w), 3039.7 (w), 2981.9 (m), 2927.5 (w), 
2905.1 (w), 1659.9 (s), 1626.3 (m), 1466.9 (m), 1332.8 (s), 1259.2 (s), 1178.1 (s), 1073.1 




Ethyl 1-hydroxy-7-methoxy-2-naphthoate (4-8g). The general protocol A was followed 
using Al(OTf)3 (6.6 mg, 1.4*10-2 mmol) and 2,3-DHF 4-7g (76.3 mg, 2.61*10-1 mmol) in 
anhydrous PhCH3 (1.3 mL). The reaction was quenched and column chromatography (2% 
Et2O/hexane, Rf = 0.12) afforded 4-8g along with 4-8g’ (51.9 mg, 81%) as a white solid (mp: 
59-60 °C). Regioisomer mixture 8.3:1.0. 1H NMR (500 MHz, CDCl3): δ 12.04 (s, 1.00, 
major), 12.02 (s, 0.12, minor), 7.96 - 8.02 (m, 0.12, minor), 7.74 - 7.80 (m, 0.12 minor), 7.70 
(d, J = 0.6 Hz, 0.12, minor), 7.68 (d, J = 2.4 Hz, 1.00, major), 7.66 - 7.67 (m, 1.00, major), 
7.65 (d, J = 3.7 Hz, 1.00, major), 7.40 - 7.45 (m, 0.12 minor), 7.23 - 7.27 (m, 1.00, major), 
7.21 (d, J = 8.9 Hz, 1.00, major), 6.93 - 6.96 (m, 0.12, minor), 4.45 (q, J = 7.2 Hz, 2.24, 
major + minor), 3.98 (s, 0.36, minor), 3.96 (s, 3.00, major), 1.45 (t, J = 7.2 Hz, 3.36, major + 
minor). 13C NMR (125 MHz, CDCl3): δ 171.2, 171.1, 160.5, 159.7, 157.7, 155.0, 132.4, 









106.1, 101.8, 61.3, 61.3, 55.5, 55.4, 14.2, 14.2. IR: 3064.2 (w), 2980.9 (w), 2829.2 (w), 
1655.2 (s), 1608.5 (s), 1443.5 (m), 1327.9 (s), 1251.8 (s), 1223.9 (s), 1175.5 (s), 1024.8 (s), 




The general protocol A was followed using Al(OTf)3 (5.5 mg, 1.2*10-2 mmol) and 2,3-DHF 
4-7h (75.5 mg, 2.34*10-1 mmol) in anhydrous PhCH3 (1.2 mL). The reaction was quenched 
and column chromatography (5% Et2O/hexane, Rf = 0.26) afforded 4-8h (60.2 mg, 93%) as a 
white solid (mp: 121-123 °C).  
 
From 4-7i: 
The general protocol A was followed using Al(OTf)3 (5.1 mg, 1.1*10-2 mmol) and 2,3-DHF 
4-7i (77.7 mg, 2.22*10-1 mmol) in anhydrous PhCH3 (1.1 mL). The reaction was quenched 
and column chromatography afforded 4-8h (53.8 mg, 88%) as a white solid. 
 
From 4-7j: 
The general protocol A was followed using Al(OTf)3 (4.5 mg, 9.5*10-3 mmol) and 2,3-DHF 
4-7j (73.0 mg, 1.90*10-1 mmol) in anhydrous PhCH3 (1.0 mL). The reaction was quenched 








Ethyl 1-hydroxy-5,7-dimethoxy-2-naphthoate (4-8h). 1H NMR (500 MHz, CDCl3): δ 
11.97 (s, 1 H), 7.62 - 7.67 (m, 1 H), 7.57 - 7.61 (m, 1 H), 7.24 - 7.28 (m, 1 H), 6.62 (d, J = 
2.4 Hz, 1 H), 4.45 (q, J = 7.2 Hz, 2 H), 3.96 (s, 3 H), 3.95 (s, 3 H), 1.45 (t, J = 7.2 Hz, 3 H). 
13C NMR (125 MHz, CDCl3): δ 171.3, 159.3, 158.3, 156.2, 126.2, 125.0, 121.3, 112.5, 
106.9, 100.7, 93.7, 61.4, 55.7, 55.5, 14.2. IR: 3112.3 (w), 2990.8 (w), 2939.3 (w), 2832.8 
(w), 1660.7 (m), 1606.9 (s), 1442.2 (m), 1247.7 (s), 1200.5 (m), 1175.1 (s), 1026.6 (m), 




The general protocol A was followed using Al(OTf)3 (6.3 mg, 1.3*10-2 mmol) and 2,3-DHF 
4-7k (73.4 mg, 2.19*10-1 mmol) in anhydrous PhCH3 (1.2 mL) at 70 °C. The reaction was 
quenched and column chromatography (5% Et2O/hexane, Rf = 0.29) afforded 4-8k (54.4 mg, 
95%) as a white solid (mp: 157-159 °C).  
 
From 4-7l: 
The general protocol A was followed using Al(OTf)3 (5.5 mg, 1.2*10-2 mmol) and 2,3-DHF 
4-7l (74.6 mg, 2.15*10-1 mmol) in anhydrous PhCH3 (1.1 mL). The reaction was quenched 
and column chromatography afforded 4-8k (28.8 mg, 51%) as a white solid. 
 
Methyl 1-hydroxy-5,7-dimethoxy-2-naphthoate (4-8k). 1H NMR (500 MHz, CDCl3): δ 







(s, 3 H), 3.96 (s, 3 H), 3.95 (s, 3 H). 13C NMR (125 MHz, CDCl3): δ 171.6, 159.3, 158.3, 
156.3, 126.2, 125.1, 121.2, 112.7, 106.7, 100.8, 93.7, 55.7, 55.5, 52.3. IR: 3012.0 (w), 
2965.3 (w), 2923.0 (w), 1663.3 (m), 1606.0 (m), 1443.1 (m), 1407.7 (m), 1334.5 (m), 1248.0 




Methyl 4-hydroxy-7-methyl-3a,7a-dihydrobenzo[b]thiophene-5-carboxylate (4-8m). The 
general protocol B was followed using Al(OTf)3 (29.5 mg, 6.22*10-2 mmol) and 2,3-DHF 4-
7m (75.0 mg, 2.95*10-1 mmol) in anhydrous PhCH3 (1.7 mL). The reaction was quenched 
and column chromatography (5% Et2O/hexane, Rf = 0.40) afforded 4-8m (52.4 mg, 80%) as 
a white solid (mp: 90-92 °C). 1H NMR (500 MHz, CDCl3): δ 11.39 (s, 1 H), 7.64 (d, J = 5.5 
Hz, 1 H), 7.50 (s, 1 H), 7.37 (d, J = 5.5 Hz, 1 H), 3.96 (s, 3 H), 2.46 (s, 3 H). 13C NMR (125 
MHz, CDCl3): δ 171.3, 156.6, 147.5, 129.3, 125.0, 123.7, 122.4, 122.2, 106.5, 52.1, 19.4. IR: 
3103.7 (w), 3080.1 (w), 2951.8 (m), 2917.3 (m), 2856.0 (w), 1661.1 (s), 1616.3 (m), 1431.7 
(s), 1361.2 (s), 1254.3 (s), 1151.7 (s), 763.5 (s). HRMS (EI) m/z: [M+] calcd. for C11H10O3S, 
222.0351; found, 222.0352. 
 
 
Ethyl 6-ethyl-4-hydroxy-3a,7a-dihydrobenzo[b]thiophene-5-carboxylate (4-8n). The 












7n (75.0 mg, 2.53*10-1 mmol) in anhydrous PhCH3 (2.0 mL). The reaction was quenched 
and column chromatography (5% Et2O/hexane, Rf = 0.38) afforded 4-8n (43.4 mg, 69%) as a 
white solid (mp: 66-68 °C). 1H NMR (300 MHz, CDCl3): δ 12.33 (s, 1 H), 7.58 (d, J = 5.5, 1 
H), 7.27 (d, J = 5.5, 1 H), 7.22 (s, 1 H), 4.47 (q, J = 7.2 Hz, 2 H), 3.05 (q, J = 7.3 Hz, 2 H), 
1.46 (t, J = 7.2 Hz, 3 H), 1.25 (t, J = 7.3 Hz, 3 H). 13C NMR (75 MHz, CDCl3): δ 172.3, 
159.6, 145.9, 142.3, 128.5, 124.2, 121.7, 114.7, 106.1, 61.6, 30.0, 16.4, 14.0. IR: 3132.3 (w), 
3095.9 (w), 2987.4 (m), 2956.5 (m), 2870.3 (m), 1641.5 (s), 1607.1 (s), 1533.7 (s), 1372.9 
(s), 1323.3 (s), 1249.3 (s), 1164.2 (s), 1022.3 (s), 773.9 (s). HRMS (EI) m/z: [M+] calcd. for 
C13H14O3S, 250.0664; found, 250.0665. 
 
 
Ethyl 3-ethyl-1-hydroxy-5,7-dimethoxy-2-naphthoate (4-8o). The general protocol B was 
followed using Al(OTf)3 (21.5 mg, 4.53*10-2 mmol) and 2,3-DHF 4-7o (77.6 mg, 2.21*10-1 
mmol) in anhydrous PhCH3 (1.5 mL). The reaction was quenched and column 
chromatography (5% Et2O/hexane, Rf = 0.23) afforded 4-8o (59.2 mg, 88%) as a white solid 
(mp: 105-106 °C). 1H NMR (500 MHz, CDCl3): δ 12.62 (s, 1 H), 7.45 (s, 1 H), 7.23 (d, J = 
2.1 Hz, 1 H), 6.59 (d, J = 2.1 Hz, 1 H), 4.48 (q, J = 7.3 Hz, 2 H), 3.95 (s, 3 H), 3.94 (s, 3 H), 
3.06 (q, J = 7.3 Hz, 1 H), 1.46 (t, J = 7.3 Hz, 3 H), 1.26 (t, J = 7.3 Hz, 3 H). 13C NMR (125 
MHz, CDCl3): δ 172.6, 160.8, 157.6, 155.6, 138.3, 124.9, 124.0, 113.5, 106.8, 100.8, 93.8, 
61.6, 55.6, 55.4, 30.1, 16.5, 14.0. IR: 3108.1 (w), 2964.7 (m), 2937.1 (w), 2832.1 (w), 1640.1 
(s), 1578.9 (s), 1416.5 (s), 1326.1 (s), 1243.9 (s), 1199.9 (s), 1148.4 (s), 1030.0 (s), 823.5 (s). 










Methyl 1-hydroxy-5,7-dimethoxy-3-phenyl-2-naphthoate (4-8p). The general protocol B 
was followed using Al(OTf)3 (24.9 mg, 5.25*10-2 mmol) and 2,3-DHF 4-7p (85.0 mg, 
2.29*10-1 mmol) in anhydrous PhCH3 (1.5 mL). The reaction was quenched and column 
chromatography (5% Et2O/hexane, Rf = 0.20) afforded 4-8p (67.1 mg, 79%) as a light yellow 
solid (mp: 144-145 °C). 1H NMR (500 MHz, CDCl3): δ 11.95 (s, 1 H), 7.54 (d, J = 0.6 Hz, 1 
H), 7.35 - 7.40 (m, 2 H), 7.30 - 7.34 (m, 3 H), 7.29 (d, J = 1.8 Hz, 1 H), 6.63 (d, J = 2.4 Hz, 1 
H), 3.97 (s, 3 H), 3.93 (s, 3 H), 3.53 (s, 3 H). 13C NMR (125 MHz, CDCl3): δ 172.4, 159.5, 
158.4, 156.3, 143.7, 136.2, 128.4 (2C), 127.4 (2C), 126.3, 125.4, 123.4, 115.6, 106.8, 101.1, 
93.8, 55.6, 55.5, 51.7. IR: 3030.2 (w), 2955.2 (w), 1653.1 (s), 1595.0 (s), 1437.6 (s), 1327.9 
(s), 1244.5 (s), 1202.1 (s), 1050.3 (m), 1011.2 (m), 768.9 (s). HRMS (EI) m/z: [M+] calcd. 
for C20H18O5, 338.1154; found, 338.1141. 
 
 
Methyl 1-hydroxy-5,7-dimethoxy-4-methyl-2-naphthoate (4-8q). The general protocol B 
was followed using Al(OTf)3 (24.2 mg, 5.10*10-2 mmol) and 2,3-DHF 4-7q (78.2 mg, 
2.54*10-1 mmol) in anhydrous PhCH3 (1.5 mL). The reaction was quenched and column 
chromatography (5% Et2O/hexane, Rf = 0.23) afforded 4-8q (60.1 mg, 86%) as a white solid 
(mp: 139-140 °C). 1H NMR (500 MHz, CDCl3): δ 11.64 (s, 1 H), 7.29 - 7.35 (m, 2 H), 6.61 













MHz, CDCl3): δ 171.4, 158.9, 157.8, 157.5, 127.6, 125.5, 124.4, 122.9, 105.8, 101.6, 94.5, 
55.4, 55.4, 52.2, 24.4. IR: 3113.6 (w), 3002.5 (w), 2954.0 (m), 2859.8 (w), 1662.6 (s), 
1609.2 (s), 1509.5 (m), 1439.0 (s), 1383.9 (m), 1245.3 (s), 1204.1 (s), 1171.1 (s), 1150.0 (s), 




Methyl 1-hydroxy-3-(3-hydroxypropyl)-5,7-dimethoxy-2-naphthoate (4-8r). The general 
protocol A was followed using Al(OTf)3 (7.9 mg, 1.7*10-2 mmol) and 2,3-DHF 4-7r (55.0 
mg, 1.72*10-1 mmol) in anhydrous PhCH3 (1.0 mL). The reaction was quenched and column 
chromatography (50% Et2O/hexane, Rf = 0.12) afforded 4-8r (46.5 mg, 85%) as a light 
yellow solid (mp: 108-109 °C). 1H NMR (500 MHz, CDCl3): δ 12.49 (s, 1 H), 7.45 (s, 1 H), 
7.23 (s, 1 H), 6.58 - 6.62 (m, 1 H), 4.01 (s, 3 H), 3.95 (s, 3 H), 3.94 (s, 3 H), 3.70 (t, J = 6.1 
Hz, 2 H), 3.05 - 3.14 (m, 2 H), 1.83 - 1.93 (m, 2 H), 1.27 - 1.41 (m, 1 H). 13C NMR (125 
MHz, CDCl3): δ 172.9, 161.0, 157.9, 155.7, 135.5, 125.1, 123.9, 114.5, 106.7, 101.0, 93.9, 
62.8, 55.7, 55.5, 52.2, 34.9, 33.4. IR: 3010.5 (w), 2957.3 (w), 1652.4 (m), 1600.9 (s), 1437.1 
(m), 1332.7 (m), 1250.4 (s), 1205.1 (s), 1047.6 (m), 806.9 (m). HRMS (EI) m/z: [M+] calcd. 
















10-Hydroxy-6,8-dimethoxy-3,4-dihydro-1H-benzo[g]isochromen-1-one (4-8s). The 
general protocol A was followed using Al(OTf)3 (6.6 mg, 1.4*10-2 mmol) and 2,3-DHF 4-7s 
(73.5 mg, 2.40*10-1 mmol) in anhydrous PhCH3 (1.2 mL). The reaction was quenched and 
column chromatography (20% Et2O/hexane, Rf = 0.20) afforded 4-8s (59.3 mg, 90%) as a 
yellow solid (mp: 149-150 °C). 1H NMR (500 MHz, CDCl3): δ 12.13 (s, 1 H), 7.41 (d, J = 
0.9 Hz, 1 H), 7.22 (d, J = 2.1 Hz, 1 H), 6.64 (d, J = 2.1 Hz, 1 H), 4.54 - 4.65 (m, 2 H), 3.96 
(s, 3 H), 3.94 (s, 3 H), 3.12 - 3.17 (m, 2 H). 13C NMR (125 MHz, CDCl3): δ 170.9, 160.4, 
158.1, 155.9, 129.8, 125.2, 124.9, 110.1, 103.3, 101.6, 93.9, 68.7, 55.7, 55.6, 28.0. IR: 
2949.1 (m), 2836.6 (w), 1659.0 (s), 1608.3 (s), 1401.1 (s), 1201.7 (s), 1161.4 (s). HRMS (EI) 




(4-8t). The general protocol A was followed using Al(OTf)3 (5.0 mg, 1.1*10-2 mmol) and 
2,3-DHF 4-7t (74.0 mg, 1.83*10-1 mmol) in anhydrous PhCH3 (1.2 mL). The reaction was 
quenched and column chromatography (20% Et2O/hexane, Rf = 0.11) afforded 4-8t (12.8 mg, 
17%) as a white solid (mp: 132-133 °C) along with unreacted DHF 4-7t (26.0 mg, 35% 
recovered). 1H NMR (500 MHz, CDCl3): δ 12.55 (s, 1 H), 7.42 (s, 1 H), 7.23 (d, J = 2.1 Hz, 
1 H), 6.60 (d, J = 2.1 Hz, 1 H), 4.49 - 4.61 (bs, 1 H), 4.02 (s, 3 H), 3.94 (s, 3 H), 3.93 (s, 3 
H), 3.39 (t, J = 6.9 Hz, 2 H), 3.19 (t, J = 6.9 Hz, 2 H), 1.38 - 1.47 (s, 9 H). 13C NMR (125 
MHz, CDCl3): δ 172.7, 161.2, 158.1, 155.9, 155.7, 132.1, 125.4, 123.8, 115.5, 106.6, 101.1, 








1600.1 (m), 1492.2 (m), 1436.8 (m), 1332.5 (m), 1246.6 (s), 1205.0 (s), 1165.9 (s), 1051.1 




8u). The general protocol B was followed using Al(OTf)3 (25.5 mg, 5.38*10-2 mmol) and a 
mixture of 2,3-DHF 4-7u and 4-7u’ (84.0 mg, 2.62*10-1 mmol) in anhydrous PhCH3 (1.5 
mL). The reaction was quenched and column chromatography (5% Et2O/hexane, Rf = 0.20) 
afforded 4-8u (34.3 mg, 47%) as a white solid (mp: 139-140 °C). 1H NMR (500 MHz, 
CDCl3): δ 11.75 (s, 1 H), 7.44 (d, J = 2.7 Hz, 1 H), 7.34 (s, 1 H), 6.87 (d, J = 2.7 Hz, 1 H), 
4.26 (t, J = 7.2 Hz, 2 H), 3.98 (s, 3 H), 3.92 (s, 3 H), 3.15 (dd, J = 6.9, 6.0 Hz, 2 H), 2.17 - 
2.26 (m, 2 H). 13C NMR (125 MHz, CDCl3): δ 171.4, 160.2, 158.4, 157.9, 128.3, 127.8, 
127.0, 120.6, 111.6, 105.4, 98.3, 73.1, 55.5, 52.2, 31.5, 29.5. IR: 3003.5 (w), 2949.1 (m), 
2852.0 (w), 1661.3 (s), 1610.5 (s), 1409.7 (s), 1251.2 (s), 1162.4 (s), 1060.3 (s), 800.5 (s). 
HRMS (EI) m/z: [M+] calcd. for C16H16O5, 288.0998; found, 288.0994. 
 
 
Methyl 4-ethyl-5-propyl-2-(thiophen-3-yl)furan-3-carboxylate (4-4v). The general 
protocol B was followed using Al(OTf)3 (33.5 mg, 7.06*10-2 mmol) and 2,3-DFH 4-7v (106 
mg, 3.41*10-1 mmol) in anhydrous PhCH3 (1.2 mL). The reaction was quenched and column 














oil. 1H NMR (300 MHz, CDCl3): δ 8.02 - 8.11 (m, 1 H), 7.56 - 7.63 (m, 1 H), 7.30 (dd, J = 
5.1, 3.1 Hz, 1 H), 3.85 (s, 3 H), 2.51 - 2.65 (m, 4 H), 1.59 - 1.75 (m, 2 H), 1.12 (t, J = 7.5 Hz, 
3 H), 0.96 (t, J = 7.3 Hz, 3 H). 13C NMR (75 MHz, CDCl3): δ 165.1, 151.9, 150.5, 131.4, 
127.3, 124.9, 124.7, 122.4, 112.6, 51.2, 27.6, 21.9, 17.7, 15.6, 13.7. IR: 2962.7 (m), 2872.0 
(w), 1737.9 (s), 1712.8 (s), 1437.0 (m), 1371.4 (m), 1238.3 (s), 1089.8 (m). HRMS (EI) m/z: 




7-carboxylate (4-12w). The general protocol A was followed using 4 Å molecular sieves (1-
2 mm beads, 0.6-0.8 g), Al(OTf)3 (18.2 mg, 3.84*10-2 mmol) and a mixture of 2,3-DHF 4-7w 
and side product 4-7w’ (65.0 mg, 1.91*10-1 mmol) in anhydrous PhCH3 (1.2 mL) at 50 °C. 
The reaction was quenched and column chromatography (50% EtOAc/hexane, Rf = 0.07) 
afforded 4-12w (49.9 mg, 77%) as a yellow oil. Diastereomeric mixture: 1.2:1 (trans:cis 
ratio) 1H NMR (500 MHz, CDCl3): δ 8.41 - 8.46 (m, 1.85, major + minor), 7.49 (dd, J = 7.5, 
0.6 Hz, 1.00, major), 7.45 - 7.48 (m, 0.85, minor), 7.30 - 7.40 (m, 3.70, major + minor), 5.71 
(td, J = 5.4, 4.4 Hz, 0.86, minor), 5.67 (t, J = 5.0 Hz, 1.00, major), 3.89 (t, J = 7.8 Hz, 1.00, 
major), 3.82 - 3.86 (m, 3.40, minor), 3.82 (s, 3.00, major), 3.26 - 3.34 (m, 0.85, minor), 3.12 - 
3.25 (m, 1.85, major + minor), 3.08 (ddd, J = 9.5, 8.2, 6.1 Hz, 1.00, major), 2.71 - 2.81 (m, 
0.85, minor), 2.57 - 2.63 (m, 2.00, major), 2.43 - 2.53 (m, 3.70, major + minor), 2.30 (dt, J = 
13.0, 5.1 Hz, 0.85, minor), 2.16 (d, J = 0.6 Hz, 3.00, major), 2.13 (d, J = 1.2 Hz, 2.55, 










169.0, 168.9, 164.3, 164.1, 134.7, 134.6, 130.9, 130.5, 128.9, 128.7, 125.8, 125.6, 124.5, 
124.4, 118.6, 118.3, 117.0, 116.7, 116.5, 116.0, 53.0, 52.8, 48.9, 48.2, 45.5, 44.5, 43.2, 42.7, 
30.9, 30.9, 29.7, 28.4, 18.3, 17.9, 8.3, 8.1. IR: 3059.5 (w), 2952.4 (m), 2910.2 (m), 1741.0 
(s), 1683.9 (s), 1457.3 (m), 1385.0 (m), 1267.3 (m), 752.7 (m). HRMS (EI) m/z: [M+] calcd. 




carboxylate (4-12x). The general protocol A was followed using 4 Å molecular sieves (1-2 
mm beads, 0.6-0.8 g), Al(OTf)3 (6.0 mg, 1.3*10-2 mmol) and 2,3-DHF 4-7x (51.7 mg, 
1.58*10-1 mmol) in anhydrous PhCH3 (1.0 mL). The reaction was quenched and column 
chromatography (60% EtOAc/hexane, Rf = 0.10) afforded 4-12x (31.2 mg, 60%) as a 
colorless oil. Diastereomeric mixture: 1.6:1 (trans:cis ratio). 1H NMR (500 MHz, CDCl3): δ 
8.43 - 8.47 (m, 0.61, minor), 8.37 - 8.42 (m, 1.00, major), 7.45 - 7.50 (m, 1.61, major + 
minor), 7.26 - 7.36 (m, 3.20, major + minor), 6.32 - 6.36 (m, 0.61, minor), 6.26 - 6.30 (m, 
1.00, major), 5.66 - 5.73 (m, 1.61, major + minor), 3.92 - 3.98 (m, 1.61, major + minor), 3.87 
(s, 3.00, major), 3.80 (s, 1.83, minor), 3.47 (m, 1.00, major), 3.25 - 3.39 (m, 2.22), 2.64 (q, J 
= 13.0 Hz, 1.00, major), 2.48 - 2.60 (m, 4.44, major + minor), 2.27 (dt, J = 12.4, 4.6 Hz, 1.00, 
major), 2.06 - 2.17 (m, 3.22, major + minor). 13C NMR (125 MHz, CDCl3): δ 175.5, 175.3, 
168.7, 168.6, 164.4, 163.7, 135.3, 135.2, 134.8, 134.7, 129.2, 129.2, 125.1, 125.1, 124.6, 
124.6, 120.4, 120.3, 116.5, 116.4, 106.9, 106.1, 53.2, 52.9, 49.8, 49.1, 45.3, 43.8, 43.4, 42.5, 










(m), 1454.3 (m), 1351.1 (m), 1283.3 (m), 1164.7 (m), 755.6 (m). HRMS (EI) m/z: [M+] 




carboxylate (4-12y). The general protocol A was followed using Al(OTf)3 (12.0 mg, 
2.53*10-2 mmol) and 2,3-DHF 4-7y (100 mg, 3.34*10-1 mmol) in anhydrous PhCH3 (1.7 
mL). The reaction was quenched and column chromatography (20% EtOAc/hexane, Rf = 





12z). The general protocol A was followed using 4 Å molecular sieves (1-2 mm beads, 0.6-
0.8 g), Al(OTf)3 (12.5 mg, 2.64*10-2 mmol) and 2,3-DHF 4-7z (70.3 mg, 2.54*10-1 mmol) in 
anhydrous PhCH3 (1.3 mL). The reaction was quenched and column chromatography (70% 
EtOAc/hexane, Rf = 0.12) afforded 4-12z (37.7 mg, 54%) as a colorless oil. Diastereomeric 
mixture: 1.7:1 (trans:cis ratio) 1H NMR (500 MHz, CDCl3): δ 7.38 (dd, J = 3.4, 0.9 Hz, 0.60, 
minor), 7.35 (dd, J = 1.8, 1.2 Hz, 1.00, major), 6.24 - 6.31 (m, 1.60, major + minor), 6.00 (dt, 
J = 3.1, 1.5 Hz, 0.60, minor), 5.93 (dt, J = 3.1, 1.6 Hz, 1.00, major), 5.45 - 5.60 (m, 1.60, 
















7.6, 5.6 Hz, 1.00, major), 3.22 - 3.30 (m, 1.60, major + minor), 3.16 - 3.22 (m, 0.60, minor), 
2.39 - 2.51 (m, 5.40, major + minor), 2.22 (dt, J = 12.5, 4.7 Hz, 1.0, major), 1.99 - 2.12 (m, 
3.20, major + minor). 13C NMR (125 MHz, CDCl3): δ 175.5, 175.3, 168.5, 168.3, 163.5, 
163.0, 129.9, 129.7, 117.8, 117.6, 113.5, 113.5, 111.1, 111.2, 53.2, 52.8, 49.0, 48.1, 45.0, 
43.7, 43.4, 42.5, 31.1, 31.0, 29.6, 29.4, 18.3, 18.2. IR: 2956.5 (m), 1715.5 (s), 1677.0 (s), 
1406.9 (s), 1271.8 (s), 1138.1 (m), 735.7 (m). HRMS (EI) m/z: [M+] calcd. for C14H16N2O4, 
276.1110; found, 276.1103. 
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CHAPTER 5 
A TANDEM, BICATALYTIC CONTINUOUS FLOW CYCLOPROPANATION-
HOMO-NAZAROV-TYPE CYLIZATION 
 
The work about to be presented is adapted from a previous publication. For a better 
understanding on the topic, access the corresponding reference.22 The experimental section 
includes all the data for cyclopropanes 5-5 and their corresponding cycloisomerized products 
5-6 obtained by the three first authors. My contribution on this project includes: batch 
reaction optimizations for 5-5a (cyclopropanation), 5-6a (cyclization), 5-6a (tandem 
protocol), and 5-6d (cyclization); as well as the purification of the continuous flow reactions. 
Shenje, R. was responsible for the batch optimization of 5-5b (cyclopropanation), 5-5c 
(cyclopropanation), 5-6c (cyclization), and 5-6c (tandem protocol); as well as the purification 
of the continuous flow reactions. Huang, Y.; Woodham, W. H.; and Saunders, S. R were 
responsible of building and operating the continuous flow reactor. 
 
5.1 Introduction 
Historically, batch processing has been the major strategy in the synthesis of complex 
molecules, especially molecules of pharmaceutical interest. In general, this approach has 
been fraught with high cost, excessive time for scale-up, and waste issues.1 In order to 
address these issues, continuous flow technology has been identified as an alternative 
production vehicle since it has both environmental and economic advantages. For instance, 
the transfer from batch to continuous flow maximizes performance in terms of product yield 
and selectivity while minimizing solvent and catalyst needs, thereby lowering production 
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costs.2-4 When compared with the traditional batch technology, continuous flow offers a 
reduced manual handling, higher control of the reaction variables, increased safety, the 
possibility of in-line purification, between many other advantages highlighted in several 
reports.1b,5 However, the large majority of reaction processes are still run in batch with a slow 
gradual change to continuous flow technology. 
Multistep continuous flow processes can provide a potential tool to the 
pharmaceutical companies for accessing complex molecules.1b To this end, many synthetic 
reports have made use of this technology, proving particular advantages of each protocol.6-7 
Recently, Ley and co-workers reported a seven-step continuous flow synthesis of 
oxamaritidine, requiring only one solvent change. No purification was employed in order to 
obtain the complex natural product in excellent yield (>40%) and in over 90% purity.8 In 
contrast, the combination of five separate flow steps reported by Martinelli required multiple 
solvent changes and in-flow purification techniques to obtain (+)-dumetorine in ~30% yield. 
However, this yield was much higher than the ~1% overall yield utilizing batch processes.9 
Despite the many advantages obtained by utilizing multistep flow technologies, there 
are still some challenges that need to be overcome depending on the type of reaction(s). 
Some of these include, but are not limited to, solvent compatibility, in-flow purification, and 
concentration management at each step of the synthetic procedure.10 Nevertheless, the 
integration of chemical engineering and chemical reaction design has helped with some of 
these issues. This can be observed in the multistep one-flow syntheses (no solvent change) of 
grossamide11 and tamoxifen12 reported by Ley. Similarly, Snead and Jamison disclosed a 3 
min continuous flow synthesis and purification of ibuprofen with a throughput of ~8 g per 
hour.13 
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Previously, our lab reported the batch synthesis of hydropyrido[1,2-a]indoles 5-6 
from N-indolyl 1,1-cyclopropane β-amidoesters 5-514 via In(OTf)3-catalyzed, homo-
Nazarov-type15-17 cyclizations (21 examples). The cyclopropanes required for this 
transformation were prepared in three steps from the corresponding 1H-indoles 5-1 via 
acylation, diazo transfer, then Rh(II)-catalyzed cyclopropanation (Figure 5-1a), with 
purifications performed for each step. We later utilized this general sequence in the six-step 
synthesis of the indole alkaloid deethyleburnamonine (Figure 5-1b). Inspired by these 
reports, we decided to take advantage of continuous flow technology to conduct the multistep 
synthesis (four steps) of the hydropyrido[1,2-a]indole framework, which is present in many 
naturally occurring indole alkaloids and pharmaceutically relevant compound.18-21 The use of 
continuous flow would be beneficial in dealing with the generation and use of reactive Rh-
carbenoid species in a controlled and reproducible fashion while alleviating any large-scale 
safety concerns. Herein, we report the development of a two-step flow synthesis of 





Figure 5-1. (a) Development of a four-step continuous flow synthesis of hydropyrido[1,2-a]indoles and (b) 
application toward deethyleburnamonine. 
 
5.2 Reactor Design 
5.2.1 Single-step reactor 
A simple plug flow reactor was developed to conduct the individual ring-opening 
cyclizations and cyclopropanations (Figure 5-2a). The reactor featured a straightforward 
design with three principal components: (i) reagent/catalyst addition module consisting of 
reagent and catalyst reservoirs and two Eldex series 2000 ReciPro reciprocating pumps; (ii) a 
reactor module comprised of a 1/16” tee-joint where the solutions initially mix and proceed 
into the reactor coil (1/4” stainless steel tubing, Figure 5-2b) extending for a final reaction 
volume of 29.5 mL; and (iii) product collection module containing a reaction quenching 
agent. The system pressure and temperature were measured prior to entering the main body 







































































Eutech Instruments Digi-Sense temperature controller and the effluent temperature was 
measured before emptying into a collection flask for analysis.  The reagent/catalyst 
concentrations and flow rates were chosen to directly mimic conditions and reaction times of 
batch reactions. Samples were taken at residence time intervals (~every 15 min) to establish 






Figure 5-2. Schematic (a) and picture (b) of single plug-flow reactor apparatus. 
 
5.2.2 Tandem reactor 
To accomplish the two-step tandem reaction, the plug-flow reactor was re-designed to 
accommodate multiple solution inlets, proper mixing and the need for two reactor coils 
(Figure 5-3). The new, tandem reactor apparatus consisted of two Teledyne Isco syringe 
pumps that feed solutions of diazoester 3 (pump 1) and a mixture of rhodium(II) catalyst, 
alkene 4 and internal standard p-xylene (pump 2) to the 30 mL single reactor 1 as described 
above.  The effluent of this reactor is then mixed with an In(OTf)3 feed stream (pump 3) by 
passing through a 6 mL mixing bed packed with 2 mm borosilicate glass beads.  The mixed 
stream is then fed into a 30 mL reactor (316 stainless steel, 0.25” OD x 0.035” wall 
thickness, 3.5” diameter).  Heating of the system to 50 ˚C was accomplished via heating tape 
a) b) 
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wound about the reactor coil and controlled with a Digisense temperature controller. Samples 





Figure 5-3. Schematic (a) and picture (b) of tandem flow reactor apparatus 
 
5.3 Results and Discussion 
5.3.1 Batch reaction optimization: Cyclopropane ring-opening cyclization 
Inspired by the literature procedure reported by France and coworkers,14 
cyclopropane 5-5a was chosen as the model system for the batch optimization studies based 
on its efficient conversion to hydropyrido[1,2-a]indole 5-6a in >99% yield in 
dichloromethane in the presence of 30 mol% In(OTf)3 in under 2 h. Batch reaction 
optimizations (Table 5-1), in terms of solvent and catalyst loading, were conducted in order 
to find a lower catalyst loading and a pharmaceutically- and/or industrially-suitable solvent. 
Given that the original reaction was complete with 15 min, we were determined to maintain 
that time marker in the transfer from batch to flow. Thus, in all experiments, the reactions 
that were the deemed most successful, were the ones that gave complete conversion 
within a 15 min timeframe. This context is central to understanding the decisions made 
throughout the optimization studies. 
a) b) 
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Table 5-1. Batch optimization of the ring-opening cyclization of cyclopropane 5-5a. 
 
 
Solvents such as acetonitrile (CH3CN), toluene (PhCH3), acetone, and ethyl acetate 
(EtOAc) gave conversions comparable to those observed in dichloromethane (CH2Cl2, DCM, 
Table 5-1, entries 1, 4-7). Solvents containing an ether moiety, such as tetrahydrofuran 
(THF) or methyl tert-butyl ether (MTBE), were excluded from further studies due to long 
reaction times even when high catalyst loadings were used (Table 5-1, entries 2 and 3). 
Alcohols, such as methanol and isopropanol, were also excluded because no reaction was 
observed in these solvents within a 24 h time frame. This lack of reactivity could be 
attributed to the insolubility of both the In(OTf)3 and cyclopropane 5-5a as well as a potential 
interaction between the solvent and Lewis acid. Based upon these results, an effort was made 
to optimize reaction temperature and catalyst loadings in CH3CN. At room temperature in 
CH3CN, the catalyst loading could be readily reduced to 5 mol% to give full conversion 
within 15 min (Table 5-1, entry 10). At 1 mol% loading, full conversion was not achieved 
Entry Solvent Loading (mol%) Temp. (oC) Time % Conversiona
1 CH2Cl2 30 20 < 15 min >99
2 THF 30 20 12 hrs >99
3 MTBE 30 20 9 hrs >99
4 PhCH3 30 20 < 15 min >99
5 PhCH3 5 20 18 hrs ~95
6 Acetone 30 20 30 min >99
7 EtOAc 30 20 30 min >99
8 EtOAc 10 77 30 min >99
9 CH3CN 30 20 < 15 min >99
10 CH3CN 5 20 15 min >99 (96)b,c











a) Determined by 1H NMR; b) Number in parentheses represents isolated yield after chromatography; 




within the 15 min window. Heating the reaction with 1 mol% catalyst at 82 ˚C failed to give 
full conversion within 15 min (Table 5-1, entry 11). Thus, for 5-5a, the optimized batch 
conditions selected for technology transfer to continuous flow were 5 mol% In(OTf)3 in 
CH3CN (0.1 M) at room temperature for ~15 min. 
With a working substrate in hand, we were interested in exploring the generality of 
the optimized conditions for other cyclopropane substrates that would ultimately be 
amenable to flow conditions. Cyclopropanes 5-5b to 5-5d were prepared and examined for 
compatibility (Figure 5-4). Cyclopropane 5-5b contains different functionality on the indole 
moiety at the 3-position as compared to 5-5a (methyl acetate vs methyl). 5-5c (derived from 
alpha-methyl styrene) contains two geminal donor groups on the cyclopropane. The product 
from this substrate would contain a quaternary center. Finally, 5-5d replaces the 4-methoxy 
phenyl group with a 2-furyl moiety. 
 
 
Figure 5-4. Expanding scope of optimized reaction. 
 
According to previous work carried out by the France lab, cyclopropane 5-5b cyclizes in the 
presence of 30 mol% In(OTf)3 in DCM to give 5-6b in a 88% yield after 3 h.14 In order to 
make this transformation pharmaceutically attractive and amenable to flow, we explored the 
use of the CH3CN as solvent for the reaction (Table 5-2). Gratifyingly, the same optimized 


















temperature, a 90% yield of hydropyrido[1,2-a]indole 5-6b was obtained (Table 5-2, entry 
2). 
 
Table 5-2. Batch optimization of the ring-opening cyclization of cyclopropane 5-5b. 
 
 
Cyclopropane 5-5c has been previously shown to provide its product 5-6c in 94% yield after 
in 2 h when using 30 mol% In(OTf)3 in DCM. To make 5-5c amenable to flow, we looked to 
optimize the formation of hydropyrido[1,2-a]indole 5-6c in CH3CN (Table 5-3). At a 
cyclopropane concentration of 0.2 M and a catalyst loading of 5 mol%, the reaction was slow 
and failed to reach >50% conversion even after 3 h in CH3CN (Table 5-3, entry 1). Increases 
in both reaction concentration and catalyst loading led to increased yields, with the highest 
yield (63%) obtained at a concentration of 5-6c of 1.0 M with a catalyst loading of 15 mol% 
after 20 min (Table 5-3, entry 6). We anticipated that an increase in temperature could help 
the overall reactivity. Given that, 15 mol% loading of In(OTf)3 gave a good yield at room 
temp, we heated 5-5c at 50 ˚C with the same loading but at a concentration of 0.1 M. We 
were pleased to find that product 5-6c was obtained in quantitative yield after 15 min (Table 
5-3, entry 8). 
 
Entry Conc. (M) Loading (mol%) Time (min) % Yielda,b
1 0.5 1 15 71
2 0.1 5 15 90
3 0.5 5 5 85













a) Isolated yield after chromatography; b) Diastereoselectivities (as determined 
by 1H NMR) 1.9:1 trans:cis dr.
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Table 5-3. Batch optimization of the ring-opening cyclization of cyclopropane 5-5c. 
 
 
Finally, the optimization of cyclopropane 5-5d required minimal effort as 5-5d 
readily gave 5-6d in 80% isolated yield in 10-15 min using the same conditions (5 mol% 
In(OTf)3, CH3CN (0.1 M)), that worked for 5-5a and 5-5b (Scheme 5-1). With four 









Entry Conc. (M) Loading (mol%) Temp. (oC) Time % Yielda,b
1 0.2 5 23 > 2 hrs not isolated
2 0.2 10 23 15 min 24
3 0.2 10 23 20 min 32
4 0.2 15 23 20 min 46
5 0.5 15 23 20 min 42
6 1.0 15 23 20 min 63
7 0.1 30 23 20 min 44












a) Isolated yield after chromatography; b) Diastereoselectivities (as determined by 1H NMR) 
range from 1.1-1.3:1 trans:cis dr.
N
O O
OMe In(OTf)3 (5 mol%)
CH3CN (0.1 M)











5.3.2 Continuous flow results: Cyclopropane ring-opening cyclization 
A simple plug flow reactor was used to conduct homo-Nazarov cyclizations at batch-
optimized conditions. The results of a number of continuous homo-Nazarov cyclization 
experiments are shown below in Figure 5-5. The first continuous flow reaction was 
performed with cyclopropane 5-5a at ambient temperatures (~18 °C) and reached full 
conversion to 5-6a (i.e., no starting material was detected by HPLC nor by 1H NMR) after 
one residence time (~15 minutes). Two or three additional samples were collected from the 
reactor at residence times two (30 min), three (45 min), and four (60 min). Initial 
concentrations of cyclopropane 5-6a and In(OTf)3 upon mixing were 0.1 M and 0.005 M, 
respectively. The lactam 5-6a was isolated and was found to have yields of 82%, 99%, 99% 
and 99% at residence times one, two, three and four, respectively. 
Cyclopropanes 5-5b and 5-5d similarly transferred well to the continuous flow 
reactor at room temperature and achieved near-quantitative yield within two residence times 
(Figure 5-5). 5-5b provided its product 5-6b in 66%, 96%, 96%, and 95% yields at residence 
times one, two, three and four, respectively. 76%, 98%, 93% and 91% yields were obtained 
for hydropyrido[1,2-a]indole 5-6d at the respective four residence times. For the methyl-
phenyl cyclopropane 5-5c we were pleased to find near-quantitative yields (65%, 93%, and 




Figure 5-5. Continuous flow ring-opening cyclizations. 
 
5.3.3 Batch reaction optimization: Cyclopropanation 
With a working homo-Nazarov cyclization (Figure 5-1, Step 4), we next decided to 
work on the batch optimization of the cyclopropanation reaction (Figure 5-1, Step 3). The 
cyclopropanation reaction to form 5-5a was optimized for batch operation prior to the 
transfer to continuous operation. 
In anticipation of the development of a multistep synthesis in flow, we focused our 
studies on obtaining a final reaction concentration of 0.2 M, which directly matches with the 
0.2 M cyclopropane solution that was employed for the optimized continuous flow homo-
Nazarov cyclizations, in order to obtain a final concentration of 0.1 M on the cyclization step. 
The results are as summarized in Table 5-4. At loadings of 1.0 mol% Rh2esp2, the reaction in 
acetonitrile at 23 °C requires more than 2 hours to achieve completion, yielding compound 5-
5a in 82% (Table 5-4, entry 1). An increase in the reaction rate was observed when the 
reaction was heated to 50 °C and the reaction reached completion in 15 min.  The product 5-
5a was observed in 73% yield (Table 5-4, entry 3). Raising the diazo 5-3a from 1.1 to 1.5 


















0.1 M CH3CN, RT
Batch: 99% yield
15 min: 82% yield
30 min: 99% yield
45 min: 99% yield
60 min: 99% yield
5 mol% In(OTf)3
0.1 M CH3CN, RT
Batch: 99% yield
15 min: 66% yield
30 min: 96% yield
45 min: 96% yield
60 min: 95% yield
15 mol% In(OTf)3
0.1 M CH3CN, 50 oC
Batch: 99% yield
15 min: 65% yield
30 min: 93% yield
45 min: 93% yield
5 mol% In(OTf)3
0.1 M CH3CN, RT
Batch: 80% yield
15 min: 76% yield
30 min: 98% yield
45 min: 93% yield
60 min: 91% yield
5-6a 5-6b 5-6c 5-6d
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optimized batch conditions selected for technology transfer to continuous flow were 1 mol% 
Rh2esp2 in CH3CN (0.2 M) at 50 °C for ~15 min. 
 
Table 5-4. Batch optimization for cyclopropane 5-5a. 
 
 
Using the same cyclopropanation conditions from cyclopropane 5-5a, cyclopropane 
5-5c was obtained in 73% yield (Scheme 5-2). With two optimized substrates in hand, we 
next focused our efforts on the transfer from batch to continuous flow. 
 
 
Scheme 5-2. Formation of cyclopropane 5-5c from diazo 5-3a in batch. 
 
5.3.4 Continuous flow results: Cyclopropanation 
The results of the cyclopropanation experiments are shown below in Figure 5-6. The 
formation of cyclopropane 5-5a at 50 °C reached full conversion after one residence time 
(~30 minutes, the flow was decreased by half). Two more samples were collected from the 
Entry 3a (equiv.) Temp. (oC) Time (min) % Yielda,b
1 1.1 23 > 120 82
2 1.1 82 5 77
3 1.1 50 15 73










CH3CN (0.2 M), temp.
C6H4-4-OMe5-3a (5-4)
5-5a
a) Isolated yield after chromatography; b) Diastereoselectivities (as 
















reactor at residence times two (60 min), and three (90 min). The cyclopropane 5-5a was 
isolated and was found to have yields of 83%, 83%, and 78% at residence times one, two, 
and three, respectively. For cyclopropane 5-5c, it was found to have yields of 54%, 57%, and 
59% at residence times one, two, and three, respectively. 
 
 
Figure 5-6. Rh2esp2-catalyzed cyclopropanation in flow 
 
5.3.5 Tandem Cyclopropanation/Cyclization Sequence 
Having the optimized conditions for the cyclopropanation and cyclization reactions to 
afford compounds 5-6a and 5-6 c, both in batch and continuous flow, we then moved to try 
the tandem cyclopropanation/cyclization sequence. A new coil attachment and pump were 
added to the continuous flow reactor (see Section 5.2.2) in order to introduce a solution of 
indium triflate, in a tandem manner, once the cyclopropanation reaction has been completed. 
 After studying the cyclopropanation and cyclization steps separately, the conditions 
for the sequenced cyclopropanation/cyclization for compounds 5-6a and 5-6c were found 
without complications (Figure 5-7). In batch, compounds 5-6a and 5-6c were obtained in 
88% and 91% yield, respectively. When the tandem cyclopropanation/cyclization sequence 
to obtain compound 5-6a was translated from batch to continuous flow, hydropyrido[1,2-










0.2 M CH3CN, 50 oC
Batch: 89% yield
36 min: 83% yield
60 min: 83% yield
90 min: 78% yield
1 mol% Rh2(esp)2
0.2 M CH3CN, 50 oC
Batch: 73% yield
30 min: 54% yield
60 min: 57% yield
90 min: 59% yield
5-5a 5-5c
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of 96%, 86%, >99%, >99%, and >99% at residence times one, two, three, four and five, 
respectively. Compound 5-6c was found to have yields of 96%, 86%, >99%, >99%, and 
>99% at residence times one, two, three, four and five, respectively. 
 
 
Figure 5-7. Tandem, bicatalytic cyclopropanation-ring-opening cyclization in flow. 
 
5.4 Development of a Strategy that Enables an Efficient One-Pot Tandem 
Cyclopropanation/Cyclization Reaction via Cooperative Catalysis: 
Based on the overwhelming successes of the batch optimization studies for the 
cyclopropanation and homo-Nazarov cyclization steps, we envisioned the development of a 
one pot, tandem reaction that would take advantage of cooperative catalysis. In sequential 
cooperative catalysis,23 two catalysts, both present at the onset of the reaction, work in unison 
along a cascade pathway to generate a desired product (Figure 5-8). One catalyst promotes 
the formation of an intermediate and the second catalyst promotes the reaction of the 










CH3CN (0.2 M), 50 oC, 15 min;
then 5 mol% In(OTf)3, 0.1 M













CH3CN (0.2 M), 50 oC, 20 min;
then 15 mol% In(OTf)3, 0.1 M






50 min: 96% yield
60 min: 96% yield
70 min: >99% yield
80 min: >99% yield








50 min: 66% yield
60 min: 58% yield
70 min: 65% yield
80 min: 56% yield
90 min: 56% yield
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Figure 5-8. Sequential cooperative catalysis. 
 
 The France group has previously reported an example of such a reaction for the 
heteroaromatic homo-Nazarov cyclization.24 However, only one or two examples provided 
results superior to the tandem or step-wise processes. This type of catalysis has not been 
applied to the N-acyl cyclopropane systems for homo-Nazarov reactions. We sought to 
explore the possibility for this reactivity based on the extensive optimization data that was 
generated (Table 5-5). The first conditions that were examined utilized CH3CN as the 
solvent. With an eye ultimately on flow, we sought reactions that could be completed within 
a short time frame (<30 min). When diazo ester 5-3a (1.1 equiv) in a solution of CH3CN was 
added to a solution of 4-methoxystyrene (1.0 equiv), Rh2esp2 (1.0 mol%) and In(OTf)3 (5 
mol%), the reaction provided very low conversion to the desired products within 2-3 h (Table 
5-5, entry 1). Various byproducts were observed for the reaction. We assume these 
byproducts are a combination of degradation/unwanted reaction of the carbenoid species and 
polymerization of the alkene. Adding credence to this hypothesis, when the reaction was 
heated to 50 ˚C, only degradation products were observed. Regardless of whether the 
stoichiometries of the various components were changed, only low conversion (<30%) of 





Table 5-5. Sequential cooperative catalysis study for formation of 5-6a. 
 
 
In contrast to CH3CN, when toluene was employed as the solvent, some interesting results 
were obtained. When the 0.1 mol% Rh2esp2 and 5.0 mol% In(OTf)3 was employed in toluene 
at a concentration of 0.2 M, hydropyrido[1,2-a]indole 5-6a was obtained in 28% yield (Table 
5-5, entry 2, ~52% yield/step). Changes to the loadings of rhodium or indium failed to 
provide any tangible amounts of product (Table 5-5, entries 3 to 5). Interestingly, when the 
concentration was changed to 0.1 M while keeping the rhodium and indium loadings the 
same [0.1 mol% Rh2esp2, 5.0 mol% In(OTf)3], the desired product 5-6a was obtained in 75% 
yield (Table 5-5, entry 6, ~87% yield/step). When the reaction was repeated a second time, a 
71% yield of 5-6a was obtained, thus confirming the validity and consistency of the protocol. 
Thus, we have laid the groundwork for the development of one-pot cyclopropanation/homo-
Nazarov cyclizations of alpha-diazoesters via sequential cooperative catalysis. Although this 
result is highly encouraging in batch, there is a major limitation to the transfer to flow. For 
the optimized reaction conditions, In(OTf)3 is not fully solubilized in toluene at the 0.1 M 















(mol%) Solvent Conc. (M) Time % Yield
1 1.0 5.0 CH3CN 0.2 2-3 h Trace
2 0.1 5.0 PhCH3 0.2 15-20 min 28
3 0.2 5.0 PhCH3 0.2 15-20 min trace
4 0.1 10.0 PhCH3 0.2 10-15 min trace
5 0.1 2.5 PhCH3 0.2 1 h trace





of most pumps to handle heterogeneous solutions. This is something that will be addressed 
by examining other more soluble In complexes or other soluble Lewis acid catalysts. 
 
5.5 Conclusion 
In conclusion, we have successfully developed a tandem, bicatalytic continuous flow 
cyclopropanation-homo-Nazarov-type ring-opening cyclization for the synthesis of 
hydropyrido[1,2-a]indoles. The continuous flow sequence employs CH3CN as the unifying 
and industrially-viable solvent and provides high conversions and reaction throughputs on 
the order of 4-7 g h-1 without the need for intermediate purification steps. Reaction times and 
conversions appear tuneable by modifying the temperature, changing reaction concentration, 
or by employing different reactor coils lengths/sizes. The tandem reaction also represents a 
significant synthetic improvement over our previously published two-pot batch protocol. 
Upon performing the corresponding batch optimization, this process could also be applied to 
all the diazo chemistry developed in the France Lab. 
Also, the development of a one-pot cyclopropanation/homo-Nazarov cyclizations of 
alpha-diazoesters via sequential cooperative catalysis is also under investigation, with 
preliminary results of 75% yield for compound 5-6a. 
 
5.6 Experimental 
5.6.1 General methods 
Chromatographic purification was performed as flash chromatography with Dynamic 
Adsorbents silica gel (32-65 µm) or preparative thin-layer chromatography (prep-TLC) using 
silica gel F254 (1000 µm) plates and solvents indicated as eluent with 0.1-0.5 bar pressure. For 
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quantitative flash chromatography, technical grades solvents were utilized. Analytical thin-
layer chromatography (TLC) was performed on EMD silica gel 60 F254 TLC glass plates. 
Visualization was accomplished with UV light. Proton and carbon nuclear magnetic 
resonance spectra (1H NMR and 13C NMR) were recorded on a Varian Mercury Vx 300 MHz 
spectrometer, or Bruker 400 MHz and 500 MHz spectrometers with solvent resonances as the 
internal standard (1H NMR: CDCl3 at 7.26 ppm; 13C NMR: CDCl3 at 77.0 ppm). A Shimadzu 
GC2010 gas chromatograph fitted with a Supelco PTA5 (30m x 0.32 mm x 1.00 µm, 
length x inside diameter x film thickness) capillary column was used to analyze the products 
of the tandem reactions in flow. All compounds synthesized matched our previously reported 
characterization data.14  
 
5.6.2 Experimental procedures 
a. Batch optimization for ring-opening cyclizations 
General Cyclization Procedure: An oven-dried round bottom flask was charged with 
In(OTf)3 (0.5 to 30 mol%) and the indicated solvent (2.0-2.5 mL). Once the mixture was 
heated to the indicated temperature, a solution of the cyclopropane 5-5 (1.0 equiv.) in the 
indicated solvent (2.3-2.5 mL) was added in one shot, keeping the reaction mixture at the 
indicated temperature. The reaction was monitored by thin layer chromatography (TLC) 
every 15 minutes until the starting material could no longer be detected. The reaction was 
then quenched with 1.0 mL of water and the 1H NMR of an aliquot was acquired to 
determine the conversion. The product was extracted from the aqueous phase with CH2Cl2. 
The combined organic layers were washed with brine and dried over Na2SO4. The organic 
layers were concentrated for silica gel flash column chromatography. 
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Table S5-1. Complete solvent screen for conversion of 5-5a to 5-6a. 
  
 
Table S5-2. Cyclization of 5-5b. 
 
In(OTf)3 (mol%)a Solvent Temp. (oC) Time % Conversionb
30 CH2Cl2 23 < 15 min >99
30 THF 23 12 hrs >99
30 MTBE 23 9 hrs >99
30 MeOH 23 24 hrs --c
30 iPrOH 23 24 hrs --c
30 PhCH3 23 <15 min >99
30 (CH3)2CO 23 30 min >99
30 EtOAc 23 15-30 min >99
10 EtOAc 23 12 hrs 90
10 EtOAc 77 20-30 min >99
5 EtOAc 23 24 hrs <10
5 EtOAc 77 30-40 min 95
30 CH3CN 23 <15 min >99
10 CH3CN 23 <15 min >99
5 CH3CN 23 15 min >99 (96)d,e
1 CH3CN 23 20-30 min 95
1 CH3CN 82 15 min 95




OMe In(OTf)3 (X mol%)





a) Reactions were run with cyclopropane 5-5a (0.3 mmol scale, 1 equiv.) and In(OTf)3 (X mol %) 
in the indicated solvent (0.1 M) at room temperature; b) Determined by 1H NMR; c) No reaction 
observed after 24 h. d) Number in parentheses represents isolated yield after chromatography; 
e) Diastereoselectivities (as determined by 1H NMR) range from 1.9-2.3:1 trans:cis dr.
In(OTf)3 (mol%)a Conc. (M) Timeb % Yieldc,d
5 0.5 5 min 85
5 0.1 10 min 90




OMe In(OTf)3 (X mol%)




a) Reactions were run with cyclopropane 5-5b (0.3-0.75 mmol scale, 1 equiv.) 
and In(OTf)3 (X mol %) in CH3CN (X M) at rt; b) Time to reach completion as 
determined by TLC; c) Isolated yield after column chromatography; d) 









Scheme S5-1. Cyclization of 5-5d. 
 
b. Continuous flow cyclopropane homo-Nazarov-type ring-opening cyclizations 
General Procedure: The ring-opening cyclizations were performed as follows: a 0.2 M 
solution of cyclopropane in acetonitrile was mixed with a 0.01 M solution of In(OTf)3 in 
CH3CN. Each reciprocating pump was set to 0.984 mL/min in order to yield a total flow rate 
1.968 mL/min and a residence time of 15 minutes. The resulting reaction stream composition 
was 0.1 M in cyclopropane and 0.005 M In(OTf)3. The composition and flow rates were 
chosen to directly mimic conditions and reaction time of batch reactions. A sample of the 
In(OTf)3 (mol%)a Conc. (M) Temp. (oC) Timeb % Yieldc
5 0.1 23 24 h --d
10 0.1 23 15 min 24
10 0.2 23 20 min 32
10 0.5 23 20 min 42
15 0.2 23 20 min 42
30 0.1 23 24 h --d (44)e,f
15 0.1 23 24 h 94 (34)e,f
15 0.1 50 10 min >99f




OMe In(OTf)3 (X mol%)




a) Reactions were run with cyclopropane 5-5c (0.3-0.75 mmol scale, 1 equiv.) and In(OTf)3 (X mol 
%) in CH3CN (X M) at the indicated temperature; b) Time to reach completion as determined by 
TLC; c) Isolated yield after column chromatography; d) Reaction products not isolated; e) Yield in 
parentheses represent isolated yields after quenching the reaction after 15 min; f) 






OMe In(OTf)3 (5 mol%)
CH3CN (0.1 M)











reactor effluent was collected for one minute into 1 mL of water (to quench further reaction) 
at every 15 min to establish equilibrium composition and yield. Samples were extracted with 
dichloromethane, washed with water and evaporated to dryness with a rotary evaporator. 
Conversions were determined by 1H NMR analysis and yields were calculated by weighing 
solid residue for each residence time sample. 
 
c. Batch optimization for cyclopropanations 
General Procedure: An oven-dried round bottom flask was charged with Rh2esp2 (0.1-1.0 
mol %), the indicated solvent (2.0-2.5 mL) and the corresponding alkene (1.0-1.5 equiv.). 
Once the reaction mixture was heated to the indicated temperature, a solution of the alpha-
diazo ester 5-3 (1.0-1.5 equiv.) in the indicated solvent (2.3-2.5 mL) was added in one shot, 
keeping the reaction mixture at the indicated temperature (the diazo solution was preheated 
for the reactions ran at elevated temperatures). The reaction was monitored via TLC and after 
complete consumption of the diazo compound, the reaction was quenched with saturated 
aqueous thiourea and allowed to stir for 30 minutes. Reactions ran in toluene were extracted 
with EtOAc (2x). The organic layer was washed with brine, dried with Na2SO4, concentrated, 
and column chromatography afforded the desired cyclopropane. For reactions ran in CH3CN, 
the solvent was removed, then the reaction mixture was extracted and purified following the 







Table S5-4. Formation of cyclopropane 5-5a. 
 
 





3a:4a Ratio Rh2(esp)2 (mol%) Solvent Temp. (oC) Timea,b % Yieldc,d
1.1:1 1.0 Toluene 23 < 5 min 86
1.1:1 0.1 Toluene 23 20 min 87
1.1:1 0.5 CH3CN 23 48 hrs --e
1.1:1 1.0 CH3CN 23 48 hrs 82
1.1:1 1.0 CH3CN 82 <10 min 77
1.1:1 0.1 CH3CN 82 15-20 min --e
1.1:1 1.0 CH3CN 50 15 min 73
1.3:1 1.0 CH3CN 50 15 min 83
1.5:1 1.0 CH3CN 50 15 min 89
1:1.1 1.0 CH3CN 50 15 min 74
1:1.3 1.0 CH3CN 50 15 min 77










Solvent (0.2 M), temp.
C6H4-4-OMe5-3a 5-5a(5-4a)
a) Reactions were run with diazo 5-3a (X equiv.), alkene 5-4a (X equiv.) and Rh2esp2 (X mol %) in 
CH3CN (0.2 M) at the indicated temperature; b) Time to reach completion as determined by TLC; c) 
Isolated yield after column chromatography; d) Diastereoselectivities (as determined by 1H NMR) 
ranged from 10.0-12.0:1 dr; e) Reaction products not isolated.
3a:4c Ratio Rh2(esp)2 (mol%) Timea,b % Yieldc,d
1.1:1 1.0 15 min 59
1.1:1 1.0 20 min 70








CH3CN (0.2 M), 50 oC
Ph
5-3a 5-5c5-4c
a) Reactions were run with diazo 5-3a (X equiv.), alkene 5-4c (X equiv.) 
and Rh2esp2 (X mol %) in CH3CN (0.2 M) at 50 oC; b) Time to reach 
completion as determined by TLC; c) Isolated yield after column 
chromatography; d) Diastereoselectivities (as determined by 1H NMR) 





d. Continuous flow cyclopropanations 
General Procedure: Using the single step plug flow reactor in Figure 5-2, the 
cyclopropanation reaction was conducted as follows: a 0.6 M solution of diazoester 2 in 
CH3CN (pump 1) was reacted with a solution of 0.004 M Rh2(esp)2 and 0.4 M styrene 
substrate in CH3CN (pump 2). The pumps were set to deliver a volumetric flow rate of 0.49 
mL/min each.  This provided a reaction mixture that was 0.3 M diazoester, 0.2 M styrene and 
1 mol% Rh2esp2. In order to quench the catalyst and prevent further reaction upon exiting the 
reactor, the effluent was quenched into saturated thiourea water solution. Every 30 minutes, a 
sample of the effluent was collected for 2-3 min, and its weight was recorded and used to 
calculate the amount of desired cyclopropane product according to equations (1) and (2). 
 




!!! = !!×!!×!!/(!!×!! + !!×!!)!!!!!!!!!!!!!!!!!!(2)!
 
Where miso. is the isolated cyclopropane product for each sample, mt2 is the partial 
weight of each sample fed by pump 2, m2 is the total weight of solution in pump 2, mstyr. is 
the total weight of styrene in pump 2, Mcycl. is the molecular weight of cyclopropane, Mstyr. is 
the molecular weight of styrene, !!and !! are the densities of solution in pump 1 and pump 
2, !!is and !! are the volumetric flow rates of pump 1 and pump 2, !! is the weight of each 
sample. 
 Due to production of N2 during the cyclopropanation reaction, the effluent volumetric 
flow rate at exit became irregular. To incorporate this irregularity, the flow rate was halved to 
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increase residence time from 15 to 30 min. Thus, sampling residence times were changed to 
36 min, 60 min and 90 min. 
 
e. Batch optimization for tandem cyclopropanation/ring-opening cyclizations 
General Procedure: The general cyclopropanation procedure was followed for the first step 
of the reaction. Once the diazo compound was consumed (monitored via TLC), a solution of 
In(OTf)3 (in 4.5-5 mL of the indicated solvent) was added, keeping the reaction mixture at 
the indicated temperature (the In(OTf)3 solution was preheated for the reactions ran at 
elevated temperatures). The reaction was monitored via TLC and after complete consumption 
of the cyclopropane compound, the reaction was quenched with saturated aqueous thiourea 
and allowed to stir for 30 minutes. Reactions ran in toluene were extracted with EtOAc (2x). 
The organic layer was washed with brine, dried with Na2SO4, concentrated, and column 
chromatography afforded the desired cyclopropane. For reactions ran in CH3CN, the solvent 
was removed, then the reaction mixture was extracted and purified following the same 











Table S5-6. Tandem reaction to form hydropyrido[1,2-a]indole 5-6a. 
 
 
Table S5-7. Tandem reaction to form hydropyrido[1,2-a]indole 5-6c. 
 
 
f. Tandem, bicatalytic continuous flow cyclopropanation-ring-opening 
cyclizations 
General Procedure: Using the tandem reactor apparatus in Figure 5-3, the tandem, bicatalytic  
reaction was conducted as follows: a 0.6 M solution of diazoester 2 in CH3CN (pump 1) was 














1.1:1 Toluene 0.5 23 5 23 5 min/20 hrs 64
1.1:1 CH3CN 1.0 82 5 23 5 min/1 h 48
1.1:1 CH3CN 0.5 82 5 23 5 min/1 h 43
1.1:1 CH3CN 0.5 50 5 50 40 min/10 min 65
1.5:1 CH3CN 1.0 50 5 50 20 min/10 min 88

















a) Reactions were run with diazo 5-3a, alkene 5-4a, and indicated amounts of Rh2esp2 and In(OTf)3 in CH3CN (0.1 M) 
at the indicated temperatures; b) t1 represents time until observed consumption of diazo 5-3a by TLC, prior to addition 











1.5:1 1.0 5 20 min/20 min 33

















a) Reactions were run with diazo 5-3a, alkene 5-4c, and indicated amounts of 
Rh2esp2 and In(OTf)3 in CH3CN (0.1 M) at the indicated temperatures; b) t1 
represents time until observed consumption of diazo 5-3a by TLC, prior to 
addition of In(OTf)3; t2 represents the time to reach completion following addition 




p-xylene (pump 2) in reactor 1. p-Xylene was used in tandem reactions as internal standard to 
keep track of the amount of styrene, and therefore to quantify the product yields. Due to 
production of N2 in the cyclopropanation reaction in reactor 1, the effluent of this reactor 
with irregular volumetric flow rate is then mixed with a feed stream (pump 3) of In(OTf)3 
(0.005 or 0.015 M) by passing through a 6 mL mixing bed packed with 2 mm borosilicate 
glass beads. The mixed stream is then fed into reactor 2.  Heating was provided via heat tape 
wound about the reactor coils and controlled with Digisense temperature controllers. Water 
was used to quench the In(OTf)3 catalyst and prevent further reaction upon exiting the reactor 
2. At the end of the first residence time (50 min), the mixture effluent was collected for 2 to 3 
minutes (5 to 6 ml) into 4 mL of water every 10 minutes. The organic phase in the sample 
was extracted with 5 ml dichloromethane for three times and then diluted to 25 ml. The 
concentration of p-xylene in the 25 ml solution was determined by gas 
chromatography/flame ionization detector (GC-FID). 
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